University of Kentucky

UKnowledge
Theses and Dissertations--Neuroscience

Neuroscience

2021

EXAMINING HUMAN APOE GENOTYPE AND SEX AS
MODULATORS OF RESPIRATORY PLASTICITY IN THE PRESENCE
AND ABSENCE OF SPINAL CORD INJURY
Lydia Ella Strattan
University of Kentucky, leha249@uky.edu
Author ORCID Identifier:

https://orcid.org/0000-0002-2559-9422

Digital Object Identifier: https://doi.org/10.13023/etd.2021.097

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Strattan, Lydia Ella, "EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF RESPIRATORY
PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL CORD INJURY" (2021). Theses and
Dissertations--Neuroscience. 25.
https://uknowledge.uky.edu/neurobio_etds/25

This Doctoral Dissertation is brought to you for free and open access by the Neuroscience at UKnowledge. It has
been accepted for inclusion in Theses and Dissertations--Neuroscience by an authorized administrator of
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

STUDENT AGREEMENT:
I represent that my thesis or dissertation and abstract are my original work. Proper attribution
has been given to all outside sources. I understand that I am solely responsible for obtaining
any needed copyright permissions. I have obtained needed written permission statement(s)
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing
electronic distribution (if such use is not permitted by the fair use doctrine) which will be
submitted to UKnowledge as Additional File.
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and
royalty-free license to archive and make accessible my work in whole or in part in all forms of
media, now or hereafter known. I agree that the document mentioned above may be made
available immediately for worldwide access unless an embargo applies.
I retain all other ownership rights to the copyright of my work. I also retain the right to use in
future works (such as articles or books) all or part of my work. I understand that I am free to
register the copyright to my work.
REVIEW, APPROVAL AND ACCEPTANCE
The document mentioned above has been reviewed and accepted by the student’s advisor, on
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of
the program; we verify that this is the final, approved version of the student’s thesis including all
changes required by the advisory committee. The undersigned agree to abide by the statements
above.
Lydia Ella Strattan, Student
Dr. Warren J. Alilain, Major Professor
Dr. Luke Bradley, Director of Graduate Studies

EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF
RESPIRATORY PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL
CORD INJURY

______________________________________
DISSERTATION
_______________________________________
A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy in the
College of Medicine at the University of Kentucky

By
Lydia Ella Strattan
Lexington, Kentucky
Co- Directors: Dr. Warren J. Alilain, Associate Professor of Neuroscience
and

Dr. Edward D. Hall, Professor of Neuroscience
Lexington, Kentucky
2021

Copyright © Lydia Ella Strattan 2021
https://orcid.org/0000-0002-2559-9422

ABSTRACT OF DISSERTATION

EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF
RESPIRATORY PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL
CORD INJURY
There are over 17,000 new spinal cord injuries (SCIs) every year in the Unites
States alone. Almost 60% of these injuries occur at the cervical level, potentially leading
to loss of function in a variety of sensory and motor systems including upper and lower
limbs, respiratory, and autonomics. In addition to the physical and emotional costs,
individuals who experience these higher level injuries also face a massive financial
burden, incurring over $1 million in expenses during the first year after injury in addition
to substantial yearly costs for the rest of their lifetime. A myriad of therapeutic
approaches targeting plasticity of spinal circuits have shown efficacy for improving
functional recovery in preclinical animal models. However, translation of these strategies
has proved less successful, leaving the SCI population with few effective therapeutic
options to improve functional outcomes and alleviate the financial toll of their injury. We
hypothesized that factors that are present in the human population, but difficult to model
in preclinical studies, such as genetic diversity and sex differences, could determine how
individuals respond to treatment strategies. Therefore, we investigated how sex and the
human alleles of the APOE gene (2, 3, and 4), which encode unique isoforms of the
lipid carrier apolipoprotein E (apoE), modulate a well-described form of spinally
mediated respiratory motor plasticity that is sufficient to restore breathing function after
cervical SCI.
To test whether E4, the isoform of apoE associated with deficits in synaptic
plasticity in the brain, also impairs spinally mediated plasticity, we exposed rats to
episodic serotonin (5-HT) dosing after they had been treated intrathecally with human
apoE3 or E4. IH induces long term facilitation (LTF) of respiratory motor function,
which is characterized as a prolonged augmentation of breathing in spinally intact rats.
LTF also rescues breathing function in the paralyzed hemidiaphragm following unilateral
cervical SCI. Although rats treated with E3 and E4 did not show significant differences in
their respiratory response to episodic 5-HT as assessed through diaphragmatic EMG
recordings, animals treated with E4 did demonstrate a downregulation of synaptic
NMDA receptors. Interestingly, this effect was only present in animals that had received

a cervical SCI. Due to the necessity of NMDA receptor signaling in synaptic
strengthening and the induction of LTF, this indicates that human apoE4 may prevent
therapeutic strategies from inducing spinal plasticity to mediate functional recovery after
SCI.
To increase the clinical relevance of these studies and investigate how sex
interacts with APOE genotype to modulate respiratory motor plasticity, we also evaluated
LTF in male and female targeted replacement APOE mice that express the human alleles
under the murine promotor. LTF was induced through exposure to therapeutic
intermittent hypoxia (IH), which is currently in clinical trials for various functional
outcomes in SCI subjects. There were significant effects of both genotype and sex on the
respiratory response to IH. Although 4 was inhibitory to plasticity in males, it was 3
that proved detrimental in females in the absence of injury. In contrast, injured males
showed no significant difference between genotypes while injured 4 females
experienced a decline in breathing activity compared to those expressing 3.
Together, these results support the hypothesis that sex and genetic background
may determine individuals’ propensity towards or against plasticity and functional
recovery after SCI. By contributing to our understanding of translational barriers for SCI
therapeutics, this investigation will inform the development of personalized medicine to
overcome these obstacles.
KEYWORDS: Spinal cord injury, Plasticity, Breathing, Genetics, Apolipoprotein E

Lydia Ella Strattan
03/23/2021

EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF
RESPIRATORY PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL
CORD INJURY

By
Lydia Ella Strattan

Warren J. Alilain
Co-Director of Dissertation
Edward D. Hall
Co-Director of Dissertation
Luke H. Bradley
Director of Graduate Studies
03/23/2021

DEDICATION

Dedicated to Ethan, Philip IV, Leah, Hannah, Rachael, and Philip V
for your love, support, encouragement, and good humor.

ACKNOWLEDGMENTS
While this dissertation is an individual work, its completion would not have been
possible without guidance, insight, support, and hard work of an incredible network of
kind and intelligent people. Primary among them is my advisor, Dr. Warren Alilain. I will
forever be grateful that you offered me a place in your lab and then took the time to
personally train me on techniques, teach me about the field, and guide me in how to think
and ask questions like a scientist. Thank you for the opportunities that you gave me to
travel and present my research and for encouraging me to interact with people who
challenged my thinking. Because of you, I am a better scientist, a more confident public
speaker, and a more competitive person in everything from presenting posters to cooking.
Next, I wish to thank all of the other members of the Alilain Lab. You have each been
instrumental in the completion of these projects. More importantly, you have been a great
source of conversation, laughter, support, and friendship over the past four years.
I would also like to thank Dr. Lance Johnson and his lab, who provided continual
support through both resources and insight that substantially improved my work. To you
and the rest of my Dissertation Committee, Dr. Ed Hall, Dr. Pat Sullivan, and Dr. Donna
Wilcock, thank you for always keeping your doors open to me, for answering my
questions, and for challenging me to approach problems in different ways. Your input has
been invaluable and your kindness exemplifies the best attributes of the scientific
community.
In addition to assistance from this scientific community, I have received endless
support from my friends and family. Caroline, Aaron, and Kelsey, you are the kind of
friends that have become family and I deeply appreciate each of you. Thank you for
listening to me talk about science even if you wished I wouldn’t. The FaceTime calls,
Netflix binges, trivia nights, and bonfires with you have kept me grounded when
experiments weren’t working or I felt overwhelmed with school.
To my family, words cannot express how much I love and appreciate you. Thank
you for your unwavering support and encouragement. Mom, thank you for showing me
what a female scientist looks like and for being the kind of woman that I will always
aspire to be. Dad, thank you for always being there when I need help with anything and
for always being ready with board games and other fun things to do when I come home.
Vitally, thank you both for shining God’s light in my life. Hannah, Rachael, and Philip,
you’re the best siblings and my best friends. Thank you for recharging me and giving me
mental breaks from being an adult. Growing up with you all gave me a love for reading
and learning, made me better at working in a team, and taught me how to argue and
defend my position. It turns out you were training me to earn a doctorate.
Most importantly, I want to thank my husband, Ethan. You were the best part of
grad school. Thank you for your scientific assistance in data analysis, all things involving
computers, and the provision of food during long days in the lab. You have encouraged
me, supported me, distracted me, and brought balance to my life. Thank you for calming
me down or pumping me up, depending on what the occasion requires. Thank you for
catching me every time I fall (literally). I am so thankful that God placed you and the rest
of the Strattans in my life as a welcoming and loving second family . To further
adventures…

iii

TABLE OF CONTENTS

ACKNOWLEDGMENTS ................................................................................................. iii
LIST OF TABLES ........................................................................................................... viii
LIST OF FIGURES ........................................................................................................... ix
LIST OF ADDITIONAL FILES ........................................................................................ x
CHAPTER 1. INTRODUCTION ....................................................................................... 1
1.1

Spinal cord injury ................................................................................................. 1

1.1.1

SCI Pathology ............................................................................................... 2

1.1.2

Assessment of Injury Severity ...................................................................... 5

1.1.3

Supportive Care After Injury ........................................................................ 7

1.1.4

Clinical trials for SCI interventions ............................................................ 10

1.1.5

Experimental approaches for preserving and restoring function after SCI. 13

1.2

Breathing Before and After Trauma................................................................... 18

1.2.1

Neural Control of Breathing ....................................................................... 19

1.2.2
Respiratory Deficits after SCI and Approaches for Restoring Breathing
Function.…………………………………………………………………………………....21
1.2.3

Respiratory Motor Plasticity ....................................................................... 22

1.2.4

Long Term Facilitation of Breathing after SCI........................................... 26

1.3

Genetic influences on neural plasticity .............................................................. 27

1.3.1

Brain-derived neurotrophic factor............................................................... 28

1.3.2

Tropomyosin receptor kinase B .................................................................. 29

1.3.3

Neurotrophin receptor p75 .......................................................................... 30

1.3.4

Apolipoprotein E ......................................................................................... 31

1.3.5

Sex as a biological variable in SCI research ............................................... 34

CHAPTER 2. HUMAN APOE AS A BARRIER TO RESPIRATORY MOTOR
PLASTICITY IN RATS.................................................................................................... 37
2.1

Introduction ........................................................................................................ 37

2.2

Materials and methods ....................................................................................... 39

2.2.1

C2 Hemisections ......................................................................................... 39

2.2.2

Chronic Spinal Cord Exposures and Episodic Serotonin Dosing ............... 40

2.2.3

Diaphragmatic EMG trace analysis ............................................................ 42

2.2.4

Labeling of phrenic motor neurons ............................................................. 42

2.2.5

Sectioning and Immunohistochemistry....................................................... 42
iv

2.2.6

Imaging and Colocalization Analysis ......................................................... 43

2.2.7

Quantitative PCR ........................................................................................ 44

2.2.8

BDNF Quantification .................................................................................. 44

2.2.9

Statistical Analysis ...................................................................................... 45

2.3

Results ................................................................................................................ 45

2.3.1

Respiratory motor plasticity in the presence of human APOE isoforms .... 45

2.3.2

The influence of apoE isoforms on synaptic glutamate receptor levels ..... 46

2.3.3

ApoE isoform-dependent modulation of spinal plasticity after SCI ........... 47

2.3.4

Synaptic glutamate receptor expression on phrenic motor neurons after SCI
……………………………………………………………………………………48

2.3.5

Influence of apoE isoforms on 5-HT-dependent BDNF production .......... 49

2.4

Discussion .......................................................................................................... 50

2.4.1

Human apoE isoforms and plasticity in the neural control of breathing .... 50

2.4.2

The influence of human apoE on plasticity in the injured cord .................. 53

2.4.3

Synaptic glutamate receptor levels on PMN after exposure to human apoE
……………………………………………………………………………………54

2.4.4

BDNF synthesis in response to episodic 5-HT ........................................... 56

CHAPTER 3. NOVEL INFLUENCES OF SEX AND APOE GENOTYPE ON SPINAL
PLASTICITY AND RECOVERY OF FUNCTION ......................................................... 65
3.1

Introduction ........................................................................................................ 65

3.2

Methods .............................................................................................................. 67

3.2.1

C2 Hemisections ......................................................................................... 67

3.2.2

Intermittent Hypoxia and Diaphragmatic Electromyography (EMG) ........ 68

3.2.3

Sectioning and Staining .............................................................................. 69

3.2.4

Trace Analysis ............................................................................................ 70

3.2.5

Imaging and image quantification .............................................................. 70

3.2.6

Experimental Design and Statistical Analyses ........................................... 71

3.3

Results ................................................................................................................ 72

3.3.1

Respiratory motor plasticity in C2 hemisected humanized APOE mice .... 72

3.3.2

Sex differences in apoE modulation of LTF ............................................... 74

3.3.3
Perineuronal net upregulation and serotonergic sprouting in the phrenic
motor nucleus ............................................................................................................ 76
3.4

Discussion .......................................................................................................... 77

3.4.1

APOE genotype and respiratory motor plasticity ....................................... 78

3.4.2

Sex effects ................................................................................................... 80
v

3.4.3
The inhibitory PNN and serotonergic presence after C2Hx in targeted
replacement mice ....................................................................................................... 82
CHAPTER 4. INTERACTIONS OF SEX AND APOE GENOTYPE IN THE
MODULATION OF RESPIRATORY MOTOR PLASTICITY ...................................... 90
4.1

Introduction ........................................................................................................ 90

4.2

Methods .............................................................................................................. 92

4.2.1

Animals ....................................................................................................... 92

4.2.2

Intermittent Hypoxia and Diaphragmatic Electromyography (EMG) ........ 93

4.2.3

Hypoxic ventilatory response assessment ................................................... 94

4.2.4

Sectioning and Staining .............................................................................. 94

4.2.5

Trace Analysis ............................................................................................ 95

4.2.6

Imaging and image quantification .............................................................. 95

4.2.7

ELISA ......................................................................................................... 96

4.2.8

Experimental Design and Statistical Analyses ........................................... 97

4.3

Results ................................................................................................................ 98

4.3.1

ApoE isoforms and respiratory motor plasticity ......................................... 98

4.3.2
Sex effects on respiratory motor plasticity in APOE targeted replacement
mice………………………………………………………………………………………..99
4.3.3

The presence of the perineuronal net and respiratory motor plasticity ..... 100

4.3.4
Presence of molecules necessary for the induction of LTF in mice
expressing human APOE ......................................................................................... 101
4.4

Discussion ........................................................................................................ 102

4.4.1

Respiratory motor plasticity in APOE targeted replacement mice ........... 102

4.4.2

Sex differences in the influence of APOE on respiratory motor plasticity 104

4.4.3

APOE-dependent density of the PNN and the neural control of breathing
…………………………………………………………………………………..107

4.4.4

LTF signaling pathways in APOE targeted replacement mice ................. 108

4.4.5

Conclusions ............................................................................................... 109

CHAPTER 5. DISCUSSION .......................................................................................... 118
5.1

APOE genotype and respiratory motor plasticity ............................................. 118

5.1.1

Respiratory Response to IH in the Presence of Human ApoE.................. 118

5.1.2
Interactions of Sex and APOE Genotype in Modulating Respiratory
Plasticity .................................................................................................................. 121
5.1.3
5.2

Significance of Findings ........................................................................... 124

Methodological Considerations and Limitations ............................................. 125

5.2.1

Induction of LTF in Rats Treated with Human ApoE Protein.................. 125
vi

5.2.2
Insights into a Novel Approach for Studying Respiratory Motor Plasticity in
Mice……………………………………………………………………………………….128
5.3

Future Directions .............................................................................................. 132

5.3.1

ApoE-astrocyte interactions in spinal and respiratory plasticity. ............. 133

5.3.2

The inflammatory milieu after SCI: impact of APOE genotype............... 136

5.3.3

Considering age as a biological variable in studies of the apoE isoforms. 139

5.3.4
Therapeutic interventions for overcoming apoE-induced constraints on
breathing plasticity .................................................................................................. 141
5.4

Conclusion........................................................................................................ 145

APPENDICES ................................................................................................................ 149
REFERENCES ............................................................................................................... 151
VITA ............................................................................................................................... 188

vii

LIST OF TABLES
Table 1.1 ........................................................................................................................... 11
Table 3.1 Injured group sizes ............................................................................................ 72
Table 4.1 Data for sample size calculation ....................................................................... 98

viii

LIST OF FIGURES
Figure 2.1 Human apoE3 and E4 affect 5-HT dependent plasticity similarly. ................. 58
Figure 2.2 ApoE4 prevents 5-HT-induced upregulation of synaptic AMPA receptors. . 59
Figure 2.3 ApoE4 is inhibitory to respiratory motor plasticity after SCI. ........................ 60
Figure 2.4 Human apoE4 decreases synaptic glutamate receptor expression after episodic
5-HT in hemisected animals. ............................................................................................ 61
Figure 2.5 BDNF expression isn’t apoE isoform-dependent. ........................................... 63
Figure 2.6 Cervical SCI alone does not change BDNF levels in the phrenic motor
nucleus. ............................................................................................................................. 64
Figure 3.1 Magnitude of respiratory motor plasticity is not determined by
APOE genotype alone. ................................................................................................. 85
Figure 3.2 ApoE3 males demonstrate a trend of decreasing diaphragmatic activity in
response to IH. .................................................................................................................. 86
Figure 3.3 ApoE4 females display significantly less diaphragmatic activity than E3
females after IH................................................................................................................. 87
Figure 3.4 E4 females have higher levels of PNN. ........................................................... 88
Figure 3.5 E4 females have higher density of spinal 5-HT fibers. ................................... 89
Figure 4.1 Magnitude of respiratory motor plasticity is not determined by APOE
genotype. ......................................................................................................................... 111
Figure 4.2 IH induces a decline in breathing activity in males expressing the human
APOE 4 allele. ............................................................................................................... 112
Figure 4.3 Amplitude of diaphragmatic activity decreases in response to IH in apoE3
females. ........................................................................................................................... 113
Figure 4.4 Hypoxic ventilatory response does not differ according to APOE genotype 114
Figure 4.5 Hypoxic ventilatory response does not differ according to APOE genotype 115
Figure 4.6 APOE genotype-dependent influences on 5-HT innervation of PMN. ......... 116
Figure 4.7 IH-induced BDNF protein synthesis is not altered according to APOE
genotype. ......................................................................................................................... 117
Figure 5.1 Graphic summarizing sex- and genotype-dependent differences in
the respiratory response to IH ................................................................................. 146
Figure 5.2 Graphic illustrating the signaling pathway that leads to manifestation of LTF.
......................................................................................................................................... 147

ix

LIST OF ADDITIONAL FILES
Supplemental Figure 3.1 The respiratory response to hypoxia is determined by APOE
genotype in male mice…………………………………………………[JPEG 266KB]
Supplemental Figure 3.2 Hypoxia induces a decline in breathing frequency in female
APOE targeted replacement mice……………………………………..[JPEG 270 KB]

x

CHAPTER 1. INTRODUCTION
1.1 Spinal cord injury
Spinal cord injuries (SCI) are life-threatening events that cause permanent
disruptions of central nervous system (CNS) physiology, leading to impaired mobility
and loss of independence, which dramatically impacts injured individuals’ quality of life.
Depending on the severity and level of injury, these events can damage both motor and
sensory function, as well as autonomic control throughout the body from the neck down.
Worldwide there are estimated to be up to 500,000 new SCI cases each year and close to
300,000 people are currently living with an SCI in the United States alone.1,2 The
majority of individuals who sustain SCIs are males and either above the age of 60 or
under the age of 30.1 In America’s aging population, an increasing number of injuries,
close to 32%, are due to falls, although most result from vehicular accidents.2 In addition
to the physical toll of the injury, SCI is a source of significant financial burden, costing
over $1 million in the first year after a high cervical injury.2 Injured persons whose
economic status is below the poverty line have a 62% higher mortality rate than those
considered to be above the poverty line.2,3 Despite decades of research dedicated to SCI
research, life expectancy after injury has not increased since the 1980’s and there are
currently no treatments clinically approved that effectively restore function.2,4 While
numerous experimental strategies have been effective in improving outcomes after SCI in
a preclinical animal models, and many have entered clinical trials, few have shown
sufficient efficacy in the human SCI population to be successfully translated for
widespread clinical use. This indicates that there may be heretofore overlooked or
understudied factors in the human population that influence how individuals recover after
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injury and how this recovery, whether spontaneous or in response to therapeutics, varies
from person to person. Elucidating the role that genetic background and sex differences
play in determining the propensity for recovery or the efficacy of treatment strategies in
unique individuals may aid us understanding and overcoming translational barriers for
SCI therapeutics.

1.1.1

SCI Pathology

SCI is a complex and heterogeneous injury. Over a century ago, it was proposed
that spinal cord injury pathophysiology could be divided into primary and secondary
insults.5 The primary injury consists of the initial event that damages the tissue of the
spinal cord and disrupts the neural circuitry housed within. The spinal cord is a crucial
bidirectional relay between the brain and the periphery, transmitting signals that supply
the brain with sensory information, as well as carrying inputs for the control of motor and
autonomic functions. In addition to functioning as a relay, the control of many crucial
physiological functions and reflexes also originates in the cord, which contains circuits
and central pattern generators that are distinct from those located supraspinally6–9. Any
mechanical force that damages these pathways can lead to motor and sensory deficits.
However, this initial trauma is not the only concern for people who sustain an SCI.
Following the primary injury, a cascade of events wreak havoc on the damaged spinal
cord tissue. Hypoxia due to a loss of blood flow, excitotoxicity from excessive glutamate
release, activation and infiltration of inflammatory cells, mitochondrial dysfunction, and
the production of oxidative compounds lead to additional cell death.10–13
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The depletion of both neuronal and non-neuronal cells, along with axonal
demyelination and Wallerian degeneration lead to cavitation of the spinal cord at the
lesion epicenter.14–17 Axonal and myelin debris, cytokines, and oxidative stress trigger the
activation of glial cells hours after injury.18,19 In an attempt to aid in wound repair,
astroglial processes hypertrophy and overlap, forming a barrier around the lesion cavity.20
Astrocytes also upregulate production of chondroitin sulfate proteoglycans (CSPGs) and
other components of the extracellular matrix that contribute to formation of the glial scar.
Injury also stimulates peripheral monocyte-derived macrophage infiltration of the spinal
cord. These cells accumulate with CNS-resident macrophages in the lesion cavity.21
Macrophages then recruit perivascular fibroblasts to accumulate in the lesion site.22 By 7
days post injury, the lesion core is filled with a fibronectin matrix secreted by these
fibroblasts, forming a fibrotic scar in the lesion core that is encompassed by the glial
scar.23,24
In addition to the astrocytes and fibroblasts that accumulate at the lesion site after
injury, immune cells from both the CNS and the periphery also contribute to secondary
the injury, scarring, and tissue repair. Microglia are the resident immune cells of the
central nervous system. In the uninjured CNS, microglia dynamically function as
sentinels, extend and withdrawing their processes in a matter of minutes to monitor their
surroundings. These processes are capable of engulfing components of the surrounding
tissue and transporting them back to the soma.25 Microglial processes monitor synaptic
functioning by directly contacting synapses in response to neuronal activity, which aids
in their crucial role of synaptic pruning during development and after injury.26,27 Upon
CNS insult, microglia are activated and polarized into M1 or M2 phenotypes, which are
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classically considered pro-inflammatory or anti-inflammatory, respectively, in
resemblance to macrophage classification. M1 macrophages and microglia secrete
reactive oxygen species and cytokines such as IL-12, IL-1, and IFN which contribute
to tissue damage after injury.28,29 Conversely, the cytokine expression profile of cells with
an M2 phenotype primarily consists of anti-inflammatory molecules including IL-10, IL13, and IL-7, which encourage neuron growth.28,29
In recent years, the accuracy of classifying macrophages and microglia in a strict
M1 or M2 dichotomy has been called into question. After CNS injury, macrophages and
microglia in the lesion penumbra simultaneously express both M1 and M2 markers and
the expression of these molecules changes over time, indicating that their response to
injury is too complex and dynamic to be characterized dichotomously as either pro- or
anti- inflammatory.30 One such example of how these terms can be misleading is in
reference to the cytokine TNF-. Historically, TNF- has been considered proinflammatory. Evidence shows that TNF- damages mitochondria, leading to reactive
oxygen species production, and ultimately causing apoptotic or necrotic cell death.31,32
However, TNF- also plays an important role in synaptic plasticity. TNF- signaling
stimulates an upregulation of synaptic AMPA receptors and strengthens excitatory
synapses, demonstrating that it has divergent functions in cytotoxicity and protection of
synaptic integrity.33,34 Indeed, the inflammatory milieu initiated by SCI may be a driver
of secondary tissue damage, while also presenting a potent and dynamic process that
could be harnessed to enhance plasticity, and subsequently, recovery.

4

1.1.2

Assessment of Injury Severity

Both primary and secondary injury contribute to the overall severity of an
individual’s SCI. Within the first 72 hours after injury, clinicians assess the extent of the
neurological injury using the American Spinal Injury Association Impairment Scale
(AIS). The AIS identifies the neurological level of injury (NLI) and evaluates both
sensory and motor function below this level. The NLI is identified as “the most caudal
segment of the spinal cord with intact sensation and antigravity muscle function”.35 The
injury is then designated as “complete” if there is no sparing of sensory or motor function
at the sacral spinal cord. Complete injuries receive an AIS grade of A. Otherwise, the
injury is deemed incomplete and given a grade of B-E, depending on the amount of motor
and sensory function preserved caudal to the NLI. An AIS grade E represents normal
sensation and motor function.35 In people who experience a complete injury, a zone of
partial preservation may be observed. This refers to dermatomes and myotomes caudal to
the NLI that retain partial innervation.36
Over time after the initial injury, individuals’ AIS grade can be re-evaluated to
measure spontaneous rate of recovery and is used as a outcome measure in clinical trials
for SCI treatment strategies.37–39 The majority of people with injuries of AIS grade B and
C improve by one AIS grade by 6 months post injury without any intervention. However,
only a third of people with AIS A injuries changed classification by 6 months and only
10% of AIS D patients show improvement in AIS grade during this time.39 Some
concerns over the utility of the AIS have been raised due to its emphasis on sparing of
sensorimotor function at the sacral levels, which could distract from the overall
neurological severity and consequently diminishes the reliability of the scale as an
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outcome measure.39 In fact, the design of the AIS allows it to reflect an increase in grade
despite functional deterioration and vice versa.40
Additional assessment of injury severity include quantitative sensory testing, in
which vibratory and thermal stimuli are applied to dermatomes caudal to the NLI in order
to evaluate the function of the dorsal columns and spinothalamic tract, respectively. This
testing provides a more quantitative analysis of sensation than the AIS sensory score.41
Conduction in the spinal cord can also be measured by electromyography (EMG) or
motor-evoked potentials, approaches that are advantageous due to their efficacy in
unconscious patients. These evaluations of descending motor tracts are predictive of
functional outcome, allowing clinicians to tailor treatment plans for individuals in order
to maximize their functional improvement.42,43 In addition to sensorimotor assessments, it
is also crucial to monitor impairments of the autonomic nervous system. Exposure to
stimuli that cause vasoconstriction leads to an increase in blood flow to the skin that can
be measured above and below the NLI. Since vasoconstriction is controlled by the
sympathetic nervous system, vasomotor reflex responses can provide an indication
autonomic damage after SCI.44
An emerging strategy for assessing severity and predicting outcomes after SCI is
the discovery and classification of biomarkers. Biomarkers can be sampled in a variety of
ways, with recent studies evaluating imaging techniques or collection of serum or
cerebrospinal fluid (CSF). T2-weighted MRI provides visualization of grey versus white
matter, allowing for the detection of compression, which is predictive of motor and
sensory deficits in non-traumatic SCI.45 Data published by Brian Kwon and colleagues
demonstrates the potential of measuring protein levels of IL-6, IL-8, and GFAP, as well
6

as certain subsets of microRNAs in CSF to indicate current AIS grade and provide a
prognosis for AIS improvements over time.46,47 Similarly, GFAP and neurofilament
protein concentrations in serum also have diagnostic value in predicting SCI severity and
outcomes.48,49 Analysis of these biomarkers associated with specific AIS grades or injury
severities has potential to aid the assessment of patients who cannot be graded on the AIS
due to unconsciousness, damage to other body systems, or other issues of noncompliance.
Accurate biomarkers could therefore contribute to accurate characterization of injuries for
enrollment in SCI clinical trials and provide additional outcome measures for therapeutic
efficacy.50

1.1.3

Supportive Care After Injury

There are currently no FDA-approved drugs that are recommended as standard of
care for the treatment of spinal cord injury. However, first responders and clinicians can
take action to minimize damage to the spinal cord tissue and prevent disturbances in other
body systems. One of the first decisions that must be made is whether to perform surgical
decompression to relieve pressure on the spinal cord and if so, when. In cases of central
cord syndrome or other stable or non-traumatic spinal cord injuries, spinal decompression
may not always be necessary due to the high likelihood of spontaneous improvement.51
However, in many cases of traumatic SCI, surgical decompression is recommended
within the first 24 hours after injury due to its correlation with greater improvements in
neurological outcome or AIS grade.52 Non-surgical decompression using spine traction,
in which weight is applied to the skull in order to pull it away from the shoulders and
lengthen the cervical spine, has also proved efficacious for some cervical level injuries.53
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In the first day after injury, SCI patients are at risk for hemodynamic instability
due to autonomic dysreflexia or loss of sympathetic tone during neurogenic shock.
Compression of the spinal cord can also prevent blood flow to the lesion penumbra,
creating a hypoxic state. In order to prevent hypoperfusion, hypotension, and
bradycardia, guidelines in the last decade have recommended that mean arterial pressure
(MAP) is maintained at 85-90 mmHg during the first week post injury.54 This aggressive
maintenance of MAP is associated with enhanced neurological outcomes measured by
AIS grade conversion, walking ability, and bladder function.55,56 Unfortunately,
administration of vasopressors comes with risks that must also be considered. Use of
common vasopressors cause complications including tachycardia, bradycardia, atrial
fibrillation, and even elevations in troponin, a biomarker of heart damage.57 Recent
research in humans and animal models has explored when and to what extent MAP
should be elevated after injury.58–60 Even chronically after injury, the spinal cord tissue
caudal to the injury can remain in a state of hypoxia, limiting the potential for functional
recovery.12
A major concern for individuals with impaired mobility and sensation after SCI is
the development of pressure ulcers. The second most prevalent cause of death after SCI is
septicemia, often as a result of epidermal ulceration.61 Pressure ulcers develop in
response to prolonged pressure on the skin, especially over bony areas, which results in a
period of ischemia. Numerous studies have examined the impact of body positioning
while patients are in supine or prone recumbency on the development of pressure
ulcers.62,63 While body positioning techniques can be used to reduce pressure on the skin
overlying the sacrum, trochanters, and hips, an additional approach is to develop a
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schedule for regularly turning patients in bed.64,65 This redistributes pressure and restores
blood flow to areas that are at risk for developing ulcers. Similarly, once quadriplegics or
paraplegics are maintaining a sitting position for extended periods after injury, pressure
relief maneuvers, such as leaning forward, reclining, and doing push-ups must be
performed regularly to reduce the risk of developing ulcers.66–68 However, multiple
factors, including individual skin physiology, age, weight, and response to stress must be
taken into consideration, emphasizing the need for personalized care in the SCI field.
For people who sustain an injury at or above the T6 spinal level, preventing
episodes of autonomic dysreflexia (AD) becomes a constant concern beginning a few
months after injury. Below the level of injury there is a disruption in the regulation of
preganglionic sympathetic neurons, which reside in the intermediolateral nucleus of the
spinal cord between the first thoracic and second lumbar level.69 The sympathetic
division of the autonomic nervous system is crucial in the control of hemodynamics.70
After injury, sympathetic tone below the level of injury becomes independent of
supraspinal control, while above the lesion it is still governed by brainstem inputs.
Unperceived noxious stimuli including hyperextension of the bowel or bladder, ill-fitting
clothes or shoes, pressure ulcers, or skin lacerations caudal to the injury activate the
sympathetic nervous system.71 The sympathetic “fight or flight” response instigates
vasoconstriction to increase arterial blood pressure, which is sensed by baroreceptors of
the carotid sinus.71,72 Baroreceptor feedback to the medullary nucleus solitarius initiates a
conversion from sympathetic to parasympathetic dominance to slow the heart rate and
decrease blood pressure. However, sympathetic neurons below the NLI that lack
supraspinal input remain uninhibited and continue to maintain vasoconstriction, leading
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to systolic arterial pressures as high as 325mmHg.73,74 If left untreated, AD puts patients
at risk for stroke, cardiac arrest, seizures, and death.75
Maladaptive plasticity in the spinal cord after injury may cause hypersensitivity
and enhanced nociception, increasing the likelihood of a stimulus being perceived as
noxious.76,77 Since the stimuli initiating AD are unperceived by the patient due to deficits
in sensory function, episodes of AD can happen multiple times a day. They are
characterized by sweating, headache, stuffy nose, and flushing above the level of injury.71
Once AD has been triggered, the most effective way to terminate it is by identifying and
removing the stimulus. However, AD is also be treated pharmacologically with
nitroglycerine paste or an L-type calcium channel blocker, which relax smooth muscle to
alleviate vasoconstriction.78,79

1.1.4 Clinical trials for SCI interventions
Although there are currently no FDA-approved drugs for the treatment of SCI, a
search on clinicaltrials.gov produces over 800 clinical trials for spinal cord injury,
including 427 that have already reached completion. Many of these trials aim to alleviate
a variety of comorbidities associated with SCI including neuropathic pain, cardiovascular
disease, sleep apnea, and loss of muscle mass. Other trials are focused on the translation
of drugs or other therapeutic approaches that have shown potential for improving motor
and sensory function to enhance independence and quality of life. Representative
examples of currently ongoing clinical trials for SCI that target a variety of complications
that can result from the injury are presented in Table 1.
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Table 1.1

Target
Neuropathic

Intervention

ClinicalTrials.gov

Principle

Identifier

Investigator
Michelle

Capsaicin patch

NCT02441660

Cardiovascular

Systemic hypothermia

NCT02991690

Alan D. Levi

Spasticity

Intrathecal Baclofen

NCT02903823

Peter Kondrad

Testosterone

NCT01652040

Ashraf Gorgey

Zoledronic acid

NCT01642901

Episodic hypoxia

NCT02922894

pain

Maintenance
of muscle mass
Preservation of
bone mass
Sleep Apnea

Trbovich

Christina V.
Oleson
M. Safwan
Badr
Mitsubishi

Inflammation

MT-3921

NCT04096950

Tanabe Pharma
Development

Riluzole

NCT01597518

Lexapro (selective serotonin
Motor/Sensory

reuptake inhibitor)

functional

FAB117-HC (human adipose

improvement

derived mesenchymal stem

NCT01788969

Michael
Fehlings
Thomas G.
Hornby
Ferrer

NCT02917291

cells)

Internacional
S.A.

Epidural stimulation

NCT04123847

Susan Harkema

Rehabilitation/Training

NCT03504826

Emily J. Fox
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In addition to these experimental treatments, many clinical trials have also tested
the efficacy of neuroprotective drugs that could reduce secondary injury. Minocycline, an
antibiotic which reduces apoptosis of oligodendrocytes and microglia, was proved safe
and feasible in a Phase II trial80 and is now being investigated in an ongoing Phase III
trial (NCT01828203). Inhibition of endogenous opioids after injury has also shown
neuroprotective effects, leading to the development of clinical trials for opioid blockers
such as naloxone and thyrotropin-releasing hormone.81,82 These antagonists have shown
preclinical efficacy in dampening excitotoxicity, preventing ischemic damage, and
improving functional recovery after SCI, although results from clinical trials were less
conclusive.81–83

Importantly, the only drug ever approved for acute SCI was also a neuroprotective
agent. Methylprednisolone sodium succinate (MP) is a glucocorticoid with antioxidant
capabilities that showed efficacy in preventing lipid peroxidation and neurofilament
degradation, while also improving blood flow to the injured cord. 84,85 In a series of three
clinical trials known collectively as the National Acute Spinal Cord Injury Studies
(NASCIS I, NASCIS II, NASCIS III), various dosages of MP were tested at different
time points after injury for a duration ranging from 1 day up to 10 days. Results from
these studies demonstrated that high dose MP administered within 8 hours of injury
resulted in improved sensory and motor recovery at 6 weeks and 6 months.82,86,87
However, subsequent criticism of the studies’ analyses and concerns over gastrointestinal
side effects and increased infection risk led to removal of MP from standards treatment of
SCI in the United States.88,89

12

1.1.5

Experimental approaches for preserving and restoring function after SCI

A plethora of diverse experimental therapeutic approaches have been evaluated for
their potential to preserve or improve function after SCI in preclinical animal models and
in clinical trials. For simplicity, these techniques can be divided into the categories of:
neuroprotection, those enhancing plasticity, and those promoting regeneration. In
addition to these unimodal methods, combinatorial approaches have also been developed
that target both the preservation of existing tissue and the cultivation of new axon growth
and synaptic connectivity.

As described in section 1.1.2, initial damage caused by an SCI leads to subsequent
secondary injury events including scarring, inflammation, oxidative stress, mitochondrial
dysfunction, and axon demyelination and degeneration. Neuroprotective strategies are
those that aim to mitigate or prevent secondary injury cascades in order to preserve tissue
and functional neural circuitry in the spinal cord. Some neuroprotective compounds have
already entered into clinical trials, including MT-3921 and Riluzole, seen in Table 1.
Indeed, the only drug that has been approved by the FDA for the treatment of SCI was
the neuroprotective corticosteroid methylprednisolone.82,87 These trials also investigated
other neuroprotective agents naloxone and tirilazad, both of which were less effective in
restoring function. While later clinical guidelines advised against the use of MP, these
guidelines remain a subject of contention for clinicians.90 Regardless, MP’s ability to
improve functional recovery emphasizes that neuroprotective agents are powerful tools in
the search for SCI treatment strategies.
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It was once thought that damaged axons in the CNS were incapable of regeneration
due to inhibitory properties of the CNS environment.91,92 Indeed, in 1981, David and
Aquayo proved that injured spinal cord axons are capable of elongating over long
distances when the CNS environment is replaced by a peripheral nerve graft.93 This
seminal discovery led to decades of research dedicated to finding treatment strategies that
create a CNS microenvironment that is more conducive to axon growth. In addition to
peripheral nerve grafts, growth permissive environments have been inserted into the
spinal cord in the form lab-manufactured scaffolds of various materials.94 Therapeutic
approaches also include amplifying the presence of neurotrophic factors such as BDNF
(brain-derived neurotrophic factor), NT-3 (neurotrophin-3), or GDNF (glial cell-derived
neurotrophic factor) to activate genes associated with regeneration.95,96

Instead of increasing growth-promoting molecules in the CNS microenvironment,
other strategies remove molecules that are inhibitory to outgrowth. A promising
therapeutic target is the degradation of chondroitin sulfate proteoglycans (CSPGs), which
are found in the perineuronal net surrounding CNS neurons. CSPGs are upregulated
following SCI, creating a barrier around the lesion site that halts axon elongation and
entraps regenerating end bulbs.97,98 Degradation of CSPGs using the bacterial enzyme
chondroitinase-ABC (ChABC) removes this inhibitory boundary and permits axon
outgrowth and regeneration through the injury site, leading to new functional synaptic
connections.99 Further studies have also shown the efficacy of interfering with
interactions between CSPGs and their neuronal receptors.100,101
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Ablation of reactive astrocytes, mediators of glial scar formation after SCI, can
also create a growth-permissive state at the cost of exacerbating the inflammatory
response to injury.102,103 However, some of these immune responses to injury can actually
stimulate axon growth. For example, macrophage-mediated release of oncomodulin
promotes optic nerve regeneration.104,105 Despite some beneficial effects acutely,
sustained immune activation leads to neuronal and glial cell death, making it difficult to
modulate inflammation to stimulate favorable responses while avoiding detrimental
outcomes.106 In the 1980’s, Schwab and colleagues realized that the myelin produced by
oligodendrocytes in CNS white matter also acts as a nonpermissive growth substrate and
neutralization of myelin membrane proteins promotes corticospinal tract regeneration
through an SCI.107–109 Since these discoveries, approaches that knockout or otherwise
inhibit receptor binding of the myelin proteins Nogo, MAG (myelin associated
glycoprotein), and OMgp ( oligodendrocyte myelin glycoprotein) have shown efficacy in
stimulating both regeneration of injured axons and sprouting of spared fibers.110–113
Altogether, studies manipulating the injury milieu have provided valuable evidence for
the competency of CNS axons to regenerate when neuron-extrinsic barriers to growth are
removed.

In contrast to approaches that aim to remove inhibitory factors from the
microenvironment to promote axon elongation, others modulate neural intrinsic factors to
stimulate the neuronal growth machinery. In a pivotal 2008 study, Park et al. found that
deletion of cell growth control genes significantly impacted cell survival and axon
regeneration. Specifically, deletion of the tumor suppressor gene PTEN (phosphatase and
tensin homolog) promoted axon growth well beyond an optic nerve lesion.114 This effect
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has also been reproduced in the injured spinal cord, even when PTEN is only transiently
inhibited by an antagonist peptide or when downstream targets of PTEN are directly
activated.115–117 Axon regeneration is an energy-intensive process, requiring
transportation of mitochondria to the growth cone.118,119 Inhibition of PTEN activates
genes associated with mitochondrial transport and enhanced regenerative capacity,
indicating that mitochondrial motility may be a key intrinsic factor that influences axon
regeneration.119,120 In a similar manner to PTEN, expression of a GTPase known as RhoA
is also implicated in preventing axon elongation.121 RhoA expression is upregulated after
SCI, leading to downstream increases in inflammation and growth cone to collapse,
effectively preventing neurite outgrowth.122 The FDA-approved non-steroidal antiinflammatory drug ibuprofen suppresses Rho signaling and promotes axonal sprouting.123
Another fascinating, yet paradoxical way to stimulate the growth machinery of spinal
axons is through a peripheral conditioning lesion.124 Lesioning the peripheral branch of
dorsal root ganglion neurons activates signaling pathways that promotes regeneration of
dorsal column axons after SCI.125

Although regeneration and sprouting of CNS axons may be considered a form of
structural plasticity, henceforth plasticity will refer to alterations in the number or
strength of synaptic connections. While CNS plasticity will be discussed in greater detail
in section 1.2.3, some therapeutic approaches that target spinal plasticity in the context of
SCI will be addressed here. Following SCI, spinal plasticity can either be beneficial,
leading to functional improvement, or maladaptive, often exacerbating spasticity, pain,
and autonomic dysreflexia. One way to combat maladaptive plasticity is through training
and rehabilitation strategies, which can reduce spasticity and normalize spinal reflex
16

firing.126,127 During such training and exercise protocols, afferent inputs in the spinal cord
modulate synaptic plasticity through BDNF-dependent mechanisms to improve motor
function after SCI.128–130

Neural excitability in the spinal cord can also be modulated through epidural
stimulation, which has shown efficacy in improving both locomotor and autonomic
function following SCI.131–135 In epidural stimulation protocols, electrodes are placed
epidurally over the targeted spinal segments while a pulse generator is implanted in the
abdominal wall.133,136 A less invasive strategy that enhances plasticity of spinal circuits is
intermittent hypoxia (IH). IH consists of exposing subjects to bouts of low inhaled
oxygen (hypoxia) interspersed with periods of normoxia or hyperoxia, which activates
serotonergic (5-HT) neurons in the raphe.137 These 5-HT fibers extend throughout the
spinal cord, allowing them to modulate the function of various motor systems.138 Clinical
studies have demonstrated improvements in breathing, locomotion, and upper limb
function after exposing spinal cord injured subjects to IH.139–143 The functional
improvements that result from IH and epidural stimulation can be further augmented by
combining them with task-specific training.136,144 All of these therapeutic strategies are
currently under investigation in clinical trials (Table 1.)

Some therapeutic approaches and combinatorial treatment strategies target
multiple mechanisms of neuroprotection, regeneration, or plasticity. In preclinical and
clinical investigations, transplantation of a variety of cell types has been of interest due to
the cells’ ability to create a protective and pro-regenerative microenvironment.145
Transplantation strategies utilizing neural stem cells, bone marrow-derived stromal cells,
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or mesenchymal stem cells have proven effective preclinically in decreasing lesion cavity
size and enhancing the amount of spared tissue after injury.146–149 They can also prevent
the spread of inflammation throughout the spinal cord.150 Neural progenitor cell grafts are
capable of forming synaptic connections with host axons to create relays through an SCI
lesion site in monkeys.151 Foundational work from the Bunge lab emphasized the power
of Schwann cells in reducing lesion cavitation, promoting axon regeneration, and
remyelinating fibers to restore axon conduction.152 Combining cell grafting techniques
with additional strategies such as ChABC-induced PNN degradation, scaffolds that fill or
bridge the lesion, peripheral nerve grafts, or genetic modification to enhance expression
of pro-regenerative molecules can also aid in promoting functional recovery.153–155

1.2 Breathing Before and After Trauma
Breathing is one of the body’s most crucial functions. Injury and disease states
that impact breathing are by nature life-threatening and require immediate medical
intervention. If the body’s natural breathing function cannot be sufficiently maintained,
patients may require permanent aids to ensure proper ventilation and adequate tissue
oxygenation. Breathing is primarily mediated through rhythmic contractions of the
diaphragm muscle, which derives its innervation from motor neuron pools in the cervical
spinal cord. The neural circuitry that sustains life by providing excitatory input to these
motor neurons can be damaged by high level cervical spinal cord injuries, making the
restoration of breathing function a top priority for individuals who sustain an SCI.
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1.2.1

Neural Control of Breathing

Breathing is a complex behavior that, by necessity, must be capable of adapting to
changes in the internal and external environment. Alterations in oxygen or carbon dioxide
levels in the blood, physical exertion, altitude, and many other factors stimulate the body
to adjust breathing to ensure that proper tissue oxygenation is maintained in any setting.
Multiple respiratory centers in the brainstem exert control over inhalation and exhalation,
as well as augmented breathing behaviors that are utilized to clear the airways.
Breathing consists of three phases: inspiration, postinspiration, and expiration. In
eupneic breathing, or breathing at rest, breathing rhythm is primarily driven by active
muscle contractions of the inspiratory phase, while expiration is typically passive. The
rhythmicity is generated by a region of the ventral medulla known as the pre-Bötzinger
Complex (preBötC).156 The groups of neurons from the ventral medulla that would later
become known as the preBötC first attracted attention because they maintain discharge
patterns consistent with inspiratory rhythm both in vivo and in vitro, even when isolated
from afferent feedback.156,157 Their axons decussate to communicate with contralateral
breathing centers and ensure bilateral synchronicity.158 Neurons of the preBötC also
extend to other pontine or medullary nuclei that modulate ventilatory behaviors including
the nucleus tractus solitarius (NTS), the retrotrapezoid nucleus, the nucleus ambiguous,
and various regions of the raphe. This densely connected network provides integration of
afferent information to adjust breathing in response to an organism’s environment.158,159
Rhythmic firing of excitatory preBötC neurons induces the active inspiratory phase of
breathing.160 Therefore, hyperpolarization or depolarization of these neurons decreases or
increases breathing rate, respectively.161 Death or pharmacologic silencing of pre-BötC
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neurons leads to severe breathing deficits and apnea in both rodents and larger species
such as goats.162–164
Axons projecting caudally from the preBötC communicate with the rostral ventral
respiratory group (rVRG) in the caudal medulla. Transmission of the rhythmic signals to
the rVRG is crucial as these premotor neurons will ultimately control the pace of
diaphragmatic contractions. Premotor neurons in the rVRG provide glutamatergic input
to phrenic motor neurons (PMNs) in the ventral horn of spinal cord levels C3-C6.165–167
PMNs are crucial for inspiration because it is their axons that will exit the spinal cord to
form the phrenic nerve. The phrenic nerve innervates the diaphragm and signals it to
contract inferiorly, increasing the volume of the thorax and creating negative pressure to
draw air into the lungs. Thus, the pre-BötC drives rhythmic inspiration by governing
excitatory input to PMNs.160
PMNs also receive serotonergic innervation from the caudal raphe, which is
crucial for breathing adaptation in response to carotid body activation.168,169 The carotid
body, located at the bifurcation of the common carotid artery, contains chemoreceptors
that are sensitive to oxygen levels. Decreases in the arterial partial pressure of oxygen
(pO2) activates the carotid body, which is innervated by the glossopharyngeal nerve.
Afferent information from the carotid body is then processed in the nucleus solitarius and
the nucleus ambiguous, which communicate with the caudal raphe to modulate
serotonergic input to the phrenic motor nucleus.137,170,171 Neurons of the raphe also
possess their own chemoreception capabilities, which is exemplified by their ability to
increase the amplitude of phrenic bursting in response to local acidosis.172 Therefore,
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both peripheral and central chemoreception provides a mechanism for modulating
breathing activity in response to environmental changes.
Following the inspiratory phase, postinpiration serves to prolong the contraction
of the diaphragm, allowing more time for gas exchange across alveolar surfaces.173
Laryngeal muscles also contract in order to guard against airway collapse during the
subsequent expiratory phase.174 Although the expiration is passive during eupnea,
expiratory muscles can be recruited when oxygen levels are reduced. For example,
abdominal muscles are recruited during the expiratory phase when rats are exposed to
hypercapnic or hypoxic conditions.175 Expiration also becomes active in response to
increased ventilatory demand during exercise and high metabolic rate. In this case,
pressure generated by abdominal muscles reduce end-volume of the lungs during
expiration, thereby increasing tidal volume.176 Active expiration is most commonly
utilized during speech, laughter, or crying because these expressions require a more rapid
inspiratory phase and a more prolonged expiratory phase.177

1.2.2

Respiratory Deficits after SCI and Approaches for Restoring Breathing Function
Almost 60% of SCIs occur at the cervical level2. Such high level injuries can

interrupt the descending pathways that extend from brainstem respiratory nuclei to the
C3-C6 spinal cord levels where they synapse on PMNs that innervate the diaphragm.
This leads to severe deficits in breathing, often necessitating the use of an artificial
ventilator and increasing hospital length of stay and associated financial burdens.178,179
Ventilator-dependency increases the risk of pneumonia and other respiratory infections,
which are the leading cause of death following SCI.180 Indeed, ventilator use greatly
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decreases the life expectancy of injured individuals.181 Cervical level injury also increases
the incidence of sleep disordered breathing, primarily in the form of obstructive sleep
apnea, which is a precursor to cardiovascular disease, insulin resistance, and impaired
cognitive function.182–184
During the first year after injury, many injured individuals who required
ventilation are successfully weaned from ventilator use. However, weaning likelihood
declines in patients who experience higher level lesions (C1-C3) and in those who
undergo tracheostomy, leaving many individuals dependent upon ventilators for extended
periods of time.185 This can lead to ventilator-induced lung injury, as well as diaphragm
muscle atrophy.186–188 In order to restore diaphragm strength and replace the use of a
ventilator, some individuals have the option of undergoing implantation of a diaphragm
pacer. Diaphragm pacing (DP) requires that electrodes be inserted into multiple sites in
the diaphragm in addition to a subcutaneous ground electrode. A pulse generator then
electrically stimulates diaphragmatic contractions to maintain breathing while the patient
is removed from the ventilator.189,190 However, if PMNs in the spinal cord or the phrenic
nerve itself is injured, this renders DP ineffective.190 A less invasive approach to
stimulating respiratory drive and enhance breathing function after SCI is through
therapeutic IH, which will be addressed further in the following section.

1.2.3

Respiratory Motor Plasticity

In the early twentieth century, it was commonly believed that the central nervous
system did not change once development was complete. Neuronal cell counts, as well as
the synaptic connections these neurons formed were thought to remain unchanged
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throughout adult life. However, this dogma was challenged, and ultimately rejected, as
evidence emerged revealing the plastic nature of the CNS. One of the first scientists to
propose that the CNS changes in response to experience was Donald O. Hebb in
1949.118,191 As Hebb observed, when a presynaptic cell repeatedly activates a
postsynaptic cell, it leads to increased strength of their synaptic connection. In the 1970’s,
this finding led to the discovery of long term potentiation (LTP), in which stimulation of
perforant pathway caused potentiation of excitatory post-synaptic potentials.192,193 This
form of plasticity is dependent upon signaling through NMDA receptors, which then
increases trafficking of AMPA receptors to the post-synaptic membrane, thereby
strengthening synaptic connections.194,195
Since Hebb’s time, LTP has become a well-characterized example of plasticity in
the brain.196 Similarly, it has long been known that spinal cord circuits are also capable of
changing in response to external stimuli. Like the brain, the spinal cord is capable of
instrumental learning, both before and after spinal cord injury.197–199 In addition, this
learning is dependent upon glutamate receptor signaling, which causes synaptic
sensitization similar to that produced by hippocampal LTP.200 While this form of
plasticity produces an advantageous increase in synaptic strength, some modes of
plasticity in the spinal cord may be maladaptive. For example, following spinal cord
injury in rodent models, loss of inhibitory GABAergic signaling, increased sprouting of
afferent fibers, and increased membrane trafficking of glutamate receptors all contribute
to development of neuropathic pain while impairing spinal learning.201–205
Spinal cord plasticity is also evident in the neural control of breathing. In 1895,
W.T. Porter discovered that the circuitry responsible for transmitting respiratory signals
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from the brainstem to the phrenic motor nucleus exhibited plasticity in response to
cervical spinal cord hemisection.206 This SCI model severs one side of the cord,
paralyzing the ipsilateral hemidiaphragm while leaving the contralateral cord intact.
Following unilateral interruption of descending respiratory pathways, compensatory
breathing activity is exhibited in the contralateral phrenic nerve207. In addition, breathing
activity returns to the ipsilateral phrenic nerve as respiratory drive intensifies207,208. These
studies, along with others6,209,210, demonstrate the potential of spared or latent spinal
pathways to modulate breathing activity after cervical SCI. The pathway that Porter
detected in the nineteenth century later became known as the crossed phrenic pathway
(CPP), which descends from the RVRG and decussates at the level of the phrenic motor
nucleus to synapse on contralateral PMN, thereby circumnavigating the cervical
hemisection206,211. Although it remains latent during eupneic breathing, it can be activated
by physiologically or pharmacologically amplifying respiratory drive after SCI, thereby
restoring function to the paralyzed hemidiaphagm207,212. Presence of the CPP has been
validated in a number of species including rats, mice, guinea pigs, dogs, and cats207,213–
215

.
Respiratory motor plasticity also manifests as a prolonged increase in breathing

motor activity following stimulation of the carotid sinus nerve216,217 or exposure to
intermittent hypoxia218,219. This well-described spinal plasticity, termed long term
facilitation (LTF), has been shown to augment diaphragmatic (phrenic nerve), external
intercostal (intercostal nerves), and upper airway muscle activity (hypoglossal nerve)220–
222

. Depending on the IH protocol used, i.e. length and number of hypoxic bouts and

severity of hypoxia, LTF can be induced through either a serotonin- or adenosine-
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dependent signaling mechanisms in PMNs223–225. These are termed the Q and S pathway,
respectively226. These signaling cascades and the crosstalk between them have been well
described in rats over the past three decades, providing optimized IH protocols and a
depth of knowledge for how to modulate the pathways pharmacologically227–230.
However, very few studies have investigated the impact of IH on the respiratory activity
of mice. No standardized IH protocol for mice is currently used across labs. However,
hypoglossal and ventilatory LTF have been demonstrated in mouse studies that utilized
different levels of hypoxia (7-14%) and number of hypoxic bouts (3-12 bouts, each of a
3-5 minute duration)231–234.
While exposure to hypoxia stimulates respiratory motor plasticity by increasing
respiratory drive, complete elimination of this drive through neural apnea can also lead to
inactivity induced facilitation of breathing function235–237. Ventilating animals sufficiently
to maintain arterial O2 eliminates respiratory drive. In the absence of respiratory drive,
the phrenic nerve ceases firing, causing a neural apnea. A single prolonged period or
short repeated bouts of neural apnea lead to augmented breathing activity when
respiratory drive returns235,238. This form of plasticity has been termed inactivity-induced
phrenic motor facilitation (iPMF)238. In contrast to LTF, iPMF is induced through either
TNF- or retinoic acid-dependent mechanisms, ultimately activating protein kinase C
signaling cascades236,237,239.
Intrathecal TNF- dosing is sufficient to induce iPMF, emphasizing the
importance of the cytokine’s role in plasticity237. TNF- has also been implicated in
homeostatic synaptic scaling. Synaptic scaling consists of increases or decreases in
excitatory post synaptic potential amplitude caused by activity-dependent changes in the
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amount of postsynaptic AMPA receptors240. In response to prolonged periods of synaptic
inactivity, glia release TNF-, which stimulates insertion of AMPA receptors into
neuronal postsynaptic membranes34,241. Thus, TNF- signaling helps neurons maintain
the ability to alter their activity in response to their environment242. However, due to the
effect of TNF- on glutamate receptor localization, it also has potential to make neurons
more vulnerable to excitotoxic cell death after injury243. Systemic inflammation induced
by lipopolysaccharide attenuates IH-induced LTF, indicating that inflammatory
mediators can have both beneficial and detrimental effects on various forms of plasticity,
perhaps dependent on magnitude and duration of inflammatory response244–246

1.2.4

Long Term Facilitation of Breathing after SCI

Early studies from Porter and others demonstrated the presence of respiratory
drive-induced plasticity in breathing circuitry following spinal hemisection.206–208 These
discoveries prompted investigations into the prospect of alleviating cSCI-induced
breathing deficits by increasing respiratory drive through exposure to IH. Almost 20
years ago, Fuller et al. showed that IH conditioning could restore ipsilateral
hemidiaphragm function following unilateral cervical SCI.139 The injury model used in
this and many other related studies was a lateral C2 hemisection, in which the left half of
the spinal cord is transected at the C2 spinal cord level, thereby severing ipsilateral
bulbospinal respiratory pathways and rendering the ipsilateral hemidiaphragm chronically
paralyzed.139,218,247 As early as four weeks after injury, therapeutic IH is capable of
restoring breathing activity for at least sixty minutes after cessation of IH.247 Activation
of the CPP and manifestation of LTF after injury correlates with the amount of 5-HT
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present in the region of the phrenic motor nucleus, which may explain why IH is
ineffective at restoring function acutely after injury when 5-HT fiber sprouting has yet to
occur.218,247
Exposure to IH can also illicit long term facilitation of ventilation in human
subjects, both in the presence or absence of cervical spinal cord injury.142,248 LTF is
expressed equally in males and females when subjects are spinally intact.249 However,
data from Tester et al. suggests that the ventilatory response to IH may differ between
males and females following SCI, providing evidence of enhanced LTF in males.142 IH is
currently in clinical trials to test its impact on a variety of outcomes after SCI, including
upper and lower limb function, alleviation of sleep apnea, and breathing (Table 1.).250–253
In these studies, it will be essential to consider sex as a biological variable to evaluate the
true efficacy of IH in the SCI population
1.3 Genetic influences on neural plasticity
Spinal plasticity induced by therapeutic approaches such as exercise and training,
electrical stimulation, and intermittent hypoxia have the potential to promote recovery of
function after spinal cord injury. However, little is known about how various factors in
the human population, such as sex and genetic background of injured individuals, could
impact the expression of spinal or respiratory plasticity. This section will discuss how
heterogeneity in the human population could modulate the potential for plasticity.
Although many of these factors have previously been studied in the context of brain
plasticity, they could have additional, unexplored consequences in the spinal cord.
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1.3.1

Brain-derived neurotrophic factor

BDNF plays a significant role in modulating dendritic protein synthesis,
neurotransmitter release, and glutamate receptor trafficking, demonstrating its importance
in regulating synaptic plasticity both pre- and post-synaptically.254–259 A single nucleotide
polymorphism of the BDNF gene in which valine is substituted with methionine at codon
66 (Val66Met) has previously been implicated in the inhibition of synaptic plasticity in
the brain, resulting in memory impairment.259–262 In the context of traumatic brain injury,
studies in combat veterans demonstrate that BDNF polymorphisms differentially
modulate the recovery of cognitive function.263,264 However, their impact on neural
recovery after SCI remains unexplored.
Individuals who express the Val66Met polymorphism have a diminished response
to transcranial magnetic stimulation (TMS), which alters the excitability of neural
circuits in the brain to improve motor rehabilitation after stroke.265 TMS has also shown
efficacy in improving outcomes after SCI, although it is unknown whether this effect is
similarly altered by the Val66Met polymorphism.266 However, the Val66Met
polymorphism does prevent the plastic responses of spinal cord circuitry that are typically
induced by electrical stimulation.267 This SNP could therefore have repercussions for the
efficacy of these and other therapies that increase plasticity in the spinal cord to restore
function after SCI.129 For example, spinal plasticity in the form of IH-induced LTF is
dependent upon synthesis of new BDNF and its binding to the TrkB (tropomyosin
receptor kinase B) receptor.268 Interestingly, the magnitude of IH-mediated BDNF
synthesis has not been compared between wild types and animals expressing Val66Met.
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1.3.2

Tropomyosin receptor kinase B

BDNF signals through its receptor, TrkB, to modulate synaptic strength.258,269,270
The Trk family of receptor tyrosine kinases dimerize upon binding of their neurotrophin
ligands, leading to transphosphorylation of the receptor’s cytoplasmic domain.271
Phosphorylated residues then serve as docking sites for signal transduction molecules.272
Downstream signaling triggered by activation of TrkB increases glutamate-evoked
excitatory postsynaptic currents through NMDA receptors.258,269 Presynaptically, receptor
activation increases glutamate release.273 Mutations in these presynaptic TrkB receptors
impair LTP induction, indicating that TrkB signaling modulates synaptic plasticity
through multiple mechanisms pre- and post-synaptically.274 Behavior of TrkB mutant
mice suggests that loss of TrkB causes deficits in learning, short term memory, and
coping responses to stressful stimuli.275
Numerous variants of TrkB are naturally occurring, including splice variants and
those containing single nucleotide polymorphisms (SNPs) in the NTRK2 gene encoding
TrkB. Due to the importance of BDNF/TrkB signaling in modulating synaptic plasticity
and depressive behavior, a considerable body of work has investigated the impact of
these variants on development of depressive disorders in human populations.276,277
Multiple SNPs within the promotor and intronic regions of NTRK2 are positively
correlated with depression and suicide attempts in human populations.278–282 In contrast,
one TrkB SNP (rs1212171) is correlated with decreased depressive symptoms in females
with HIV (human immunodeficiency virus), a population known to experience a higher
incidence of depression.283,284 This disparity points to the complex influence of
BDNF/TrkB signaling on synaptic plasticity (previously reviewed by Dwivedi, 2009285).
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Although it has been established that TrkB signaling is crucial for functional
recovery after spinal cord injury286,287, it is unknown how recovery and response to
therapeutics is impacted by polymorphisms in the NTRK2 gene. Spinal plasticity is
dependent upon activation of TrkB, indicating that alterations in TrkB signaling could be
detrimental to plastic responses in the spinal cord.268 As an example of spinally-mediated
plasticity, LTF requires BDNF-dependent activation of TrkB receptors.268 It has been
proposed that TrkB then stimulates phosphorylation-induced trafficking of glutamate
receptors to the postsynaptic membrane of PMNs, thereby strengthening connections
with the CPP.288 Therefore, variants of the NTRK2 gene could have either detrimental or
beneficial impacts on the induction of LTF, depending on how they alter TrKB ligand
binding and kinase activity.

1.3.3 Neurotrophin receptor p75
The p75 neurotrophin receptor binds neurotrophins in both their mature and their
uncleaved pro- forms to execute a wide range of functions. During development and after
CNS injury, binding of proNGF (nerve growth factor) leads to p75-induced apoptosis.289
Interaction of p75 and the Nogo receptor inhibits neurite outgrowth in response to
myelin-associated proteins.290,291 The p75 receptor also has a role in regulating
hippocampal synaptic plasticity by altering currents through glutamate receptors. Its
binding of proBDNF enhances NR2B-mediated currents and increases NMDA receptordependent long term depression (LTD).292 Repeated induction of LTD stimulates
production of additional proBDNF, which reduces synaptic strength, as well as dendritic
spine density.293 Knockout of p75 alters levels of glutamate receptor subunits, leading to
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impairments in LTD.294,295 These studies reveal that while mature BDNF strengthens
synaptic connections, pro-BDNF depresses synaptic transmission through its interactions
with p75.295
A polymorphism in the human p75NTR gene in which serine 205 is changed to a
leucine (S205L) has been associated with decreased incidence of depressive and suicidal
behavior compared to individuals with ser205.296,297 While this could indicate a protective
role of this polymorphism in regard to mood disorders, it is unknown whether this
polymorphism performs a similar role in other neural disorders or neurotrauma.
However, complete inhibition of proNGF/75 receptor interactions improves limb
function, coordination, and bladder function after experimental SCI.298,299 The role of p75
signaling in increasing NR2B-mediated currents is also of not because NR2B-containing
NMDA receptors are crucial in mediating hyperexcitability in the dorsal horn, and effect
which is associated with neuropathic pain.300,301 Therefore, the S205L polymorphism
could alleviate neuropathic pain if it alters mechanisms of maladaptive plasticity that
increase NR2B signaling in the dorsal horn.

1.3.4

Apolipoprotein E

Apolipoprotein E (apoE) is a lipid transport protein that is primarily synthesized
in the liver and the brain.302 In the periphery, apoE is typically a component of very low
density lipoproteins (VLDL) and mediates cellular uptake of triglycerides and cholesterol
through high-affinity binding to the low-density lipoprotein receptor family. In the CNS,
astrocytes are the primary cell type responsible for synthesis of apoE, although microglia
and neurons are capable of secreting apoE when injured or stressed.303–306 ApoE is crucial
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for CNS development and plasticity because neurons themselves only produce enough
cholesterol for survival. They require apoE-mediated delivery of cholesterol for repair
and synapse formation.307,308 ApoE is encoded by the APOE gene, which occurs as three
alleles in the human population each differing by single cysteine-arginine substitutions.
The alleles are designated as 2 (cys112, cys158), 3 (cys112, arg158), and 4 (arg112,
arg158) .309
In the 1990’s, the 4 allele gained notoriety as a major risk factor for sporadic
Alzheimer’s Disease (AD).310–312 This discovery provided the impetus for numerous
studies during subsequent decades that revealed apoE4’s association with pathological
hallmarks of AD such as amyloid beta plaques and neurofibrillary tangles.313–315 The 4
allele, which is expressed in anywhere from 14%-25% of the population, simultaneously
increases the risk of developing AD and decreases the age of onset in a dose-dependent
manner.310,316–318 In addition to its role in exacerbating AD pathology, the presence of
apoE4 has also been associated with deficits in synaptic plasticity and cognitive function
in a variety of other disorders and dementias.319–322
Throughout development, synaptic pruning refines the circuitry of the CNS. Some
synapses are strengthened, while other are phagocytosed, depending upon their level of
activity. Astrocytes play a crucial role in the phagocytosis of unneeded synapses.323
However, the apoE isoforms differentially modulate this astrocytic function, with E2
enhancing and E4 decreasing phagocytosis and pruning compared to E3-expressing
animals.324 This could explain why apoE4 knock-in mice display deficits in synaptic
functioning even at a young age.325 Deficiencies in synaptic functioning in E4 animals
could additionally be attributed to apoE4’s modulation of glutamate receptor recycling.
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Compared to neurons expressing apoE3 or E2, those expressing human E4 sequester
AMPA and NMDA receptors intracellularly. This sequestration is possibly due to an
apolipoprotein E receptor 2 (Apoer2)-mediated decrease in receptor
phosphorylation.326,327
ApoE genotype also influences synaptic integrity through altering the influx of
calcium ions. Expression of the apoE4 protein increases influx of extracellular calcium,
inducing neurotoxicity in vitro.328 This excessive calcium influx could also be responsible
for the increased in calcineurin activity in the cortex of apoE4 targeted replacement mice,
which results in a loss of dendritic spines density.329 In contrast with evidence supporting
the presence of excessive intracellular calcium in E4 neurons, a lack of Ca2+-mediated
signaling in hippocampi of E4 animals is also evident.330 Impairment of signal
transduction through CaMKIIa (Ca2+/calmodulin-dependent protein kinase IIa) and pCREB (phosphorylated cAMP response element-binding protein) impairs synaptic
plasticity in rats injected with human E4 protein.330 Together, these results suggest that
apoE4-dependent influences on Ca2+ signaling may be region-dependent within the CNS,
making it difficult to predict how intracellular Ca2+ levels may be impacted in the spinal
cord.
The detrimental effects of apoE4 on synaptic plasticity have functional
consequences. Long term potentiation in the dentate gyrus is attenuated by the E4
isoform.331,332 Mice expressing human apoE4 have deficits in learning, retention, and
spatial memory.333–335 Deficits in learning and memory are more pronounced in females,
as observed in targeted replacement mouse models that express human APOE
alleles.336,337 These differences in brain plasticity observed amongst humanized APOE
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mice are also evident in the human population. Individuals who have at least one E4
allele display deficits in episodic memory and exhibit a decline in cognitive function over
time.338–340
In addition to its role in neural development and cognitive functioning, apoE is
also involved in repair processes following neurotrauma in the CNS and the
periphery.341–343 These processes include neuroprotection, axon regeneration, and
synaptogenesis, all of which are impaired in apoE4 mice following CNS insult.344–346
Indeed, the 4 allele has been associated with worse outcomes in individuals who
experience traumatic brain or spinal cord injuries.347–349 Studies of traumatic brain injury
reveal that apoE4 delays repair of the blood brain barrier, exacerbates ischemic damage,
and impairs plasticity in the form of learning and memory.350–352 Less is known about the
impact of APOE genotype on plasticity of neural circuits after spinal cord injury,
although studies in knockout mice have emphasized that apoE protein is crucial for white
matter sparing and functional recovery after SCI.341,353,354 Data from our lab provides
evidence that apoE4 animals exhibit attenuations in spinal and respiratory plasticity both
in the absence and presence of cervical spinal cord injury.

1.3.5

Sex as a biological variable in SCI research

A crucial variable that accounts for much of the heterogeneity in the human
population but is often not modeled preclinically is sex. Prior to 2009, the majority of
preclinical biomedical research was performed in males, with only 15% of studies solely
focused on females. Publications that did feature experiments in which both sexes were
included did not analyze data in a manner that considered sex a variable, instead grouping
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data from males and females.355 This led to incomplete understanding of disease
pathologies and the therapeutic potential of drugs, with women suffering from unforeseen
drug-related health risks as a result.356 In response to this issue as well as the
reproducibility crisis, the National Institutes of Health developed policies in 2014 that
require grant applicants to include both male and female subjects in their studies unless it
can rigorously be proven unwarranted.357,358
Studies addressing sex differences in nervous system structure and function have
revealed that sex hormones impact CNS inflammation, neuronal dendrite morphology,
and synaptic plasticity.359–362 Sex differences are also evident in the prevalence and
manifestation of affective disorders including depression and post-traumatic stress
disorder.363–365 These disparities indicate that the functioning, or malfunctioning, of
neural circuits is strongly modulated by sex. Males and females also report different
symptoms after traumatic brain injury, with females often experiencing increased anxiety
and depression while males display enhanced aggression.366,367 When compared to males,
improved functional outcomes have been observed in females who experience a
neurotraumatic even, possibly due to protective effects of estrogen and progesterone.368–
370

While little is known about the influence of sex on synaptic plasticity after SCI, a
series of investigations by Zabka et al. revealed that sex hormones influence 5-HTdependent plasticity in the spinal cord.371–373 For example, gonadectomy abolishes LTF in
male rats, but can be restored through administration of testosterone, which undergoes
conversion to estradiol in vivo.372 Estrogen modulates respiratory motor plasticity by

35

increasing 5-HT levels in the raphe while progesterone acts as a breathing stimulant.374–
376

Interestingly, sex effects on CNS plasticity have also been observed in the context
of the three APOE variants. Brain plasticity in the form of learning and memory is
impaired in mice expressing the 4 allele, an effect that is more severe in females.336
Until now, the manner in which sex and APOE genotype interact to influence plasticity
and recovery of function after SCI has remained uninvestigated. However, conclusions
from previous studies collectively emphasize the importance of considering both sex and
genetic background when developing treatment strategies for the diverse spinal cord
injured population since individuals may be predisposed toward or against plasticity and
functional recovery. Indeed, a recent review from Fouad et al. emphasized the importance
of considering variation in the human population and the response to therapeutics as a
key to improving translation.377 Current work in our lab has aimed to address this gap in
knowledge and provides novel insight into the interplay of sex and the human APOE
alleles that modulates spinally-mediated plasticity in the presence or absence of injury.
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CHAPTER 2. HUMAN APOE AS A BARRIER TO RESPIRATORY MOTOR
PLASTICITY IN RATS
2.1 Introduction
The majority of spinal cord injuries (SCIs) occur at the cervical level. 2 These
high-level injuries can disrupt axons that descend from the brainstem to synapse on
phrenic motor neurons (PMNs) at the C3-C6 level. PMNs control the contraction of the
diaphragm, which is the primary muscle responsible for breathing function, and damage
to these bulbospinal pathways leads to significant breathing impairments. As a result,
cervically injured individuals who do not achieve sufficient spontaneous recovery
become reliant on artificial ventilation, increasing their risk for respiratory infections and
death after injury. Indeed, the restoration of independent breathing function is a top
priority for the SCI community.378
Therapeutic approaches that are being developed preclinically with the goal of
improving breathing function after SCI are plentiful and diverse, yet clinically available
therapeutics are extremely limited. Currently, the primary commercially available method
of restoring diaphragmatic function is surgical implantation of diaphragm pacers.190 Less
invasive approaches to improve motor function, such as transcranial magnetic stimulation
and intermittent hypoxia (IH) often work through a mechanism of modulating plasticity
in the spinal cord to induce lasting changes in neural circuitry function.266,288,379 However,
preclinical investigations into the efficacy of these strategies often utilize homogenous
populations of animal models that are incapable of reflecting the diversity found in the
human population. Therefore, the question of how plasticity in the spinal cord may be
modulated by genetic factors currently remains unanswered. Indeed, human genetic
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diversity could constitute a major confounding factor in clinical studies. For example,
when therapeutics which show preclinical efficacy are advanced into clinical trials only
to show conflicting or variable results. Ultimately, genetic variation could contribute to
the lack of bench to bedside translation for the SCI population.
One well-described form of plasticity that has been validated to restore function to
the paralyzed diaphragm after cervical SCI is long term facilitation (LTF). LTF can be
induced through exposure to intermittent hypoxia (IH), which activates BDNF (brainderived neurotrophic factor)- and glutamate receptor-dependent synaptic
strengthening.268,380 While LTF was first described as a prolonged augmentation of
respiratory activity in intact animals, it was later discovered that it is also sufficient to
improve diaphragm function in spinally injured animals.139,224,247 In addition to
respiratory LTF, IH also induces plasticity in other motor systems. Indeed, IH has been
utilized in clinical trials as a therapeutic approach to improve hindlimb, forelimb, and
ventilatory outcome in SCI populations.140–142 Despite consistent preclinical findings,
clinical studies have demonstrated that up to one-third of patients are “non-responders” to
IH, meaning that they show no benefit from treatment.141,381 This indicates that factors in
the human population, which are not represented in preclinical animal models, may limit
the propensity for plasticity in some individuals, thereby reducing the potency of IH as a
therapeutic tool.
The vast majority of preclinical investigations of the respiratory response to IH
have been performed in rats. This has advantageously allowed for the optimization of IH
protocols and provided a thorough understanding of the molecular mechanisms behind
LTF in this particular animal. For example, because LTF is known to be serotonin (538

HT)-dependent, MacFarlane and Mitchell (2009) demonstrated that LTF can also be
induced through episodic 5-HT dosing of the spinal cord. Unfortunately, the dependence
on rat models of LTF limits the potential for studying the influence of human genetic
diversity on this plasticity. To circumvent this deficiency while still utilizing a wellcharacterized rat model of respiratory motor plasticity, the current study applies
exogenous human apolipoprotein E (apoE) proteins directly to the spinal cord prior to
episodic 5-HT dosing to determine how different isoforms of a human protein could alter
spinal plasticity both in the presence and absence of cervical SCI.
Of the three isoforms of apoE, designated E2, E3, and E4, the E4 isoform has
previously been associated with impaired synaptic plasticity. The E3 and E4 isoforms
(encoded by the 3 and 4 alleles of the APOE gene) are much more prevalent than E2,
which is only present in around 7% of the human population.318 Therefore, the E3 and E4
isoforms of apoE are ideal targets to test whether genetic factors in the human population
may limit individuals’ propensity for plasticity, and consequently reduce the efficacy of
therapeutic approaches that harness spinally-mediated plasticity as a means of improving
functional recovery after SCI. We hypothesize that rats dosed with human apoE4 will
display an abatement in respiratory motor plasticity, emphasizing the importance of
considering human genetic diversity when developing and translating SCI therapeutics.
2.2 Materials and methods

2.2.1

C2 Hemisections

All experiments were approved by the Institutional Animal Care and Use
Committee of the University of Kentucky. Female Sprague-Dawley retired breeder rats
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were obtained from Envigo (Indianapolis, IN). Animals were acclimated for at least one
week before injury C2 hemisection. Prior to surgery, rats were anesthetized with
ketamine (75-100mg/kg, Ketaset, Zoetis) and xylazine (5-10 mg/kg, AnaSed, Akorn
Pharmaceuticals). When the proper plane of anesthesia was reached, the surgical site was
shaved and sterilized with alternating 70% ethanol and betadine swabs. Puralube
ophthalmic ointment was applied to the eyes to prevent drying during surgery. A skin
incision was made on midline, extending from the ears to the level of the scapula. An
incision was then made through the acromiotrapezius, semispinalis capitus, and rectus
capitus muscles along the midline and muscles were retracted. Paravertebral musculature
wass cut away from the C2 vertebra. A C2 laminectomy was performed by cutting the
pedicles of the C2 vertebra bilaterally. The dura was perforated and resected using
microscissors. The tip of a 27 gauge needle was bent at a 45 degree angle. Under a
dissecting microscope, the needle tip was then inserted at the midline of the spinal cord at
the C2 level, caudal to the C2 dorsal roots, and a cut was made extending from midline to
the lateral edge of the cord. The needle was passed through the spinal cord in the same
location for a total of three passes to ensure lesion completeness. Musculature was
sutured with 6-0 absorbable suture and skin was closed with wound clips. Rats received
subcutaneous buprenorphine (0.05mg/kg) and carprofen (5mg/kg) immediately as they
began regaining consciousness.

2.2.2

Chronic Spinal Cord Exposures and Episodic Serotonin Dosing

Episodic 5-HT dosing was performed 20 weeks post-injury in C2 hemisected
animals. Episodic 5-HT dosing utilized the same protocol for spinally intact and C2
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hemisected rats. Animals were anesthetized with urethane (1200mg/kg) intraperitoneally.
An incision was made through the skin on the dorsal aspect of the neck as previously
described for a C2 hemisection. Musculature and scar tissue were removed to expose the
spinal cord at the C2/C3 level and a durotomy was performed with microscissors. Once
the spinal cord was exposed, animals were moved into a supine position and a
laparotomy was performed by incising the rectus abdominis, external oblique, and
internal oblique muscles. Bipolar electrodes, connected to an amplifier and data
acquisition system (CED 1401 with Spike2 Data Analysis Computer Interface,
Cambridge Electronic Design), were inserted into the left and right hemidiaphragm and
ground electrodes were inserted into the hind paws. Abdominal muscles were sutured and
the animal was returned to prone position.
With animals in prone position, 20ul of apoE protein (1g/ml in physiological
saline, optimal concentration was determined by preliminary studies, data not shown)
was applied to the spinal cord. After 30 minutes, the apoE solution was swabbed from the
spinal cord and 6ul of 5-HT (1M in apoE solution, as described by MacFarlane and
Mitchell, 2009) was applied to the spinal cord. After 5 minutes, the first dose of 5-HT
was absorbed with a swab and the second dose was applied. This was repeated for a total
of three doses (Figure 1 B). Diaphragmatic activity was recorded for 40 minutes after the
final 5H-T dose. Animals were then perfused with 4% paraformaldehyde (PFA) and the
spinal column was removed and placed in 4% PFA at 4C. After 2 days, spinal columns
were removed from PFA and placed in 30% sucrose at 4C for cryoprotection until
sectioning.
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2.2.3

Diaphragmatic EMG trace analysis

After recording, raw diaphragmatic EMG traces were rectified and integrated
using Spike2 software. Analysis was performed at six time points: twice during baseline
recording, once 5 minutes before the final 5-HT dose, and at 5, 20, and 40 minutes after
the final 5-HT dose (Figure 2.1 B). For each time point, peak amplitude was averaged
over a 30 second period. Amplitude of diaphragmatic bursts at each time point were
normalized to that animal’s pre-hypoxia baseline amplitude. Baseline amplitude was
calculated by averaging the amplitudes quantified at 10 minutes and 5 minutes before the
first dose of 5-HT.

2.2.4

Labeling of phrenic motor neurons

Labeling of PMNs was performed as previously described by Mantilla et al. 383
Briefly, three days prior to terminal EMG recordings, animals received bilateral
intrapleural injections of recombinant cholera toxin subunit B (CTB) conjugated to
AlexaFlour 488 (Invitrogen, C22481). CTB was diluted in physiological saline to a
concentration of 0.2%. Animals were anesthetized with isoflurane. The ventral thoracic
region was shaved and swabbed with 70% ethanol. Using a Hamilton syringe, 20l of
diluted CTB was injected in each the left and right sides of the thoracic cavity at a depth
of 6mm from the skin.

2.2.5

Sectioning and Immunohistochemistry

Spinal cords were dissected out of the spinal columns and embedded in Optimal
Cutting Temperature embedding medium (OCT, Sakura Tissue-Tek). Tissue was
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cryosectioned at a thickness of 30m and placed directly onto slides. For the injury site
(C2), every other section was collected. For the region of the phrenic motor nucleus (C3C6) every section was collected serially onto 10 slides so that every slide held sections
from each spinal cord level. Sections from the C3-C6 were then labeled with antibodies
for synaptophysin (Invitrogen 50-6525-82, diluted 1:32) and either GluR1 (Abcam
Ab31232, diluted 1:500) or NR1 (Abcam 52177, diluted 1:100). Antibodies were diluted
in blocking buffer (5% normal goat serum, 0.1% bovine serum albumin, and 0.1% tritonX100 in 1xPBS). Slides were mounted with Flouromount (Southern Biotech, cat No.
0100-20) and immediately sealed with clear nail polish.

2.2.6

Imaging and Colocalization Analysis

Imaging was performed on a Nikon Eclipse Ti series inverted confocal
microscope at 20x. For staining quantification in tissue from uninjured animals,
snapshots of phrenic motor neurons were captured at the C4 level of each animal. For
quantification in injured animals, Z stacks (2.19m per step) of phrenic motor nucleus
were taken at the C4 level both ipsilaterally and contralaterally to injury. Investigators
were blinded to genotype during imaging and quantification.
For colocalization analysis, images were opened in ImageJ (National Institutes of
Health). Investigators were blinded to treatment and injury status until after quantification
was complete. A region of interest was drawn around each phrenic motor neuron labeled
by CTB. Colocalization was quantified through the “colocalization threshold” plugin.
The Costes method for statistical significance was used to calculate Pearson’s correlation
coefficient between randomized images and a study image to ensure that detected
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colocalization was real (ImageJ, “Colocalization Analysis”, 2020). To determine the
percentage of synaptic glutamate receptor subunits compared to total subunits in each
PMN, the number of colocalized voxels was then normalized to all voxels that were
positive for NR1 or GluR1 in the region of interest.

2.2.7

Quantitative PCR

Fresh spinal cord tissue was collected from a cohort of animals for mRNA and
protein quantification. These animals were sacrificed 1 hour after the final dose of 5-HT
and the region of the phrenic motor nucleus (C3-C6) was excised and immediately frozen
on dry ice. Tissue was kept at -80C until analysis was performed. The tissue was then
divided for protein or RNA isolation, with 35-40mg of tissue being used for RNA
extraction. Tissue was homogenized using a Bead Ruptor (Omni International). RNA was
purified using an RNeasy Lipid Tissue Mini Kit (Qiagen, Cat #74804) and quantified by
NanoDrop (ThermoFisher Scientific). Reverse transcription was performed in a Thermal
Cycler (Bio-Rad) using 25ng/l of sample RNA. Quantitative PCR was performed on
25ng of cDNA in a QuantStudio 7 (Applied Biosystems) using Luna Universal Probe
Master Mix (New England BioLabs, Cat #M3004S) and primers for BDNF
(ThermoFisher, Rn01484924_m1) and actin (ThermoFisher, Rn00667869_m1). Fold
change from vehicle-treated animals was then calculated for E3- and E4-treated animals.

2.2.8

BDNF Quantification

Remaining fresh tissue was homogenized in RIPA buffer (Alfa Aesar, J62524)
with protease inhibitor (Pierce, Cat #A32965) for protein isolation. Protein was
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quantified by a BCA assay (Pierce, Cat #23227). Protein was quantified using a Meso
Scale Discovery UPLEX Assay (C0292-2).
2.2.9

Statistical Analysis

For statistical analysis of EMG traces, repeated measures (RM)-ANOVA was
used to account for within-subject correlation given repeated measurements over time.
Additionally, Student’s t-tests were performed at three time points (5 minutes before final
5-HT, 5 minutes after final 5-HT, and 40 minutes after 5-HT) to determine whether there
was a significant difference in diaphragmatic burst amplitude at any single time point.
However, RMANOVA was the primary statistical analysis for this data. One injured
apoE3-dosed rat was excluded due to its classification as a significant statistical outlier
according to the Grubbs test. Two-way ANOVAs were used to analyze colocalization
staining. Student’s t-tests were used to analyze qPCR and ELISA data. Results were
considered statistically significant if p < 0.05. Investigators were blinded until all
diaphragmatic EMG and histology analyses were complete.
2.3 Results

2.3.1

Respiratory motor plasticity in the presence of human apoE isoforms

Episodic 5-HT dosing of the cervical spinal cord is sufficient to induce LTF,
which manifests as prolonged augmentation of breathing motor output.382 Utilization this
method of induction, in contrast to exposure to IH using hypoxia chambers, allowed for
simultaneous recordings of diaphragmatic EMGs. Human apoE protein in either the E3 or
E4 isoform was applied intrathecally (1g/ml) to the exposed spinal cord at the C3-C6
level, where phrenic motor neurons are located (Fig. 2.1 A). After thirty minutes of
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baseline diaphragmatic EMG recording in the presence of human apoE, rats received
three doses of 5-HT (1M) separated by 5 minutes (Fig. 2.1 B). Diaphragmatic activity
was recorded for 40 minutes after the final dose of 5-HT. Representative traces from E3
and E4-treated animals are shown in Fig. 2.1 C. Quantification of burst amplitude
demonstrated that there was no difference in the 5-HT-induced breathing changes
between animals exposed to E3 and E4 protein (Fig 2.1 D,E). Time points for burst
amplitude quantification are indicated by green arrows in Fig. 2.1 B.

2.3.2

The influence of apoE isoforms on synaptic glutamate receptor levels

LTF is dependent upon activation of glutamate receptors on phrenic motor
neurons.384,385 Because apoE4 is known to impair glutamate receptor trafficking326, we
quantified the amount of synaptic AMPA and NMDA receptors on CTB-labeled phrenic,
as previously described by Huie et al. (2015)203, motor neurons to determine whether E4
would impede synaptic localization. Fig. 2.2 A-B shows representative images of
colocalized staining of the synaptic marker synaptophysin and either the NMDA receptor
subunit NR1 (A) or the AMPA receptor subunit GluR1 (B) on PMNs. Synaptic glutamate
receptor subunits were normalized to the total amount of intracellular subunit staining.
Quantification of synaptic NR1 and GluR1 demonstrated no significant difference
between genotypes (Fig. 2.2 C-D, 2-way ANOVA, NR1 p=0.21 and GluR1 p=0.31).
However, a trend emerged in which episodic 5-HT led to increases in synaptic
localization of NR1 in rats exposed to E3 and E4 (Fig. 2.2 C). While a similar trend of 5HT-induced upregulation was observed in synaptic GluR1 in E3-treated animals, it was
not evident in animals receiving E4 protein (Fig. 2.2 D). An inability to increase synaptic

46

glutamate receptors in response to 5-HT suggests a potential apoE4-dependent deficiency
in the ability to initiate synaptic plasticity.

2.3.3

ApoE isoform-dependent modulation of spinal plasticity after SCI

In addition to enhancing breathing activity in intact rats, LTF also restores
breathing function to the paralyzed hemidiaphragm after cervical SCI.139,247 To determine
whether the impact of human apoE isoforms on spinally-mediated respiratory motor
plasticity are altered by SCI, we performed episodic 5-HT dosing on C2 hemisected rats.
In order to increase clinical relevance, we performed this 5-HT dosing protocol on
animals that were chronically injured (20 weeks) when they received episodic 5-HT
concurrently with terminal diaphragmatic EMG recordings. All rats in this study
displayed spontaneous recovery of diaphragmatic recovery by 20 weeks post injury (data
not shown). Fig. 2.3 A illustrates the lateral C2 hemisection injury model and depicts the
resultant interruption of bulbospinal respiratory axons. As depicted in Fig. 2.3 B, our
injury completely destroys the left half of the spinal cord at the C2 level. Diaphragmatic
EMG recordings were performed concurrently with human apoE isoform administration
and subsequent episodic 5-HT dosing as in intact animals. In contrast to intact animals,
injured animals receiving apoE3 appeared to increase breathing activity after the final
dose of 5-HT (Fig. 2.3 C). This is analogous to the effect observed in rats dosed with
episodic 5-HT in the absence of human apoE.382 Although injured apoE4-treated animals
did not exhibit a similar augmentation in breathing, there was no statistically significant
difference between groups (Fig. 2.3 D-E, RM ANOVA p=0.58). Diaphragmatic burst
amplitude peaked at 5 minutes after the final dose of 5-HT in E3 animals. However, there
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was no significant difference between amplitude in E3 and E4 animals at this time point
(Fig. 2.3 E, Student’s t-test p=0.27).

2.3.4

Synaptic glutamate receptor expression on phrenic motor neurons after SCI

Similar to the procedure performed on tissue from spinally intact rats, tissue
harvested from C2 hemisected rats was stained for synaptophysin and either NR1 (Fig.
2.4 A) or GluR1 (Fig. 2.4 B). Colocalization of these molecules was quantified on PMN
that had been retrogradely labeled with CTB, then normalized to total glutamate receptor
subunits in the cell. Quantification of NR1 colocalization revealed that there was no
difference between E3 animals that did receive episodic 5-HT and those that didn’t (2way ANOVA, multiple comparisons with Tukey’s post hoc test p=0.97). In contrast, 5HT induced a significant reduction in synaptic NR1 levels in E4-treated animals (Fig. 2.4
C, 2-way ANOVA, multiple comparisons with Tukey’s post hoc test p=0.0266). The
pattern of synaptic localization of GluR1 in injured animals differed greatly from that of
NR1. Episodic 5-HT dosing appears to upregulate the synaptic localization of GluR1containing AMPA receptors in E3 animals, although this trend did not reach statistical
significance (Fig. 2.4 D, 2-way ANOVA, multiple comparisons with Tukey’s post hoc
test p=0.075). Episodic 5-HT treatment did not lead to changes in synaptic GluR1 levels
in animals with apoE4 (2-way ANOVA, multiple comparisons with Tukey’s post hoc test
p=0.60). This supports the trend observed in spinally intact E4 animals, further
insinuating that E4 prevents 5-HT-induced increases in GluR1 trafficking to the
postsynaptic membrane of PMNs.
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To determine whether C2 hemisection alone stimulated changes in synaptic
glutamate receptor levels, we also compared NR1 and GluR1 colocalization between
intact and injured animals that did not receive episodic 5-HT dosing. Figure 2.4 E-H
shows this quantification in E3 (E,G) and E4 (F,H) animals. In both E3 (E. Student’s ttest p<0.0001) and E4 (F. Student’s t-test p<0.0001) treated animals, synaptic NR1
colocalization significantly decreases after injury. However, synaptic GluR1 localization
did not differ significantly between uninjured and injured animals treated with human E3
(G. Student’s t-test p=0.29) or E4 (H. Student’s t-test p=0.41) protein.

2.3.5

Influence of apoE isoforms on 5-HT-dependent BDNF production

Previous studies have shown that induction of LTF leads to production of new
BDNF following 5-HT receptor activation.223,268 Since this BDNF synthesis and
subsequent binding of its TrkB (tropomyosin receptor kinase B) receptor is necessary for
LTF, we investigated whether BDNF production differs between E3- and E4-treated
animals. In uninjured animals, presence of human apoE3 or apoE4 did not appear to
influence BDNF synthesis at either the mRNA or protein level in the region of the
phrenic motor nucleus (Fig. 2.5 A,C, Student’s t-tests, mRNA p=0.73, protein p=0.69).
Likewise, mRNA and protein quantification in tissue harvested from injured animals
exposed to episodic IH revealed no significant difference between animals treated with
E3 and E4 (Fig. 2.5 B, D, Student’s t-tests, mRNA p=0.83, protein p=0.43). Comparison
of vehicle-treated animals that did not receive human apoE protein prior to episodic 5-HT
dosing demonstrated no significant difference between BDNF mRNA expression in intact
and injured animals (Fig. 2.6, Student’s t-test p=0.74). This suggests that although
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episodic 5-HT did not induce the expected increase in BDNF levels in hemisected
animals, this was not due to an injury-induced ceiling effect on BDNF production.
2.4 Discussion
Harnessing neural plasticity in the spinal cord by strengthening synaptic
connections or activating spared latent pathways can provide a means of improving
functional recovery after spinal cord injury. While therapeutic approaches that enhance
neuroplasticity have proven effective in homogenous populations of preclinical rodent
models, the impact of genetic variation in the diverse human population remains
underexplored. The current study represents the first investigation into how genetic
variation may impact individuals’ predisposition towards neuroplasticity, and
consequently, their response to treatment strategies after SCI. By utilizing a welldescribed model of respiratory motor plasticity in rats, we were able to model the impact
of the plasticity-limiting human apoE4 protein on serotonin-dependent recovery of
breathing function after SCI. Contrary to our hypothesis, we did not observe significant
differences in the respiratory response to IH between E3 and E4 treated animals.
However, apoE4 did cause a decline in synaptic NMDA receptor levels, indicating that
apoE isoforms modulate plasticity at the molecular level in PMN synapses or in
intracellular signaling cascades that are activated by therapeutic IH or episodic 5-HT.

2.4.1

Human apoE isoforms and plasticity in the neural control of breathing

Long term facilitation of respiratory activity was first discovered as a result of
carotid sinus nerve or carotid body afferent stimulation.386 This plasticity can also be
induced through hypoxic stimulation of the carotid body, but only if the hypoxia
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exposure consists of repeated bouts opposed to a single, sustained hypoxic period.387
Both electrical and hypoxic stimulation of carotid body afferents induce respiratory
motor plasticity through serotonin-dependent mechanisms that result in strengthening of
synaptic inputs onto PMNs.217,224,388 Indeed, directly administering episodic doses of 5HT directly to the cervical spinal cord of rats activates LTF through a mechanism similar
to that of IH.382 However, episodic 5-HT in animals that had human apoE3 or E4 protein
present in the cervical spinal cord did not induce augmentation of breathing motor output
that is typically characteristic of LTF.
The lack of LTF observed in apoE-treated rats could be due to a variety of factors.
The original studies that describe LTF of breathing utilized animals that were
vagotomized and artificially ventilated to maintain phrenic activity at the level that would
be present during eupneic breathing. This was accomplished through monitoring pCO2,
which created a feedback loop with the ventilator to preserve eupneic activity levels.
Exhaled CO2 and body temperature were also monitored to control for changes in
metabolic rate, cardiac output, and resulting CO2 return to the lungs.386,389 While rats in
the present study were kept on heating pads throughout IH and diaphragmatic EMG
recordings, body temperature and CO2 levels were not monitored. As a result, animals
may have experiences hypoxia-induced metabolic adjustments or vagal feedback that led
to changes in breathing, which could negate the induction of LTF.
Apolipoprotein E is a prominent protein of interest in the Alzheimer’s Disease
(AD) literature, due to its designation as a significant risk factor for developing AD in
people who express the apoE4 isoform. As a result, thousands of publication have
described its role in the central nervous system in health and disease, although very few
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studies have examined its role in spinal cord repair and recovery of function after SCI.
Interestingly, spinally injured individuals who are apoE4+ exhibit less motor recovery
than those who don’t carry the allele encoding E4.348,390 Although mouse studies have
revealed that apoE levels in the spinal cord are elevated for up to three weeks post-injury,
it is unknown how the distinct human isoforms may influence recovery or the response to
therapeutics such as IH after SCI.341,391 While our data indicates that there is no
difference in the response to episodic 5-HT between E3 and E4-treated animals, there are
some methodological considerations to be addressed. The cervical spinal cord was bathed
in human apoE protein for 30 minutes prior to episodic 5-HT. However, it is unknown
whether apoE penetrated the cord sufficiently to reach PMN in the ventral horn.
Additionally, apoE could have been interacting with various cell types in the spinal cord
including astrocytes, microglia, and interneurons to influence signaling in the spinal
circuitry. Rats were also still producing the rat form of apoE, which may have been
competing with the exogenous human isoforms for receptor binding. These uncontrolled
circumstances could have dampened the effect of the human isoforms in the spinal cord.
The human apoE proteins used in these experiments were unlipidated. ApoE
functions as a lipid carrier in the CNS and is lipidated by the ABCA1 (ATP binding
cassette A1) transporter. ABCA1 transports cholesterol and phospholipids into HDL-like
molecules that contain apoE.392 Lipidated apoE then binds its receptors such as LDLR
(low density lipoprotein receptor) or apoer2.393,394 Because the different isoforms of apoE
are known to have different lipidation profiles and also display isoform-dependent
interactions with apoE receptors, the lack of lipidation may have altered or inhibited the
capacity of human apoE isoforms to enter cells through receptor binding in the rat
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CNS.395–397 To address these methodological concerns, we have performed additional
studies in targeted replacement APOE mice, which express the human APOE alleles
instead of the murine form under the control of the mouse promoter, allowing the animals
to produce physiologically relevant lipidated human apoE protein for the duration of their
lives, including during the recovery period following SCI.398–400

2.4.2

The influence of human apoE on plasticity in the injured cord

The restoration of breathing function after SCI is crucial to limit hospital costs
and lengths of stay, increase life expectancy, and decrease the occurrence of
comorbidities such as respiratory infections.179,401,402 Intermittent hypoxia is therefore an
intriguing therapeutic approach because it not only enhances spinally-mediated plasticity
for the improvement of respiratory motor function, it also modulates plasticity in other
motor systems. IH has undergone clinical trials with positive outcomes for ventilation,
hand function, and ankle strength.140,142,403,404 However, subjects demonstrate varied
responses to IH treatment, with some demonstrating notable functional improvement
while others appear unaffected or even exhibit a slight decline in function.141,381 While
the heterogeneous nature of SCIs could account for some of this variability, genetic
variability that isn’t represented in preclinical animal models could also interfere with
individuals’ capacity to respond to therapeutic approaches that stimulate plasticity of
spinal circuits.
In support of this hypothesis is the emergent trend in C2 hemisected animals that
were exposed to human apoE isoforms. While those treated with E3 displayed the
expected increase in diaphragmatic burst amplitude following episodic 5-HT, E4 animals
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had no change in breathing activity. Although this trend did not reach significance, it
indicates that the human apoE isoforms may have a role in modulating respiratory motor
plasticity. ApoE4 has gained notoriety for impairing synaptic plasticity in the brain, but
this is the first investigation to find similar effects in spinally-mediated forms of
plasticity.331,405 The dosing strategy utilized in this study had been previously described
in rats by MacFarlane and Mitchell (2009). However, since both human apoE protein and
5-HT were applied as solutions to the dorsal surface of the exposed spinal cord, there
could have been inter-animal variation in the diffusion patterns of these molecules,
explaining the variation observed between animals that prevented our data from reaching
statistical significance. Future studies utilizing targeted replacement APOE mice will
nullify this concern by ensuring that human apoE is expressed equally under the same
promoter in all animals.

2.4.3

Synaptic glutamate receptor levels on PMN after exposure to human apoE

Although statistically significant differences in the diaphragmatic activity of E3
and E4 animals were not observed, this does not rule out the possibility that the human
apoE isoforms influences synaptic plasticity through a mechanism that isn’t robust
enough to be observed in EMG recordings. LTF is induced through a signaling cascade in
PMN that relies on newly synthesized BDNF signaling through the TrkB receptor,
ultimately leading to phosphorylation and trafficking of glutamate receptors to the
postsynaptic membrane.268,288 These postsynaptic glutamate receptors are crucial for
synaptic strengthening of synaptic inputs on PMN and are necessary for the induction and
maintenance of LTF.384,385 A lack of synaptic glutamate receptors on PMN would
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therefore indicate a deficiency in the ability to induce spinal plasticity. ApoE4 is known
to decrease trafficking of both AMPA and NMDA receptors, leading to deficits in
synaptic plasticity.326 By utilizing a colocalization staining method described by Huie et
al. (2015), we found that uninjured animals displayed no difference in synaptic AMPA or
NMDA receptor subunit levels, regardless of apoE isoform or episodic 5-HT exposure.
However, our data did indicate that 5-HT dosing led to slight increases in NR1 synaptic
localization in both E3 and E4 animals, but only increased GluR1 in those with E3.
Interestingly, although E4 animals did not demonstrate a similar increase in GluR1 after
episodic 5-HT, they did have higher levels of GluR1 in the absence of 5-HT. Thus, the
absence of GluR1 upregulation could indicate a ceiling effect on synaptic AMPA
receptors, perhaps to compensate for the reduced dendritic spine density and loss of
synaptic integrity that has been associated with apoE4.329,407
Glutamate receptor localization after C2 hemisection differed greatly from that
observed in intact animals. Both E3- and E4-treated animals downregulated synaptic
localization of NR1 after injury. Perhaps more striking was the finding that episodic 5HT dosing caused a significant decrease in synaptic NMDA receptors when apoE4 was
present. Since LTF requires signaling through NMDA, but not AMPA, receptors, this
loss of postsynaptic NMDA receptors could contribute to the effect of E4’s dampening
effect on the respiratory response to IH in injured animals. NMDA receptors (NMDAR)
are heterotetramers composed of NR1, NR2, and NR3 subunits.408 While NR1 is an
obligate subunit of functional NMDA receptors and therefore indicative of total
NMDARs present, future investigations into the synaptic presence of additional NMDAR
subunits would provide greater insight into how synaptic plasticity is altered by human
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apoE isoforms. For example, previous work has shown that synaptic strengthening in the
form of cortical long term potentiation relies on NR2A-containing NMDAR.409 Similarly,
spinal cord plasticity leading to spontaneous recovery of breathing function and
activation of the crossed phrenic pathway (the spared anatomical substrate mediating
LTF after C2 hemisection) correlates with NR2A levels on phrenic motor neurons.410,411
Subunits of AMPA receptors, GluR1 , 2, 3, or 4, also have unique impacts on
synaptic signaling and plasticity, particularly since the GluR2 subunit confers calcium
impermeability.412 Decreases in GluR2 after SCI are associated with synaptic
strengthening mediated by calcium-permeable AMPA receptors.411,413 However,
respiratory drive to PMN is communicated through glutamatergic bulbospinal pathways,
emphasizing the importance of synaptic AMPAR expression.414,415 Accordingly, in
response to SCI, GluR2 subunits decline as levels of the GluR1 subunit rise, although the
increase in GluR1 after SCI in our apoE-treated animals did not reach statistical
significance.411 Due to the different signaling properties conferred by various NMDA and
AMPA receptor subunits and their role in modulating plasticity, further studies are
needed to determine how additional subunits are altered in E3- and E4-treated animals.

2.4.4

BDNF synthesis in response to episodic 5-HT

The differences observed in synaptic glutamate receptor localization following
exposure to episodic 5-HT dosing between animals whose spinal cords had received
apoE3 or E4 suggest that there could be apoE isoform-dependent influences on 5-HTinduced signaling mechanisms upstream of glutamate receptor trafficking. Synthesis of
new BDNF is necessary for downstream glutamate receptor trafficking and the induction
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of LTF.268 ApoE4 is associated with lower levels of BDNF in the brains of targeted
replacement mice, making this step in the signaling cascade a likely candidate for
apoE4’s inhibitory effect on synaptic glutamate receptor localization, and subsequent
dampening of respiratory motor plasticity.416 Contrary to expectation, levels of BDNF
mRNA and protein did not differ between spinal cord tissue from E3- and E4-treated rats.
BDNF initiates downstream signaling through binding of its TrkB receptor.268 Although
some evidence indicates that TrkB expression and kinase activity are attenuated by
apoE4, other studies have suggested otherwise.416,417 Further investigation into the
expression and activity of TrkB in the spinal cord of E3 and E4 animals may contribute to
the understanding of the mechanism leading to loss of synaptic glutamate receptors that is
associated with E4.
Through measuring diaphragmatic EMG recording and histological analysis, we
show that the variant human isoforms of the apoE protein modulate plasticity in spinal
circuits. Considering that many therapeutic approaches for SCI are developed to promote
functional recovery by enhancing spinal plasticity, this data has important implications
for how genetic diversity in the SCI population may influence individuals’ response to
treatment strategies. Indeed, previously understudied factors such as APOE genotype
could contribute to the lack of translation encountered by many SCI therapeutics.
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Figure 2.1 Human apoE3 and E4 affect 5-HT dependent plasticity similarly.
A. Schematic of the neural circuitry that mediates breathing. B. Timeline of the episodic
5-HT dosing protocol with concurrent diaphragmatic EMG recordings. C. Representative
diaphragmatic EMG traces illustrating breathing activity during and after episodic 5-HT.
C. Quantification of diaphragmatic burst amplitude over time in response to episodic 5HT. There was no significant difference between animals exposed to E3 and E4 (RM
ANOVA p=0.762). E. Quantification of diaphragmatic amplitude 5 minutes before and
40 minutes after the final dose of 5-HT (Student’s t-tests E3xE4 5min before final dose
p=0.80, E3xE4 40min p=0.74)

58

Figure 2.2 ApoE4 prevents 5-HT-induced upregulation of synaptic AMPA receptors.
A. Representative images of the C4 ventral horns with staining of synaptophysin (green)
and NMDA receptor subunit NR1 (red) on labeled PMN (blue). Ventral horns are
outlined in white. B. Representative images of synaptophysin (green) and the AMPA
receptor subunit GLuR1 (red) on labeled PMN (blue). C. Quantification of the
colocalization of synaptophysin and NR1. Neither E3 or E4 treated animals significantly
increased synaptic NR1 in response to episodic 5-HT (2-way ANOVA p=0.21) and there
was no difference between genotypes (2-way ANOVA p=0.868). D. Quantification of
synaptic GLuR1 in the presence or absence of episodic 5-HT. Neither apoE isoform
displayed a significant increase in synaptic GluR1 in response to episodic 5-HT (2-way
ANOVA p=0.31). There was no significant difference between genotypes (2-way
ANOVA p=0.731).
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Figure 2.3 ApoE4 is inhibitory to respiratory motor plasticity after SCI.
A. Schematic of the left lateral C2 hemisection injury model and its impact on the
breathing circuitry. B. Representative image of the rat spinal cord at the C2 level after C2
hemisection stained with cresyl violet. C. Representative EMG traces from injured rats.
Traces show activity of the hemidiaphragm ipsilateral to injury. Arrows indicate the
timing of application of the three 5-HT doses. Dashed lines indicate baseline amplitude.
D. Quantification of diaphragmatic burst amplitude in the left hemidiaphragm of injured
animals in response to episodic 5-HT. There was no significant difference in the change
in activity over time between genotypes (RM ANOVA, p=0.58). E. Quantification of
diaphragmatic EMG amplitude 5 minutes before and 5 minutes and 40 minutes after the
final dose of 5-HT (Student’s t-tests, E3xE4 5min before final dose p=0.83, E3xE4 5 min
after final dose p=0.27, E3xE4 40 min after final dose p=0.40)

60

Figure 2.4 Human apoE4 decreases synaptic glutamate receptor expression after
episodic 5-HT in hemisected animals.
A. Representative images of staining for colocalization of NR1 (red) and synaptophysin
(green) on phrenic motor neurons labeled with CTB (blue). Ventral horns are outlined in
white. B. Representative images of spinal cord sections with CTB-labeled PMN (blue)
stained for GluR1 (red), synaptophysin (green). C. Quantification of synaptic NR1
colocalized with synaptophysin normalized to total intracellular NR1. There was no
significant difference between ApoE3 and E4 animals (a priori 2-way ANOVA
p=0.0727). ApoE4-treated animals had significantly less synaptic NR1 in response to
episodic 5-HT than those that did not receive 5-HT (a priori 2-way ANOVA and Tukey’s
post hoc test p=0.0.0196). D. Quantification of colocalization of GluR1 and
synaptophysin normalized to total cellular GluR1 in PMN. There was no significant
difference between E3 and E4 (2-way ANOVA p=0.269). E3-treated animals exhibited a
trend of increased synaptic GluR1 expression in response to 5-HT (2-way ANOVA and
Tukey’s post hoc test p=0.075). E-H. Comparisons of synaptic glutamate receptor subunit
levels in intact and C2 hemisected mice that did not receive 5-HT. In both E3 and E4
animals, NR1 decreased significantly in response to injury (E., Student’s t-test p<0.0001
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and F. p<0.0001, respectively). Levels of synaptic GluR1 were not significantly different
between intact and injured animals in the presence of either apoE isoform (G., apoE3
Student’s t-test p=0.29 and H., apoE4 p=0.41).
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Figure 2.5 BDNF expression isn’t apoE isoform-dependent.
A,B. Expression of BDNF mRNA in the region of the phrenic motor nucleus in uninjured
(A) and injured (B) rats. There was no significant difference between genotypes in the
presence or absence of injury (Student’s t-test, uninjured p=0.73, injured p=0.83). C,D.
Quantification of BDNF protein. There was no significant difference between genotypes
in uninjured (C, Student’s t-test, p=0.69) or injured (D, Student’s t-test, p=0.43) animals.
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Figure 2.6 Cervical SCI alone does not change BDNF levels in the phrenic
motor nucleus.
BDNF mRNA expression did not significantly differ between intact and C2 hemisected
rats that were not exposed to human apoE protein (Student’s t-test p=0.74)

64

CHAPTER 3. NOVEL INFLUENCES OF SEX AND APOE GENOTYPE ON SPINAL
PLASTICITY AND RECOVERY OF FUNCTION
3.1 Introduction
Over 17,000 Americans experience a spinal cord injury every year.2 Depending
on the level of injury, damage to neural pathways in the spinal cord can lead to a
multitude of sensory deficits and loss of crucial motor functions. Over the past few
decades, many promising therapeutic approaches have been developed to enhance
neuroprotection or induce anatomical and functional plasticity of spinal pathways to
restore function.139,418–421 Moreover, pivotal studies using nerve grafts, PTEN deletion,
NOGO inhibition, or degradation of the perineuronal net or chondroitin sufate
proteoglycans (CSPGs) have demonstrated that the CNS is capable of overcoming neural
intrinsic and extrinsic barriers to regeneration after injury, leading to meaningful
preclinical recovery.93,114,116,422,423 However, these therapeutic strategies have met with
varied clinical success and there remains a lack of effective treatment strategies for the
human SCI population.424
A striking difference between individuals living with SCI and the animals used to
model them is the level of genetic diversity represented in these populations. In contrast
to the incredible diversity of the human population, preclinical studies typically utilize
homogenous groups of animals with the same sex and similar genetic backgrounds.
While this does facilitate easier determination of treatment effects, it also makes it less
likely that discoveries in these models will translate to human patients. Although an
increasing number of preclinical investigations are addressing how sex influences the
efficacy of therapeutic strategies, the impact of genetic variability remains largely
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unexplored. A recent review by Fouad et al. specifically outlined the importance of
evaluating the influence of factors such as sex and genotype to address the
neuroanatomical-functional paradox and lack of therapeutic translation in SCI.377 Indeed,
we hypothesize that genetic factors could play a considerable role in determining how
individuals respond to treatment strategies.
Apolipoprotein E (ApoE) is a highly expressed lipid carrier in the CNS.303 It is
encoded by the APOE gene, which exists in three common alleles designated 2, 3, and
4. The 4 allele, which is carried by nearly 1 in 5 individuals, has been associated with a
number of detrimental outcomes, including a weakening of synaptic plasticity in the
brain.425 However, despite a robust body of literature in neurodegenerative diseases and
traumatic brain injury347,350,426, the impact of 4 on plasticity in the spinal cord remains
underexplored. We hypothesized that spinally-mediated plasticity is constrained in apoE4
animals, thereby demonstrating the importance of considering the diversity of the human
population when developing therapeutic approaches for people with SCI.
To test this hypothesis, we utilize a model of cervical injury to examine how
APOE genotype alters the response to intermittent hypoxia (IH). Most SCIs occur at these
high levels and can disrupt the neural circuitry that mediates breathing, leading to
respiratory insufficiency and potentiating the need for mechanical ventilation.2,427,428
Mechanical ventilation increases the risk of respiratory infection, a leading cause of
rehospitalization and death following cervical spinal cord injury (cSCI).402
In recent years, there has been a growing appreciation for the potential of
intermittent hypoxia (IH) as a treatment strategy for a host of conditions including SCI.230
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In clinical trials, therapeutic IH has been utilized to increase limb function and to
facilitate ventilation in persons with SCI by enhancing plasticity in the spinal
cord.140,142,381 Neural pathways in the cervical region which mediate breathing are critical
therapeutic targets of IH, including spared pathways which might remain after injury.
However, the influence of human genetic variability on IH-induced recovery is unknown.
Therefore, we utilized this model of spinally-mediated plasticity to examine how
expression of different human APOE alleles alter the efficacy of therapeutic strategies,
such as IH, that are being developed to enhance plasticity following SCI. Our results
provide evidence that both sex and APOE genotype determine the propensity for
plasticity in humanized mice that are exposed to therapeutic IH.
3.2 Methods
This chapter of the Dissertation has been adapted from a manuscript published in
eNeuro.429

3.2.1

C2 Hemisections

All experiments were approved by the Institutional Animal Care and Use
Committee at the University of Kentucky. Mice expressing human apoE isoforms under
control of the mouse APOE promotor (targeted replacement mice) were backcrossed for
at least 10 generations to the C57BL/6 background.398–400 Mice were group-housed on a
twelve-hour light/dark cycle and fed normal chow diet ad libitum. All mice were 92-105
days old at the time of injury. Female (20-24g) and male (22-30g) mice were anesthetized
with isoflurane. Animals were then prepped for surgery by shaving the surgical area
followed by disinfecting with alternating betadine and 70% ethanol swabs. Puralube
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ophthalmic ointment was applied to the eyes to prevent drying during surgery. A midline
incision was made through the skin just caudal to the ears to between the scapulae.
Marcaine/bupivacaine was instilled along the incision site. The acromiotrapezius,
semispinalis capitus, and rectus capitus posterior muscles were cut along their midline,
bluntly dissected, and retracted. Paravertebral muscles were cut away from the C2
vertebra using ToughCut Spring Scissors (Fine Science Tools). The lamina of the C2
vertebra was then removed using Spring Scissors. Under a dissecting microscope (Meiji
EMZ), a left lateral C2 hemisection (C2Hx) was performed by inserting a 27-gauge
needle into the midline of the spinal cord at the C2 level and dragging the needle to the
left lateral edge of the cord. This was then repeated once to ensure a complete injury.
Musculature was sutured (6-0 absorbable suture) and skin was closed with Vetbond
Tissue Adhesive (3M). Animals received subcutaneous buprenorphine (0.75mg/kg) and
carprofen (10mg/kg) immediately after surgery. Male mice were housed individually
following surgery to prevent fighting amongst cagemates.

3.2.2

Intermittent Hypoxia and Diaphragmatic Electromyography (EMG)

Three weeks after hemisection, animals were anesthetized with isoflurane using
the SomnoSuite Anesthesia System (Kent Scientific). A laparotomy was performed by
cutting through the rectus abdominis, external oblique, and internal oblique muscles.
Bipolar electrodes, connected to an amplifier and data acquisition system (CWE BMA400 Four-channel Bioamplifier, CED 1401 with Spike2 Data Analysis Computer
Interface), were inserted into the dorsal region of the left hemidiaphragm, where they
were secured using Vetbond. Bilateral recordings were not performed due to the

68

increased attrition rate we observed after performing bilateral electrode insertion. The
laparotomy was also closed using Vetbond. Ten minutes of baseline breathing activity
was recorded. The air input to the Somnosuite was then changed from room air
(normoxia) to a tank of 11% oxygen, 89% nitrogen gas (hypoxia) for 5 min, at which
point it was switched back to room air for 5 minutes. This was repeated for 3 bouts of
hypoxia separated by 5 minutes of normoxia. Diaphragmatic activity was recorded for 1
hour after the final hypoxic bout (Fig. 1 A). Although core temperature was not
monitored during recordings, animals were kept on heating pads throughout all recording
procedures to maintain body temperature.

3.2.3

Sectioning and Staining

To harvest tissue for immunohistochemistry, mice were perfused with 4%
paraformaldehyde (PFA) following the diaphragmatic EMG recording. The spinal
column was isolated and placed in 4% PFA at 4C. After two days, tissue was removed
from PFA and placed in a 30% sucrose solution at 4C for cryoprotection until
sectioning.
Tissue was mounted and frozen in Tissue Plus O.C.T. Compount (Fisher
Healthcare) and cut at a thickness of 20m on a cryostat (Leica). Serial sections from the
injury site (C1-C2) were placed on one set of slides while serial sections from the level of
the PMN (C3-C6) were placed on another set. Injured tissue slides were dehydrated in
ethanol and stained with 0.1% Cresyl violet solution (Sigma Cat #C5042). Slides were
then mounted using permount (Electron Microscopy Sciences Cat #17986-01). For 5-HT
staining, frozen section were thawed to room temperature, rinsed with 1x PBS, and
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blocked in a solution of 5% normal goat serum, 0.1% bovine serum albumin, and 0.1%
TritonX-100 dissolved in PBS. Slides were incubated in 5-HT primary antibody diluted
1:10,000 (rabbit, ImmunoStar Cat #20080) then goat anti-rabbit AlexaFluor488
secondary antibody (1:500, Life Technologies Cat #A11034). Stained slides were
mounted with ProLong Gold mountant with DAPI (Invitrogen Cat #P36931). For WFA
(Wisteria Floribunda Lectin) staining, frozen sections were thawed to room temperature,
washed with 1xPBS, then blocked in 3% normal goat serum diluted in PBS. Slides were
then incubated in WFA primary antibody conjugated to Fluorescein at a dilution of 1:400
(Vector Labs Cat #FL-1351). Stained slides were mounted in ProLong Gold with DAPI.

3.2.4

Trace Analysis

After recording, raw diaphragmatic EMG was rectified and integrated using
Spike2 software. Analysis was performed at twelve time points: twice during baseline
recording, once during each hypoxic and normoxic bout, and at 10, 20, 30, and 40
minutes after the final hypoxic period (Figure 3.1 A). For each time point, peak amplitude
was averaged over a 30 second period. Amplitude of diaphragmatic bursts at each time
point were normalized to that animal’s pre-hypoxia baseline amplitude. Frequency of
diaphragmatic bursts, indicative of breaths, was also quantified over a 30 second period
at each time point.

3.2.5 Imaging and image quantification
Staining for cresyl violet and WFA was imaged on a Keyence BZ-X810
fluorescence microscope for quantification. Cresyl violet stained sections were imaged
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using brightfield illumination at 2x. Sections stained for WFA were imaged at 10x using
the monochromatic camera with high resolution (0.75488m/pixel) for quantification.
Additional images for publication were acquired on a Nikon Eclipse Ti series inverted
confocal at 40x, focused on the ventral horn in the region of the putative PMN. Sections
stained for 5-HT were imaged on the Nikon at 20x. Images of 5-HT staining for
publication were taken at 40x in the region of the PMN. All imaging and quantification
was performed on the ventral horn of the left side of the cord, ipsilateral to the injury.
WFA labeling was quantified using the HALO image analysis platform (Indica
Labs). We developed and optimized an algorithm on the Area Quantification v1.0 to
capture positive staining for WFA while omitting any nonspecific fluorescence. A region
of interest (ROI) was drawn around the left ventral horn of sections at the level of C4.
The quantification algorithm was applied to the ROI of each section. The area of staining
was then normalized to the total area of the ROI. Three tissue sections at level C4 were
analyzed for each animal. 5-HT labeling was also quantified with HALO. A region of
interest was drawn around the left ventral horn. Serotonergic fibers within the ROI were
traced using the embedded annotation tool. The total length of fibers was then normalized
to the area of the ROI.

3.2.6

Experimental Design and Statistical Analyses

Sample sizes for mice receiving diaphragmatic EMG recordings were calculated
based on preliminary data from 10 hemisected mice representing all three genotypes
using Cohen’s D to estimate effect size (data in Table 3.2). Group sizes for each sex and
genotype are found in Table 1. Tissue from a subset of animals was perfused with PFA
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and spinal cord tissue was harvested from these animals for IHC and quantification of
WFA and serotonergic sprouting (apoE3 n=4, apoE4 n=5)
For statistical analysis of EMG traces, repeated measures (RM)-ANOVA was
used to account for within-subject correlation given repeated measurements over time.
Stratified RMANOVA analyses were performed on male and female traces. Results were
considered statistically significant if t1.96. Student’s t-test was used to analyze 5-HT
fiber staining on spinal cord tissue. Welch’s t-test for unequal variances was used to
analyze staining of WFA. Results were considered statistically significant if p < 0.05.
Investigators were blinded until all diaphragmatic EMG and histology analyses were
complete. The mean difference (MD) and 95% confidence interval (CI) were calculated
to provide an estimate of the range of possible differences between groups.
Table 3.1 Injured group sizes
Male Female
E3 n=7

n=8

E4 n=6

n=11

3.3 Results

3.3.1

Respiratory motor plasticity in C2 hemisected humanized APOE mice

At 3 months of age, male and female mice received a left C2 hemisection by
making an incision from the midline to the left lateral edge of the spinal cord just caudal
to the C2 dorsal roots. This injury effectively disrupts the neural circuitry that descends
from the ipsilateral medullary respiratory nuclei to phrenic motor neurons on the left side
(Fig. 3.1 B). At the time of injury, hemisection was visually confirmed by observing the
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thorax of each mouse to ensure that only the right side of the thorax continued
rhythmically expanding with each breath. Injury completeness was histologically
confirmed upon sacrifice of a subset of mice (n=16) using cresyl violet (Fig. 3.1 C). All
mice were homozygous for human 3 or 4 alleles expressed under control of the murine
APOE promoter as described previously.398,400 At 3 weeks post-injury, mice were
exposed to intermittent hypoxia. This consisted of 3 hypoxic (11% O2) bouts of 5 minute
duration separated by 5 minutes of normoxia as illustrated in Figure 1. We evaluated the
breathing response to IH by concurrently recording diaphragmatic EMG, which
continued for 1 hour following the final hypoxic bout. Amplitude of diaphragmatic bursts
was quantified while blinded and then grouped according to APOE genotype. No
difference was found in the response to IH between mice expressing 3 or 4 (Fig. 3.1 D,
RMANOVA p=0.741). All animals appear to experience an initial decrease in
diaphragmatic activity during the first hypoxic bout. Breathing in both apoE3 and apoE4
mice remained constant once the IH protocol ended (Fig. 3.1 D).
Previous studies in rodents have shown that IH treatment gives rise to an
augmentation of breathing activity that characterizes LTF.224,232,387,388 We therefore
compared amplitude at the beginning of IH and 40 minutes after the final bout of hypoxia
to determine whether breathing activity increased in response to IH. Neither genotype
exhibited significant augmentation of diaphragmatic activity at 40 minutes post-hypoxia,
indicative of a lack of LTF in the humanized mice (Fig. 3.1 E, paired t-test E3 p=0.741,
E4 p=0.405).
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3.3.2

Sex differences in APOE modulation of LTF

To investigate sex-dependent influences of APOE genotype on LTF, we separated
data from males and females for independent analysis. Animals were weighed every day
for the first 4 days after injury and then once a week until diaphragmatic EMG recordings
were performed. When comparing weights over time after injury, there was no significant
difference between genotypes in male (p=0.16) or female (p=0.65) mice (data not
shown). Figure 3.2 A shows representative traces from male apoE3 and E4 mice. As
evidenced in these traces, both genotypes exhibited a decrease in frequency over time
after IH. However, there was no significant genotype effect on the magnitude of this
decrease (Fig. 3.2 A, supplementary Fig. 3.1 A, RMANOVA, p=0.846). Previous studies
in rats have reported no spontaneous recovery in the paralyzed hemidiaphragm even
chronically after C2 hemisection.218 In contrast, the overwhelming majority of the 32
mice used in the current study showed spontaneous functional recovery of the paralyzed
mouse hemidiaphragm. Considering all males and females from which we recorded
diaphragmatic EMG’s, only 2 mice displayed no spontaneous recovery: 1 male of each
genotype (Fig 3.2 B). Quantification of the diaphragmatic EMG data demonstrates that
males expressing the 3 allele display a decline in the amplitude of diaphragmatic
bursting beginning in the first hypoxic bout and persisting throughout the recording
period (Fig. 3.2 C). Although this deterioration of activity did not reach statistical
significance (RMANOVA, t=0.03), it is worthwhile to highlight how the apoE3 males
diverged from apoE4, which demonstrate slightly heightened activity at 40 minutes postIH (Fig. 3.2 C,D, RMANOVA, t=-0.65).
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Analysis of diaphragmatic EMGs in female mice of both genotypes showed a
similar negative trend in the breathing frequency induced by IH (Fig. 3.3 A,
supplementary Fig. 3.2, RMANOVA, p=0.673). A subset of mice displayed a complete
loss of diaphragmatic activity following hypoxic exposure. We refer to these animals as
“non-responders”. Three non-responders emerged in the apoE4 group, while none were
observed in the mice that expressed 3 (representative trace shown in Fig. 3.3 B).
However, unlike the male mice, all females demonstrated spontaneous recovery prior to
IH (data not shown). Quantification of diaphragmatic burst amplitude in females that
maintained diaphragmatic activity after IH showed that apoE3 mice responded to IH with
an initial decrease in burst amplitude. This decline was temporary and activity returned to
near baseline levels by 40 minutes (Fig. 3.3 C). However, apoE4 females exhibited an
immediate reduction in burst amplitude that is still evident the end of the recording
period. At 40 minutes post-IH, breathing of apoE4 females is significantly depressed
compared to that of apoE3’s at the same time point (Fig. 3.3 C,D, mixed model
RMANOVA t=2.08). Consistent with the combined data, none of the female mice
expressing human APOE developed the gradual and prolonged breathing augmentation
that is characteristic of LTF.
When animals are challenged with a brief bout of hypoxia, feedback from
peripheral chemoreceptors induces an augmentation of respiratory output. This change in
ventilation is known as the hypoxic ventilatory response (HVR).430 During the hypoxic
bouts of IH treatment, all apoE mice exhibited a decline in diaphragmatic activity instead
of the expected amplification. To further investigate the HVR in our humanized mice, we
exposed an additional, smaller cohort of mice to a 10-minute bout of hypoxia and
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assessed the changes in amplitude and frequency of diaphragmatic bursting. No females
of either genotype displayed an increase or decrease in amplitude, but breath frequency
began to decline by the end of the hypoxic period in those expressing 4 (supplementary
Fig. 3.2 B,C). In male mice expressing 3, there was a sharp decline in both amplitude
and frequency of diaphragmatic firing in response to hypoxia such that breathing activity
was abolished at 10 minutes. Conversely, amplitude and frequency in apoE4 males
remained constant during hypoxia (supplementary Fig. 3.1 B,C).
3.3.3

Perineuronal net upregulation and serotonergic sprouting in the phrenic motor
nucleus
Secretion of chondroitin sulfate proteoglycans (CSPGs), a component of the

perineuronal net (PNN), is upregulated after SCI in wild type animals, creating a barrier
to plasticity, regeneration, and sprouting.422,431 Thus far, it is unknown if the magnitude
of this upregulation is modulated by human APOE genotype. Therefore, we utilized WFA
staining to compare the amount of PNN present in injured spinal cords at the C4 level to
determine if the IH-induced reduction in diaphragmatic activity observed in E4 females
was correlated with increased amounts of inhibitory PNN. Indeed, we found that apoE4
females tended to have a higher density of WFA around the phrenic motor nucleus after
injury, although this trend did not reach significance (Fig 3.4 A-C, Welch’s t-test,
p=0.0697).
The PNN can limit 5-HT sprouting after injury.422 To determine whether
differences in respiratory motor plasticity observed in females were due to the amount of
serotonin at the level of the phrenic motor nucleus after C2Hx, serotonergic fibers were
labeled and quantified in the ventral horn ipsilateral to injury. Serotonergic sprouting
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after injury has previously been correlated with the restoration of breathing function and
enhancement of LTF.247 We postulated that dampened respiratory plasticity in 4 females
may be due to a lack of serotonergic sprouting after injury. Surprisingly, quantification of
5-HT+ fibers ipsilateral to injury revealed enhanced serotonergic sprouting in apoE4
females compared to apoE3 (Fig. 3.5 A-C Student’s t-test, p=0.0193). This contradicted
our expectation that a blunted respiratory response to IH would correspond with
attenuated fiber sprouting after injury. Quantification of 5-HT fibers contralateral to
injury showed no significant difference between E3 and E4 females, although E4 tended
to have more 5-HT staining (Fig. 3.5 D, Student’s t-test, p=0.286). After injury, E4
females had more 5-HT fibers ipsilateral than contralateral to injury, although this did not
reach statistical significance (Fig. 3.5 E, Student’s t-test, p=0.187).
3.4 Discussion
This study represents the first investigation into human genetic influences on the
efficacy of experimental therapeutic strategies for SCI. Our results demonstrate that
individuals’ propensity for initiating beneficial neuroplastic responses to therapeutic IH is
modified by sex and apolipoprotein E genotype. By utilizing a well-described model of
SCI and spinally-mediated motor plasticity, we provide evidence to support the
hypothesis that human genetic factors that are not represented by preclinical animal
models limit the potential for recovery after SCI. Our physiology and histology data
indicate that sex and genotype influence the CNS response to injury and therapeutic
intervention, which poses a significant challenge to translating one-size-fits-all treatment
strategies.
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3.4.1

APOE genotype and respiratory motor plasticity

Recovery of breathing function is a top priority for people living with cervical
SCI.378 Intermittent hypoxia has promising potential to enhance spinal plasticity for the
restoration of a variety of motor behaviors, including breathing.139,404,432 Studies by
Wadwha et al. (2008) and Tester et al. (2014) in human participants have demonstrated
that ventilatory LTF is expressed by both male and female subjects, even when living
with a chronic SCI. However, to our knowledge, the interaction of sex and genetic factors
remains unexplored in the LTF literature. Preclinical studies that have addressed the
impact of sex on respiratory motor plasticity revealed that sex hormone levels have
significant ramifications for the potential to induce plasticity, likely due to the interaction
of sex hormones and the serotonergic system.373,433,434 Additionally, Baker-Herman et al.
(2010) found that rat strains of different genetic backgrounds vary in their responses to
IH, which was associated with differences in the expression of 5-HT2A receptors on
PMNs.
To further address how genetic variability impacts spinal plasticity, we examined
the efficacy of IH for inducing LTF in targeted replacement mice expressing the human
APOE 3, and 4 alleles. Since APOE first gained notoriety as a genetic marker for
Alzheimer’s Disease (AD), an extensive body of literature has investigated the impact of
the apoE isoforms in the brain. The 4 allele increases the risk of developing AD and
lowers the age of onset in a dose-dependent manner.310,312 E4 carriers display
mitochondrial dysfunction, aggravated neuroinflammatory responses to CNS damage,
loss of blood brain barrier integrity, and impaired synaptic plasticity.436 These factors are
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also key determinants for the extent of tissue damage, plasticity, regeneration, and the
potential for recovery after SCI.11,437–439
APOE further became a gene of interest in our investigation after studies in
human SCI patients found that people who carried the 4 allele experienced significantly
less motor recovery than non-carriers, despite spending more time in rehabilitation.348,390
ApoE4 is known to curb recycling of NMDA and AMPA receptors to the postsynaptic
membrane and reduces levels of BDNF in the CNS.326,416,440 Since LTF requires BDNF
signaling and activation of NMDA receptors, individuals expressing the 4 allele may
have a constrained response to IH.268,384 However, our data demonstrates that mice
expressing human apoE isoforms did not differ in their diaphragmatic response to IH,
indicating that there may be no effect on LTF when APOE genotype is the sole variable
being considered,
The lack of divergence between genotypes and the absence of augmented
diaphragmatic activity in response to IH could also be due to metabolic changes. Many
protocols for the induction of LTF, which are primarily conducted in rats, include the
measurement of pCO2 throughout recording.221,224 This measurement provides a gauge of
how metabolism is changing as a result of hypoxic hypometabolism: instead of increasing
respiratory activity, small mammals respond to hypoxic conditions by downregulating
their metabolic rate to reduce oxygen consumption.441 Because we did not measure pCO2
during EMG recordings due to the low blood volume of mice, we were unable to control
for changes in metabolic rate, which could have prevented IH-induced breathing
augmentation. However, we do not think that hypometabolism was responsible for
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masking genotype effects since differences emerged when animals were grouped
according to sex.
Interestingly, mice displayed a decrease in ipsilateral hemidiaphragmatic activity
during hypoxic bouts, instead of the heightened activity that is typical of the HVR
observed in rats.430 Very little data is available on the respiratory response to IH and
manifestation of LTF in C2 hemisected mice, although Minor et al. (2006) demonstrated
the presence and viability of the murine crossed phrenic pathway (CPP), the anatomical
substrate that mediates LTF.247 The few studies performed in mice are variable in IH
protocols and methods of assessing LTF.231–233 Our HVR data indicates that mice respond
to bouts of hypoxia differently than rats, but further experiments are needed to
characterize this phenomenon. Considering the availability of transgenic mouse models, a
standardized protocol for inducing and evaluating LTF in murine models would be
extremely advantageous for studying how human genes influence spinally-mediated
breathing plasticity.
3.4.2

Sex effects

Another explanation for the lack of observable differences between genotypes is
that they could be masked by sex effects. APOE has long been studied in the Alzheimer’s
field, where genotype influences are known to be modulated by sex. While expression of
the 4 allele increases the risk of developing AD in both males and females, this risk is
greater in females.442,443 In rodents, apoE4-related deficits in learning and memory are
aggravated in females, indicating that synaptic plasticity in the brain is impaired in a sexdependent manner.336,444 The implication for similar trends in spinally-mediated plasticity
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led to further analysis of our data, in which the influence of genotype was investigated
separately in males and females.
Diaphragmatic EMG recordings from females revealed a significant difference
between the response of apoE3 and apoE4 animals. Forty minutes after IH, diaphragmatic
activity was significantly depressed in females expressing 4. Consistent with findings in
the brain, this demonstrates that apoE4 females have a limited propensity for plasticity in
the spinal cord. This pattern was not reflected in male mice. In contrast with the current
body of literature, we show that apoE3 males experience a barrier to synaptic plasticity,
as they display the largest decrease in diaphragmatic activity.
To our knowledge, apoE3-associated attenuations of plasticity have never been
reported in young adult mice. Since the majority of apoE literature describes its effects on
the brain and the periphery, it is possible that our results are due to a unique action of
apoE in the spinal cord. The mechanism behind induction of LTF in the bulbospinal
breathing circuitry is similar to that of long term potentiation (LTP) in the hippocampus:
both rely on synaptic strengthening brought about by activation of postsynaptic NMDA
receptors and signaling through ERK.384,445,446 Disparate results from a variety of studies
in targeted replacement mice suggest apoE4 can be detrimental or beneficial to LTP
depending on brain region, sex, and age.331,335,447,448 Taking this into account, it is less
surprising to see that apoE3 also has the potential to augment or impede similar
mechanisms of plasticity. This effect may also be dependent on age and region of the
CNS.
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3.4.3

The inhibitory PNN and serotonergic presence after C2Hx in targeted replacement
mice
Following SCI, there is a dramatic upregulation of inhibitory CSPGs at the site of

injury and in denervated targets.99,422,449 Indeed, after dorsal column transections, there is
an upregulation of the CSPG-containing PNN around sensory nuclei 449 and in previous
studies utilizing lateral C2 hemisections, PMNs became further encased by CSPGs and
the PNN.422 Despite the abundance of evidence implicating the importance of CSPGs in
limiting plasticity, regeneration, and recovery (reviewed by Tran et al., 2018), the
influence of human genetics (and APOE alleles) on PNN structure and neuronal sprouting
in the injured spinal cord has never been investigated. However, a study of human brains
indicated that apoE4 augments expression of a CSPG known as brevican in the brain of
Alzheimer’s patients, which could explain the more extensive staining of PNN observed
in E4 mice.451
Indeed, our findings indicate that apoE4 females exhibit a greater density of the
PNN in the ventral horn region containing PMNs after injury. Although PMNS were not
discreetly labeled, upregulation of the PNN at the C4 level ipsilateral to injury suggests
that deficits in respiratory motor plasticity could be a consequence of the PNN’s
numerous influences on CNS function and plasticity. Appearance of the PNNs containing
CSPGs during development ends critical periods in which experience-dependent
plasticity shapes neural circuitry. Degradation of CSPGs reopens this critical period and
restores synaptic plasticity in the adult CNS.452 Following lateral spinal hemisection,
increasing densities of CSPG molecules impede calcium diffusion and block action
potential conduction in intact axons that are spared by the injury.453,454 These molecules
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also create an inhibitory microenvironment that prevents sprouting and regeneration of
fibers in the injured spinal cord, including 5-HT fibers that have the potential to enhance
functional recovery after experimental SCI.209,218,422
Since serotonergic signaling at the level of PMNs is crucial to induction of
LTF224, we quantified 5-HT staining around the putative PMN in spinal cords from E3
and E4 females. Density of 5-HT fibers was higher in E4 females both contralateral and
ipsilateral to injury, although this difference did not reach statistical significance on the
contralateral side. This indicates that compared to apoE3, apoE4 females may have
greater serotonergic innervation of the PMN in the absence of injury. However,
additional studies are needed to determine whether females expressing 4 have greater
serotonergic innervation prior to injury, as well as after C2Hx. Indeed, if this pattern is
consistent regardless of injury status, increased 5-HT fiber density could represent a
compensatory mechanism that maintains motor neuron excitability in these animals while
combatting the loss of synaptic integrity over time that is observed in E4 animals.407 The
observed attenuation of LTF after injury may therefore be due to apoE4-dependent
decreases in 5-HT receptor expression on PMNs, or a result of alterations downstream of
5-HT receptor activation in the signaling pathways that are necessary for the induction of
LTF.
Although the higher density of PNN in E4 females is not associated with a
decrease in the amount of 5-HT at the level of the PMN after injury, the CSPGcontaining PNN could still play a role in abrogating respiratory motor plasticity. Further
investigations are needed to determine whether CSPGs block ion flow in spared axons
such as the CPP after cervical hemisection similar to the inhibition observed after
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thoracic injury.453,454 Previous studies have shown that degradation of CSPGs leads to
increased presence of 5-HT around PMNs, which is associated with recovery of breathing
function. However, these studies did not address at the effect of CSPG upregulation or
degradation on glutamatergic sprouting or regeneration.209,218,422 Therefore, alterations in
glutamatergic innervation of PMNs could also contribute to the enhancement of
diaphragmatic function demonstrated in these studies. Although E4 females displayed
more 5-HT fibers than E3 females, further examination of glutamatergic axon
regeneration and sprouting, as well as how enzymatic degradation of CSPGs alters this
innervation, could provide insight into whether PNN upregulation contributes to a lack of
respiratory motor plasticity in females expressing 4.
The primary goal of this study was to investigate the role of genetic variability in
determining an individual’s propensity for spinal plasticity and recovery of breathing
function after SCI. Preclinical studies typically test therapeutic approaches in a
homogenous group of animals, which does not represent the diversity found in the human
population. As IH and other therapeutics enter clinical trials, their efficacy for treating a
heterogeneous population is an important consideration. Overall, our findings that sex
and APOE genotype modulate the response to therapeutic IH, along with the current
dearth of successful treatment strategies for SCI, emphasizes the importance of advancing
personalized medicine to improve outcomes for injured individuals.
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Figure 3.1 Magnitude of respiratory motor plasticity is not determined by
APOE genotype alone.
A. Timeline of intermittent hypoxia protocol. Green arrows represent time points at which
peak amplitude was analyzed. B. Schematic of the neural circuitry that mediates
breathing. Location of the left C2 hemisection is indicated by red X. C. Representative
image of cresyl violet staining of the spinal cord at the C2 level after injury. D.
Quantification of diaphragmatic amplitude over time during and after IH. There was no
difference between genotypes in the change in amplitude over time (RM ANOVA
p=0.741) E. Quantification of diaphragmatic amplitude during the first normoxic bout
and 40 minutes after IH (Paired t-test E3 normoxia v. 40min p=0.741, E4 normoxia v.
40min p=0.405)
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Figure 3.2 ApoE3 males demonstrate a trend of decreasing diaphragmatic
activity in response to IH.
A. Representative traces of diaphragmatic activity during the first normoxic bout and 40
minutes after IH. B. representative traces from male mice that had no spontaneous
recovery. C. Quantification of diaphragmatic activity over time during and after IH.
Amplitude of diaphragmatic bursts is not significantly different between E3 and E4
animals. D. Quantification of diaphragmatic activity during the first normoxic bout and
40 minutes after IH (RM ANOVA E3/E3 t=0.03, E3/E4 norm t=-0.55, E3/E4 40 min t=0.91, E4/E4 t=-0.67).
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Figure 3.3 ApoE4 females display significantly less diaphragmatic activity
than E3 females after IH.
A. representative traces of diaphragmatic activity during the first normoxic bout and 40
minutes after IH.B. representative traces from an apoE4 female non-responder. C.
Quantification of diaphragmatic activity over time during and after IH. Amplitude of
diaphragmatic bursts are significantly greater in E3 females than in E4 at 40 minutes
post-IH (RMANOVA t=1.01. D. Quantification of diaphragmatic activity during the first
normoxic bout and 40 minutes after IH (RM ANOVA E3/E3 t=-0.32, E3/E4 normoxia
t=0.84, E3/E4 40 min t=2.08, E4/E4 t=1.01).
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Figure 3.4 E4 females have higher levels of PNN.
A. Representative images of WFA staining at the C4 spinal cord level (DAPI is in red,
WFA is in green). B. Higher magnification images show the PNN surrounding putative
phrenic motor neurons. C. Quantification of WFA indicates that apoE4 mice express
more WFA than E3 mice, although this trend is not statistically significant (Welch’s t-test
p=0.0697). Bars represent mean  SEM.
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Figure 3.5 E4 females have higher density of spinal 5 -HT fibers.
A. Representative images of stained 5-HT fibers in the C4 spinal cord level. Higher
magnification shows individual 5-HT fibers in the area of the putative PMN. C.
Significantly more serotonergic fibers are found ipsilateral to injury in apoE4 females
(Student’s t-test p=0.0193). D. 5-HT fibers contralateral to injury at the C4 level
(Student’s t-test p=0.286). E. Ipsilateral 5-HT staining normalized to contralateral
(Student’s t-test p=0.187). Bars represent mean  SEM.
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CHAPTER 4. INTERACTIONS OF SEX AND APOE GENOTYPE IN THE
MODULATION OF RESPIRATORY MOTOR PLASTICITY
4.1 Introduction
Drawing breath is crucial for maintaining life. The respiratory system must be
adaptable to changes in the environment or alterations in homeostatic signaling in order
to preserve its optimal functioning at all times. The neural pathways that mediate
breathing form complex and interconnected circuits throughout the brainstem and
cervical spinal cord that regulate respiratory motor output in response to physiological
signals from peripheral systems. This dynamic system changes throughout an organism’s
life as metabolic demand is altered during exercise, sleep, stress, or more gradual
processes like aging.455–457 When these experience-dependent changes in the neural
control of breathing persist long after a stimulus is removed, they are considered a form
of respiratory neuroplasticity.458
Breathing is controlled by respiratory nuclei in the brainstem.459,460 The preBötzinger complex (pre-BötC), located bilaterally in the ventral medulla, is one such
nucleus that performs the crucial function of rhythmogenesis for the respiratory phases.461
Classically, rhythmogenesis was thought to depend solely pro-Bötc neurons. More
recently, however, other centers of rhythmicity such as the parafacial nucleus have been
identified in the brainstem.177,462 Neurons in the pre-BötC extend their axons across the
midline to synchronize respiratory rhythm with the contralateral pre-Bötc.159,461,463 These
neurons also communicate with other medullary respiratory nuclei including the rostral
ventral respiratory group (rVRG).158 Glutamatergic premotor neurons of the rVRG
project to the phrenic motor nucleus at levels C3-C6 of the spinal cord to synapse on
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phrenic motor neurons (PMN).415,464 Utilizing this circuitry, brainstem respiratory nuclei
control inspiratory rhythms by determining the timing of inspiratory muscle contraction.
Excitation of the PMN is additionally modulated by serotonergic projections descending
from the caudal medullary raphe.465
Adjustments in breathing activity are imperative to maintain tissue oxygenation
and prevent hypercapnia. Therefore, the neural control of breathing must be sensitive and
responsive to changes in O2 and CO2 levels. To this end, the brainstem has local
chemosensation capacity. The retrotrapezoid and parafacial nuclei sense changes in CO2
and pH, which are communicated to the preBötC, inducing alterations in ventilation to
increase pO2.175,466 Brainstem nuclei also respond to feedback from peripheral
chemoreceptors.170 Afferent signals from chemosensitive neurons in the carotid body are
transmitted to the NTS, which communicates with the preBötC to influence breathing
activity171,467
Decreased environmental oxygen levels lead to the hypoxic ventilatory response
(HVR), consisting of an initial increase in ventilation followed by short term potentiation
of phrenic nerve activity once the hypoxic bout ends.430,468,469 In contrast, intermittent
bouts of hypoxia can induce long term facilitation (LTF) through serotonin and BDNFdependent mechanisms.224,268 LTF is characterized by a prolonged increase in breathing
motor output that endures long after cessation of hypoxia.387 The capability of
intermittent hypoxia (IH) to induce LTF has been demonstrated in human subjects and
numerous animal models.231,249,386,387 This well-characterized model of respiratory motor
plasticity is a useful indicator for the capacity of the breathing circuitry to respond to the
external environment. Since the ability to trigger plastic responses is an essential function
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of the central nervous system (CNS), we sought to determine whether individuals’
propensity for breathing plasticity may be impacted by human genetic diversity.
One gene of particular interest is apolipoprotein E (APOE), which is present in
three isoforms in the human population: 2, 3, and 4. Previous studies of the APOE
alleles, which encode the apoE protein, have indicated that the E4 isoform is associated
with depressions in synaptic plasticity in neuronal cell culture and in the brain.326,331,337
However, the influence of the distinct apoE isoforms on respiratory or spinal plasticity
remains unexplored. Therefore, we utilized LTF, to investigate how APOE genotype
impacts the propensity for plasticity in the neural circuitry that controls ventilation. We
hypothesize that humanized mice expressing the human 4 allele will display a lower
magnitude of LTF compared to other genotypes, indicating that genetic background
predisposes individuals toward or against neural plasticity in the breathing circuitry.
4.2 Methods
This chapter of the Dissertation has been adapted from a manuscript submitted to
Respiratory Physiology and Neurobiology for review.

4.2.1

Animals

All experiments were approved by the Institutional Animal Care and Use
Committee of the University of Kentucky. Mice expressing human apoE isoforms under
control of the mouse APOE promotor (targeted replacement mice) were backcrossed for
at least 10 generations to the C57BL/6 background.398–400 Mice were group-housed on a
twelve-hour light/dark cycle and fed normal chow diet ad libitum. Diaphragmatic EMG
recordings were performed in male and female mice at 3.5-4 months of age, at which
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time C57BL/6 mice are considered mature adults.470 Since APOE alleles differentially
influence CNS health during aging, young adults were utilized in this study to avoid these
confounds.471–473

4.2.2

Intermittent Hypoxia and Diaphragmatic Electromyography (EMG)

Mice were anesthetized with isoflurane using the SomnoSuite Anesthesia System
(Kent Scientific). A laparotomy was performed by cutting through the rectus abdominis,
external oblique, and internal oblique muscles. Bipolar electrodes, connected to an
amplifier and data acquisition system (CWE BMA-400 Four-channel Bioamplifier, CED
1401 with Spike2 Data Analysis Computer Interface), were inserted into the dorsal region
of the left hemidiaphragm, where they were secured using Vetbond. The laparotomy was
also closed using Vetbond. 10 minutes of baseline breathing activity were recorded. The
air input to the Somnosuite was then changed from room air (normoxia) to a premixed
gas of 11% oxygen, 89% nitrogen gas (hypoxia) for 5 minutes, at which point it was
switched back to room air for 5 minutes. This was repeated for 3 bouts of hypoxia
separated by 5 minutes of normoxia. Diaphragmatic activity was recorded for 1 hour after
the final hypoxic bout.
To harvest tissue for immunohistochemistry, mice were perfused with 4%
paraformaldehyde (PFA). The spinal column was isolated and placed in 4% PFA at 4C.
After two days, tissue was removed from PFA and placed in a 30% sucrose solution at
4C for cryoprotection until sectioning.
To harvest fresh tissue for molecular analysis, mice were sacrificed through
overdose with isoflurane. The region of the spinal cord containing the PMN (C3-C6) was
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isolated and immediately placed on dry ice. The brainstem was also preserved on dry ice
for future genotyping. All tissue samples were stored at -80C.

4.2.3

Hypoxic ventilatory response assessment

Mice were anesthetized with isoflurane and diaphragmatic EMGs were recorded
as described in section 2.2. Recordings were performed for 1 hour and 40 minutes to
serve as a time control for mice that underwent IH with concurrent EMG recordings. At
the end of that time, mice were exposed to a 10 minute bout of hypoxia. Mice were then
returned to normoxic conditions and overdosed with isoflurane.

4.2.4

Sectioning and Staining

Tissue was mounted and frozen in Tissue Plus O.C.T. Compound (Fisher
Healthcare) and cut at a thickness of 20m on a cryostat (Leica). Serial sections from the
level of the PMN (C3-C6) were collected on gelatin-coated slides then placed on a slide
warmer at 32C to prevent section from washing away during IHC. For serotonin (5-HT)
staining, frozen sections were thawed to room temperature, rinsed with 1x PBS, and
blocked in a solution of 5% normal goat serum, 0.1% bovine serum albumin, and 0.1%
TritonX-100 dissolved in PBS. Slides were incubated in 5-HT primary antibody diluted
1:10,000 (rabbit, ImmunoStar Cat #20080) then goat anti-rabbit AlexaFluor488
secondary antibody (1:500, Life Technologies Cat #A11034). Stained slides were
mounted with ProLong Gold mountant with DAPI (Invitrogen Cat #P36931). For WFA
(Wisteria Floribunda Lectin) staining, frozen sections were thawed to room temperature,
washed with 1xPBS, then blocked in 3% normal goat serum diluted in PBS. Slides were
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then incubated in WFA primary antibody conjugated to Fluorescein at a dilution of 1:400
(Vector Labs Cat #FL-1351). Stained slides were mounted in ProLong Gold with DAPI.

4.2.5

Trace Analysis

After recording, raw diaphragmatic EMG was rectified and integrated using
Spike2 software. Analysis was performed at twelve time points: twice during baseline
recording, once during each hypoxic and normoxic bout, and at 10, 20, 30, and 40
minutes after the final hypoxic period (Fig. 4.1 A). For each time point, peak amplitude
was averaged over a 30 second period. Amplitude of diaphragmatic bursts at each time
point were normalized to that animal’s pre-hypoxia baseline amplitude. Frequency of
diaphragmatic bursts, indicative of breaths, was also quantified over a 30 second period
at each time point.
To quantify diaphragmatic activity during hypoxia as a proxy for assessing HVR,
analysis was performed at 0, 5, and 10 minute time points during the hypoxic bout (Supp
Fig. 1 A). Amplitude was normalized to the animal’s pre-hypoxia baseline amplitude.

4.2.6 Imaging and image quantification
Staining for WFA was imaged on a Keyence BZ-X810 fluorescence microscope
for quantification. Cresyl violet stained sections were imaged using brightfield
illumination at 2x. Sections stained for WFA were imaged at 10x using the
monochromatic camera with high resolution (0.75488m/pixel) for quantification.
Additional images for publication were acquired on a Nikon Eclipse Ti series inverted
confocal at 40x, focused on the ventral horn in the region of the putative PMN. Sections
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stained for 5-HT were imaged on the Nikon at 20x. Images of 5-HT staining for
publication were taken at 40x in the region of the PMN. All imaging and quantification
was performed on the ventral horn of the left side of the cord, ipsilateral to the injury.
WFA labeling was quantified using the HALO image analysis platform (Indica
Labs). We developed and optimized an algorithm on the Area Quantification v1.0 to
capture positive staining for WFA while omitting any nonspecific fluorescence. A region
of interest (ROI) was drawn around the left ventral horn of sections at the level of C4.
The quantification algorithm was applied to the ROI of each section. The area of staining
was then normalized to the total area of the ROI. Three tissue sections at level C4 were
analyzed for each animal. 5-HT labeling was also quantified with HALO. A region of
interest was drawn around the left ventral horn. Serotonergic fibers withing the ROI were
traced using the embedded annotation tool. The total length of fibers was then normalized
to the area of the ROA.

4.2.7

ELISA

Spinal cord tissue was homogenized in protein lysis solution (10ml of 1x RIPA
with 1 tablet of Roche protease inhibitor) buffer using a Tissuemiser Homogenizer
(Fisher Scientific). The supernatant was isolated and diluted 1:24 in 1x PBS for a BCA
assay (Pierce, cat #23225). Once protein concentration was determined, samples were
diluted 1:4 and BDNF protein was quantified using the Meso Scale Discovery BDNF
Uplex Assay (cat # K1526WK-1). The Meso Scale assay was run by the Biomarker
Analysis Lab in the Center for Clinical and Translational Science at the University of
Kentucky.
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4.2.8

Experimental Design and Statistical Analyses

Sample sizes for mice receiving diaphragmatic EMG recordings were calculated
based on preliminary data from 10 hemisected mice representing all three genotypes
using Cohen’s D to measure effect size (same analysis as Chapter 3.2.6). Group sizes for
each sex and genotype are found in Table 1. Tissue from a subset of animals was
perfused with PFA and spinal cord tissue was harvested from these animals for IHC and
quantification of WFA and serotonergic sprouting (n=3 for each genotype)
For statistical analysis of EMG traces, repeated measures (RM)-ANOVA was
used to account for within-subject correlation given repeated measurements over time.
Stratified RMANOVA analyses were performed on male and female traces. For a priori
pairwaise comparisons, results were considered statistically significant if t1.96.
Student’s t-test was used to analyze 5-HT fiber staining on spinal cord tissue. Welch’s ttest for unequal variances was used to analyze staining of WFA. Results were considered
statistically significant if p < 0.05.
To analyze BDNF ELISA results, the amount of BDNF was calculated in pg/mg
for each animal. One-way ANOVAs were performed to compare genotypes in female
mice (2 n=9, 3 n=8, 4 n=8) and male mice (2 n=7, 3 n=7, 4 n=6). Results were
considered statistically significant if p < 0.05.
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Table 4.1 Data for sample size calculation
Male

Female

E2 n=8

n=10

E3 n=8

n=10

E4 n=8

n=9

4.3 Results

4.3.1

ApoE isoforms and respiratory motor plasticity

Diaphragmatic EMG recordings were performed in male and female mice at 3.5-4
months of age (2 n=18, 3 n=18, 4 n=17). Mice were exposed to three bouts of
intermittent hypoxia (11% O2) while concurrent diaphragmatic EMGs were recorded
from the left hemidiaphragm. Fig. 4.1 A illustrates the IH protocol utilized in these
experiments, along with the time points at which diaphragmatic burst amplitude and
frequency were quantified. Fig. 4.1 B highlights some of the neural pathways in the
medulla and spinal cord that mediate respiratory motor control and rhythmicity. Plasticity
in this neural circuitry can be enhanced by IH, leading to augmentation of diaphragmatic
activity that is typically observed as an increase in burst amplitude.224 However, instead
of the expected augmentation of diaphragmatic output, mice of all genotypes displayed a
decrease in burst amplitude over time after IH (Fig. 4.1 C., p<0.0001). The magnitude of
this decrease did not differ between genotypes (p=0.955). Since mice of all genotypes
demonstrated an immediate deterioration of diaphragmatic burst amplitude in response to
the first bout of hypoxia, we compared amplitudes during the first 5-minute bout of
normoxia and 40 minutes after the IH protocol was complete. The objective of this
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comparison was to determine whether there was an IH-induced increase in breathing
output after the initial decline in amplitude. There was no difference in burst amplitude
between these time points within or between genotypes, as shown in Fig. 4.1 D (p=0.955)

4.3.2

Sex effects on respiratory motor plasticity in APOE targeted replacement mice
EMG data was then divided according to sex to investigate whether there were

sex-dependent influences on how apoE isoforms influence breathing. Fig. 4.2 A. shows
representative traces from male mice expressing 2, 3, or 4 (n=8 for each genotype)
during the first normoxic bout and forty minutes after IH. As seen in these EMG traces,
breathing frequency declines over time in all three genotypes, which is quantified in Fig.
4.2 B (p=0.0013). The magnitude of this decrease does not differ between genotypes
(p=0.210). There was also no statistically significant difference in the amplitude of
diaphragmatic activity during or after IH when comparing genotypes (Fig. 4.2 C).
However within the male apoE4 mice, there was a significant decrease in burst amplitude
over time (Fig. 4.2 D, t=0.16) while E2 and E3 males demonstrated no change in
amplitude (t=0.12 and t=0.29, respectively).
Representative traces in Fig. 4.3 A demonstrate how breathing in female APOE
targeted replacement mice changes in response to IH. Similar to male mice, females also
displayed a decrease in breathing frequency over time (p<0.0001, 2 n=10, 3 n=10, 4
n=9), but no difference between genotypes emerged when measuring the degree of this
decline (Fig. 4.3 B, p=0.429). Quantification of EMG amplitude revealed that females
expressing 3 experience an attenuation of breathing activity after IH treatment. By 40
minutes post IH, amplitude of diaphragmatic bursts is significantly reduced in 3 females
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compared to those expressing 2 (Fig. 4.3 A,C,D, t=2.20), indicative of maladaptive
plasticity in these animals.
In response to hypoxic conditions, rodents increase breathing ventilatory
frequency and volume in order to compensate for decreased levels of arterial O2 detected
by peripheral chemoreceptors. This phenomenon is known as the hypoxic ventilatory
response (HVR, previously described by Pamenter and Powell, 2016). In our APOE
humanized mice, there was a consistent decrease in diaphragmatic activity in response to
the first hypoxic bout during IH, instead of the expected increase. Therefore, we exposed
small cohorts (n=2-3) of male and female mice to a single 10-minute bout of hypoxia
(11% O2) and quantified their diaphragmatic response to determine whether this hypoxiainduced decrease in respiratory activity is apoE isoform-dependent. Males displayed no
change in frequency or amplitude of diaphragmatic output. Females likewise did not
demonstrate a change in amplitude in response to hypoxia. However, E4 females did
display a trend of diminishing frequency of breaths during hypoxia (Fig. 4.4 B-E).

4.3.3

The presence of the perineuronal net and respiratory motor plasticity

The perineuronal net (PNN), is a specialized extracellular matrix that surrounds
CNS neurons that contains chondroitin sulfate proteoglycans (CSPGs). High densities of
these CSPG molecules has previously been shown to interfere with neuronal signaling
453,454

. Therefore, we quantified the density of the PNN around the putative phrenic motor

neurons in the ventral horn of the C4 spinal cord (Fig. 4.5 A,B) in female mice to
determine whether the differences between genotypes observed in diaphragmatic EMG
traces was correlated with the amount of PNN enveloping PMNs. Quantification of WFA
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staining in APOE targeted replacement mice indicated that there was no difference
between genotypes in the amount of PNN detected (Fig. 4.5 C, 1-way ANOVA
p=0.5853, n=3 for each genotype).

4.3.4

Serotonin and BDNF levels in mice expressing human APOE

LTF is a serotonin (5-HT)-dependent form of plasticity.224 To assess whether the
divergence of respiratory responses to IH observed in females was due to apoEdependent alterations in the amount of 5-HT present around PMNs, we quantified
staining of serotonergic fibers in the C4 ventral horns (Fig. 4.6 A-B). There was no
significant difference between genotypes when comparing the volume of 5-HT+ fibers in
the vicinity of putative PMN (Fig. 4.6 C, p=0.182, n=3 for each genotype). However, a
trend emerged of E3 females exhibiting fewer 5-HT fibers than females expressing the 2
or 4 alleles. Due to low n’s in this experiment, future work will further investigate
whether this trend persists when group sizes are increased.
Following IH, increased activation of 5-HT receptors on phrenic motor neurons
leads to downstream production of new BDNF, a molecule which is both necessary and
sufficient to induce LTF.268 Although 5-HT levels around putative PMNs were not
significantly different between genotypes, downstream signaling pathways could still be
disrupted in E4 males and E3 females, leading to the observed maladaptive responses to
IH. Therefore, we quantified downstream production of BDNF. However, measurement
of BDNF protein by ELISA in the region of the phrenic motor nucleus also revealed no
difference between genotypes in males (Fig. 4.7 A, p=0.216, 2 n=9, 3 n=8, 4 n=8) or
females (Fig. 4.7 B, p=0.137, 2 n=7, 3 n=6, 4 n=6).
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4.4 Discussion
The body’s ability to alter breathing in response to stimuli is imperative to
maintain proper tissue oxygenation in different environments or metabolic states. This
plasticity in the neural circuitry that mediates breathing is therefore critical in health and
disease. The current study represents the first investigation into how the three alleles of
the APOE gene could influence individuals’ capacity for this plasticity in intact animals.
Understanding how sex and genetic differences alter respiratory control in an intact
system will facilitate the development of approaches to enhance the ventilatory response
to respiratory challenges and disease in the diverse human population. The 2, 3, and 4
alleles have previously been shown to differentially alter synaptic integrity and plasticity
in the brain, although the impact on spinally-mediated plasticity has hitherto remained a
mystery.407,474,475 Indeed, our results support the hypothesis that APOE genotype
predisposes individuals towards or against respiratory motor plasticity, an effect which is
further dependent upon sex.

4.4.1

Respiratory motor plasticity in APOE targeted replacement mice

A vast body of literature has investigated and described the respiratory response
to intermittent hypoxia in rodents. What has emerged from this work is a well-described
model of respiratory motor plasticity known as LTF, which is characterized by a
prolonged increase in breathing output.219,227 Although the induction of ventilatory LTF
through exposure to IH is also viable in human populations, the influence of human
genetic factors on the development of this plasticity remains underexplored.142,249 By
exposing APOE targeted replacement mice to IH and recording changes in diaphragmatic
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activity, we were able to demonstrate that there were no significant differences between
genotypes in the respiratory response to IH when sex was not considered as a biological
variable.
The majority of previous studies examining IH-induced changes in breathing have
been performed in rats, leading to optimized IH protocols that have determined how
severity and duration of hypoxia changes the breathing response.226 In contrast, few
studies have addressed the mouse response to IH. The limited existing literature describes
IH protocols and outcome measures that vary greatly between labs.231–234 Due to the
disparities in both approach and evaluation, it is unclear how the manifestation of LTF
differs in mice and rats, as well as how that manifestation might further diverge as a
result of which IH protocol is used.
An important consideration when evaluating LTF expression and the efficacy of
IH is that LTF can be induced through two conflicting signaling mechanisms, known as
the Q and S pathways. While the Q pathway is activated through 5-HT2A or 5-HT2B
receptors in response to moderate IH, the S pathway is activated through adenosine 2A or
5-HT7 receptors after severe IH.226,476–478 The IH protocol that our mice experienced
corresponded with moderate IH protocols used in rats. However, while the differences in
these pathways and the crosstalk between them has been well-documented in rats, these
distinctions may not be comparable in mice. Therefore, further studies are needed to
determine whether our protocol is activating the Q or S pathway. If it is activating both
pathways, evidence from Hoffman and Mitchell (2013), Devinney et al. (2016), and
Perim et al. (2018) has verified that LTF may be prevented through cross-talk inhibition.
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This could explain why mice of all genotypes did not demonstrate the expected increases
in breathing after IH treatment that would be indicative of LTF.

4.4.2

Sex differences in the influence of APOE on respiratory motor plasticity

The importance of considering sex as a biological variable in biomedical research
has been emphasized in recent years. Regarding breathing, sex determines lung volume,
airway size, and the respiratory response to exercise.481,482 Indeed, the sex hormone
progesterone acts as a breathing stimulant and has been used to treat breathing disorders
such as obstructive sleep apnea and chronic respiratory insufficiency.374,483,484 Although
sex hormones do not appear to alter pre-Bötc function, as demonstrated by unaltered
respiratory frequency in ganodectomized animals371, other components of the neural
control of breathing are influenced by estrogen and progesterone. The serotonergic raphe
nuclei, which communicate with respiratory nuclei both in the brainstem and spinal cord,
express estrogen and progestin receptors. Estrogen signaling in the raphe enhances 5-HT
neurotransmission, suggesting that high estrogen levels in females could augment IHinduced plasticity.485
Considering the impact of sex on the neural control of breathing and the
importance of 5-HT signaling in inducing LTF, we divided our APOE targeted
replacement mice into males and females for individual analysis. As in the combined
analysis, EMG recordings in males demonstrated no statistically significant genotypedependent divergence in the amplitude of diaphragmatic bursting at any analyzed
timepoint. However, males expressing the 4 allele did reveal a significant decline in
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burst amplitude over time after IH compared to baseline, indicating that these males may
have a maladaptive response to hypoxia-induced increases in respiratory drive.
By exposing young adult male rats to IH, Zabka et al. (2006) previously provided
evidence that male rodents increase breathing motor output in response to IH. The
contradictory attenuation of breathing that we observed in E4 males could be due to
hypoxia-induced changes in metabolism that are exacerbated by sex and APOE genotype.
In small rodents, hypoxia induces a decrease in metabolism in order to decrease oxygen
consumption.441 This hypoxic hypometabolism prevents the need for increased
ventilation in hypoxic conditions, which could explain the lack breathing augmentation in
our animals. To control for the potential of metabolism to impact the manifestation of
LTF, artificial ventilation with pCO2 and temperature sampling would be necessary to
ensure that metabolism is being held constant for the duration of IH exposure. However,
due to the low blood volume of mice, pCO2 sampling throughout EMG recordings was
not possible. Previous work has shown that APOE genotype alters glucose flux through
cerebral metabolic pathways of humans and targeted replacement mice, with 4 carriers
displaying hypometabolism in various brain regions, an effect which is aggravated in
males.486–488 Less is known about how apoE isoforms differentially impact metabolism in
the spinal cord and the neural circuitry that mediates breathing. Metabolic impairments in
E4 males could explain why they displayed more significant decreases in breathing
activity.
In contrast to male mice, female diaphragmatic burst amplitude after IH differed
significantly between genotypes. Compared to 2 females, those expressing 3 have
significantly smaller bursts by 40 minutes after IH treatment. This contradicted our
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hypothesis that apoE4 would be the isoform that proved to be detrimental to spinal and
respiratory plasticity. Previous studies of the APOE targeted replacement mouse CNS
have focused on the brain due to the implication of the 4 allele in contributing to the
development of Alzheimer’s Disease (AD). A vast body of literature has investigated the
influences of the APOE alleles on neural plasticity and metabolism, especially in the
areas of the brain that are most severely impacted by AD. In the hippocampus and
entorhinal cortex, E4 carriers exhibit reduced dendritic spine density and synaptic
plasticity, leading to learning and memory impairments.331,489–492 Little is known about
how the APOE alleles may influence neural plasticity in the spinal cord. However, the
E3-induced deficits in respiratory motor plasticity found in females was unexpected. To
our knowledge, E3 has never been shown to have inhibitory effects on plasticity.
Interestingly, modulation of plasticity by apoE is age and region-dependent in the brain,
as evidenced by apoE4’s ability to enhance hippocampal synaptic plasticity in young
mice, an effect that declines with aging.447,448 Therefore, influences of the 3 allele could
be equally as varied and dependent upon age, region of the CNS, and sex.
The diaphragmatic response to hypoxia, representative of HVR, in female mice
also exhibited genotype-dependent deviations. Although there was no significant
difference in diaphragmatic burst amplitude, the breath frequency of E4 females did
display a sharp decline after five minutes of hypoxic exposure, which persisted until the
end of the ten-minute bout. These findings indicate that there may be genotype influences
on pre-Bötc rhythmogenesis. Although this decline in breathing frequency was exhibited
by females expressing 4 after a single hypoxic bout, repeated hypoxic episodes lead to a
decline in burst amplitude in females expressing 3. This could reflect a difference in
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how APOE genotype influences plasticity in the neural control of breathing at different
neurological levels. While alterations in frequency are brainstem-mediated, differences in
amplitude after IH could result from effects on brainstem respiratory nuclei or on PMNs
themselves.430

4.4.3

APOE-dependent density of the PNN and the neural control of breathing

There are many possible mechanisms by which the variant isoforms of apoE may
alter the neural control of breathing and impact the respiratory system’s response to the
environment. One potential route is through changing the density of the perineuronal net
(PNN). The PNN is a specialized network of CSPG-containing extracellular matrix that
appears during development to surround neurons and modulate synaptic plasticity in the
CNS (reviewed by Bosiacki et al., 2019; Wang and Fawcett, 2012). Development of the
PNN is dependent upon neuronal activity, with its appearance beginning as periods of
synaptogenesis and myelination of the nervous system are closing.495–497
While the CSPG-containing PNN has important functions in maintaining synaptic
homeostasis, it can also impede axonal ion transport and conduction of action
potentials.453,454 Postsynaptically, PNN molecules can prevent lateral diffusion of AMPA
receptors.498 Therefore, alterations in signaling or synaptic plasticity in the breathing
circuitry could be a result of apoE-dependent variations in the density of the PNN, which
leads to changes in the efficiency of neural communication. In female mice that
demonstrated significant genotype-dependent differences in the respiratory response to
IH, staining of the PNN around putative PMNs demonstrated no difference in PNN
density between genotypes. While this could indicate that changes in PNN density are not

107

the cause of respiratory differences between APOE genotypes, further studies are needed
to determine whether there could be apoE-dependent alterations in the molecular
composition of the PNN. Conejero-Goldberg et al. (2015) previously established that
expression of a specific CSPG known as brevican, which is implicated in brain plasticity,
varies between APOE genotypes. This suggests that distribution of various CSPGs
subtypes within the PNN could also be a source of genotype-induced modifications in the
neural circuitry that mediates breathing.

4.4.4

LTF signaling pathways in APOE targeted replacement mice

LTF is a serotonin-dependent form of plasticity.224 Activation of 5-HT receptors
leads to downstream production of new BDNF in PMNs.268,499 In targeted replacement
mice, APOE genotype did not alter the levels of 5-HT or BDNF observed in the area of
the phrenic motor nucleus, suggesting that differences in the breathing response to IH are
not dependent on the expression of these molecules. While the disparities observed in the
neuroplastic response to IH may not be due to apoE’s influence on presence of BDNF or
5-HT, there could also be downstream genotype-dependent deficits in the signaling
pathways that lead to the manifestation of LTF. Newly synthesized BDNF binds to the
TrkB (tropomyosin receptor kinase B) receptor, which is ultimately thought to induce
phosphorylation of glutamate receptor subunits in PMNs.380,500 The manner in which
isoforms of apoE may influence this downstream signaling cascade currently remains a
subject of ongoing investigation. However, E4 has previously been shown to mitigate
glutamate receptor phosphorylation and membrane localization in cortical neurons326, an
effect which could be mirrored in PMNs.
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ApoE in the CNS is primarily synthesized and lipidated by astrocytes and
isoforms of apoE differentially modulate astrocytic cell functions such as phagocytosis,
glucose metabolism, and lipid homeostasis.303,324,395,501,502 In the brainstem, astrocytes
perform important oxygen sensing functions that regulate the neural control of breathing
(reviewed by Gourine and Funk, 2017). Even in the absence of peripheral
chemosensation, brainstem astrocytes sense local hypoxia when mitochondrial O2
consumption decreases.504 Inhibition of mitochondrial respiration stimulates an influx of
Ca2+, inducing vesicular release of ATP. In the preBötC, this astrocytic ATP release
activates the hypoxic ventilatory response in order to increase breathing activity.505
However, the impact of APOE genotype on this central O2 sensing mechanism is
unknown. Intriguingly, apoE4 is associated with impaired mitochondrial respiration and
disruptions in Ca2+ homeostasis, suggesting that it could also undermine the role of
central chemosensation in activating the respiratory response to hypoxia.328,486,506
Although further studies are needed to determine how brainstem astrocytes are affected in
our model, this could contribute to the lack of hypoxia-induced breathing augmentation
observed in APOE targeted replacement mice.

4.4.5

Conclusions

Breathing function must be maintained throughout life to ensure that tissue
oxygenation does not decline to deleterious levels. As people encounter hosts of diverse
environments during their lifespan, their respiratory systems need to be able to quickly
adapt to varying amounts of atmospheric oxygen, as well as oscillating activity levels.
This requires the breathing circuitry in the brainstem and spinal cord to alter breathing
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patters in response to chemoreceptor feedback. However, little is known about how
genetic diversity and sex interact to determine individuals’ ability to initiate this
respiratory motor plasticity. Our data demonstrates that both sex and APOE genotype
dictate the respiratory response to hypoxia, thereby establishing that a subset of the
population may not have beneficial responses to respiratory challenge. This data could
have important repercussions for individuals who are often faced with hypoxic challenge,
including athletes, people traveling to high altitude areas, or people who live with
conditions that regularly expose them to hypoxic challenge including sleep apnea,
chronic obstructive pulmonary disease (COPD), high level cervical spinal cord injuries,
and many others. More studies are needed to further investigate the mechanism behind
these APOE-depended effects, thereby paving the way to discover approaches to combat
deficits in respiratory plasticity.
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Figure 4.1 Magnitude of respiratory motor plasticity is not determined by
APOE genotype.
A. Schematic of intermittent hypoxia protocol. Green arrows represent time point at
which peak amplitude was analyzed. B. Schematic of the neural circuitry that mediates
breathing. C. Amplitude of diaphragmatic bursts over time during and after IH). D.
Comparison of burst amplitude during the first normoxic bout and 40 minutes after IH.
(RMANOVA p=0.955)
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Figure 4.2 IH induces a decline in breathing activity in males expressing the
human APOE 4 allele.
A. Representative diaphragmatic EMG traces from E2, E3, and E4 males during the first
normoxic bout and 40 minutes after IH. B. Breath frequency in male humanized mice
decreases over time (p=0.0013), regardless of APOE genotype (p=0.210). C,D.
Quantification of diaphragmatic burst amplitude during and after IH. Amplitude
significantly decreases over time after IH in E4 males. (RMANOVA for a priori pairwise
comparisons 2x2: t=0.12, 3x3: t=-0.29, 4x4: t=2.00, 2x3 normoxia t=-.052,
2x4 normoxia t=-0.68, 3x4 normoxia: t=-0.16, 2x3 40 min: t=-0.81, 2x4 40 min:
t=0.69, 3x4 40 min: t=1.50).
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Figure 4.3 Amplitude of diaphragmatic activity decreases in response to IH in
apoE3 females.
A. Representative traces from APOE targeted replacement mice during the first normoxic
bout and 40 minutes after IH. B. Breathing frequency in female mice declines over time
after IH (p <0 .001). However, there is no difference between genotypes (p=0.429). C,D.
Quantification of diaphragmatic burst amplitude over time during and after IH. E3
females displayed significantly decreased amplitude at 40 minutes post IH compared to
E2 females (RMANOVA with a priori pairwise comparisons 2x2: t=-1.05, 3x3: t=1.15, 4x4: t=-0.39, 2x3 normoxia t=0.79, 2x4 normoxia t=-0,06, 3x4 normoxia:
t=-0.84, 2x3 40 min: t=2.20, 2x4 40 min: t=0.43, 3x4 40 min: t=-1.72)

113

Figure 4.4 Hypoxic ventilatory response does not differ according to APOE
genotype
A, C. Quantification of diaphragmatic burst amplitude (A, RMANOVA p=0.2349) and
frequency (C, RMANOVE p=0.4756) in male mice (n=3 for each genotype). There were
no statistically significant differences between genotypes. B, D. Quantification of the
HVR response in female mice. No significant difference appears to emerge in the
diaphragmatic burst amplitude (B). However, the frequency exhibits a decline by 5
minutes that persists at 10 minutes. No statistics were performed for female mice due to
low n’s (E2 n=3, E3 n=3, E4 n=2)
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Figure 4.5 Hypoxic ventilatory response does not differ according to APOE
genotype
A. Representative images of the spinal cord at level C4 stained for WFA, a marker of the
PNN (green), and DAPI (blue). B. Higher magnification images of WFA staining. C.
Quantification of WFA shows that there is no difference between genotypes (1-way
ANOVA p=0.585)
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Figure 4.6 APOE genotype-dependent influences on 5-HT innervation of
PMN.
A. Representative images of the spinal cord at the C4 level stained for 5-HT (green) and
DAPI (blue). B. Higher magnification images of 5-HT staining. C. Quantification of 5HT. There is no statistically significant difference between genotypes (1-way ANOVA
p=0.182)
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Figure 4.7 IH-induced BDNF protein synthesis is not altered according to
APOE genotype.
Quantification of BDNF protein levels in APOE targeted replacement male (A. 1-way
ANOVA p=0.216) and female (B. 1-way ANOVA p=0.137) mice.
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CHAPTER 5. DISCUSSION
5.1 APOE genotype and respiratory motor plasticity
Because survival is dependent upon breathing function, the neural control of
breathing must be able to adapt and maintain oxygen homeostasis in response to changes
in the external environment or fluctuations in activity level and O2 consumption.
Although some of these ventilatory modifications endure only as long as the stimulus is
present, others last long after the stimulus is removed. These long-lasting changes,
comparable to a sort of “memory”, are collectively known as respiratory motor
plasticity.507 These forms of plasticity can manifest naturally over time, as observed
throughout development, or in response to injury or disease.420,508,509 Alternatively,
respiratory motor plasticity can be induced through a variety of experimental or
therapeutic approaches, many of which rely on a mechanism of increased 5-HT signaling
in the spinal cord.224,510,511 While respiratory plasticity is important for maintaining O2
homeostasis in healthy individuals, its potential to compensate for or even restore lost
breathing function has even greater implications for people whose breathing circuitry has
been damaged. Therefore, it is crucial that we understand how factors in the human
population, such as sex, genetic make-up, and age, may positively or negatively impact
individuals’ ability to express this plasticity.

5.1.1

Respiratory Response to IH in the Presence of Human ApoE

The human population consists of individuals who are genetically dissimilar and
it is likely that this heterogeneity results in varying aptitudes for expressing respiratory
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plasticity. Therefore, to investigate the role of genotype in modulating the propensity for
plasticity, we examined the impact of human apolipoprotein E (apoE) isoforms on a wellcharacterized model of respiratory motor plasticity. Although polymorphisms in a variety
of human genes could alter spinal plasticity, a few of which were discussed in Chapter
1.3, the three alleles of the APOE gene were of particular interest due to the vast body of
literature describing their influence on brain plasticity in health and disease, which
starkly contrasts with the lack of knowledge regarding their impact in the spinal cord.
Despite the relative paucity of information on apoE’s role in spinal plasticity, previous
work has shown that individuals who have experienced a spinal cord injury (SCI)
demonstrate less motor recovery when at least one 4 allele is present.348,349 This suggests
that APOE genotype does influence the plasticity of spinal circuits after injury. The
current work aimed to determine if this effect was also present in the neural control of
breathing and whether it was a result of spinal cord insult or if it could be observed in the
intact state as well.
As a model of respiratory motor plasticity, we utilized long term facilitation
(LTF), which is characterized by a measurable and prolonged increase in breathing motor
output.224,507 LTF was first discovered as a response to repeated stimulation of the carotid
sinus nerve.386 Subsequently, numerous studies in rats have investigated the signaling
mechanism in phrenic motor neurons (PMNs) that leads to the augmentation of breathing
activity seen during LTF, finding that it could also be induced through exposure to
intermittent hypoxia (IH) or episodic intrathecal 5-HT dosing.224,268,382,387 By applying the
episodic 5-HT dosing protocol described by MacFarlane and Mitchell (2009)382 to rats
that had human apoE3 or E4 protein present in the spinal cord, we discovered that the
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respiratory response to IH was not altered by the variant forms of apoE in spinally intact
femaless. However, this lack of observable difference could have been due to insufficient
sensitivity of diaphragmatic EMGs. It therefore did not rule out the possibility of apoE
isoform-dependent influences at the synaptic level. Quantification of synaptic glutamate
receptors, which are necessary for the induction of LTF384, showed no difference between
E3 and E4 animals. However, rats treated with E3 demonstrated a slight increase in
synaptic AMPA receptors in response to episodic 5-HT while E4 animals did not.
Although the difference in synaptic receptor levels did not reach significance, this may
indicate that human E4 protein diminishes the potential for inducing synaptic plasticity in
response to stimuli.
To determine whether isoform-dependent influences on spinal plasticity would be
altered by SCI, these experiments were replicated in animals that undergone a C2
hemisection. The majority of SCIs occur at the cervical level, which contains axons from
brainstem respiratory nuclei, as well as PMNs themselves.464 Damage these bulbospinal
fibers can disrupt breathing function, leading to diaphragm paralysis, ventilator
dependence, and increased risk of life-threatening respiratory infections.178,180 However,
in a rat C2 hemisection model of SCI, LTF is capable of restoring breathing function to
the ipsilateral paralyzed hemidiaphragm.139,247 Following SCI in our animals, a trend
emerged in which E3-treated rats demonstrated the expected 5-HT-induced augmentation
of breathing activity while those receiving E4 did not. This trend did not reach
significance, possibly due to small group sizes or inadequate sensitivity of diaphragmatic
EMGs. Perhaps more insightful were the changes observed at the synaptic level. Episodic
5-HT dosing led to a significant decline in the number of synaptic NMDA receptors
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localized to PMNs in spinal cords that had been treated with human apoE4. Since
signaling through NMDA receptors is necessary for LTF induction, this synaptic
weakening could lead to a deficits in spinal plasticity and functional recovery after SCI in
individuals that express the 4 allele.385

5.1.2

Interactions of Sex and APOE Genotype in Modulating Respiratory Plasticity
Initial studies utilizing rats treated with exogenous human apoE protein were

valuable due to the amount of available literature describing the induction and
manifestation of LTF in that model, which simplified experimental design and the
interpretation of results. However, APOE targeted replacement mice that endogenously
express the human apoE isoforms at physiological levels provide a more clinically
relevant model. Therefore, subsequent studies examined allele-dependent influences on
the propensity for LTF in humanized APOE mice. To explore the mechanism behind the
lack of synaptic strengthening demonstrated by apoE4-treated rats, we also quantified
signaling molecules that are required for LTF upstream of glutamate receptor trafficking
in the mouse model.
The few studies that have characterized LTF in mice have induced LTF through
exposure to IH instead of the episodic 5-HT dosing previously described in rats.231–234
Therefore, we utilized IH as a means of inducing LTF in our humanized mice.
Comparison of diaphragmatic EMG activity in hemisected APOE mice that
homozygously express the 3 or 4 allele showed no allele-dependent differences in the
respiratory response to IH. However, because sex is an important biological variable that
modulates many processes that are relevant to the current work, such as CNS plasticity,
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breathing function, APOE allele effects, and individuals’ response to therapeutics, we
also independently analyzed data from males and females.355,358,362,442,512 There was no
significant difference in diaphragmatic activity between E3 and E4 males, although IH
appeared to decrease burst amplitude in those expressing 3. This data contradicts the
trend observed in the brain, where the 4 allele is typically associated with attenuated
plastic responses. This indicates that allele-dependent outcomes could be region-specific
in the CNS, further emphasizing the need for deeper understanding of the influence of the
unique apoE isoforms in the spinal cord. In contrast to the detrimental impact of 3
observed in injured males, it was the 4 allele that correlated with a significant decline in
diaphragmatic burst amplitude in females. These results are in alignment with previous
studies in the Alzheimer’s literature reporting that detrimental effects of apoE4 are
aggravated in females.336,442
LTF is a serotonin-dependent form of plasticity.224 Manifestation of LTF after
SCI is dependent upon the sprouting of 5-HT fibers in the spinal cord, suggesting that
barriers to sprouting or regeneration would limit the capacity for respiratory motor
plasticity.247 One notable barrier to regeneration and sprouting is the presence of CSPG
(chondroitin sulfate proteoglycan) molecules. The secretion of these molecules is
upregulated in response to SCI, although prior to the current study, it remained unknown
whether the magnitude of this upregulated is modulated by human APOE alleles.99,409,422
Despite increased levels of CSPGs located around the PMNs of E4 females, this did not
correspond to a deficiency in 5-HT in the same region. Indeed, 5-HT levels were
significantly increased in E4 animals, compared to those expressing the 3 allele. Since
CSPGs are known to impede growth of 5-HT fibers after SCI, and because E4 females
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also demonstrate elevated 5-HT levels in the intact state, this may be the result of a
compensatory mechanism that maintains PMN excitability in the presence of apoE4,
which is associated with loss of synaptic integrity and impaired excitatory synaptic
signaling.209,218,407,422,513 Although the availability of 5-HT in the phrenic motor nucleus
may not cause the abatement of respiratory plasticity in E4 females, further studies are
needed to determine whether 5-HT receptor expression and synaptic localization are
altered by apoE4.
Activation of the chemosensitive carotid bodies during a single bout of hypoxia
stimulates the hypoxic ventilatory response (HVR), characterized by a transient increase
in respiratory output.430 Interestingly, mice utilized in the current study displayed a
decrease in breathing activity in response to a single 10 minute bout of hypoxia, as well
as during the first 5 minute hypoxic bout during IH. Intrigued by this unexpected result,
as well as the lack of IH-induced ventilatory augmentation that we observed in uninjured
apoE-treated rats, we next investigated the respiratory response to IH in spinally intact
APOE mice. Similar to hemisected mice, there was no difference between genotypes
when males and females were grouped together. However, upon separating the sexes for
further analysis, 4 males and 3 females displayed significant IH-induced reductions in
breathing activity, opposite of the trends observed after IH in injured mice. Quantification
of CSPGs and 5-HT in intact mice revealed that E4 was again associated with higher
levels of both molecules when compared to E3, although this did not reach significance.
As part of the signaling cascade that leads to LTF, 5-HT signaling stimulates synthesis of
new BDNF in PMNs, which is necessary for IH-induced augmentation of ventilation.268
Therefore, we also measured BDNF mRNA and protein levels in the region of the
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phrenic motor nucleus, which revealed no genotype-dependent differences, indicating
that apoE isoform-dependent influences on LTF signaling occur downstream of BDNF
synthesis.
5.1.3

Significance of Findings

Together, results from our studies in two rodent species reveal that both sex and
APOE genotype modulate spinal and respiratory motor plasticity. While no APOE
genotype-dependent differences are evident when males and females are grouped for
analysis, the 3 and 4 allele are each associated with IH-induced decline in
diaphragmatic activity, depending on which sex is being evaluated. Interestingly, these
effects also seem to change in response to SCI (illustrated in Figures 5.1 and 5.2). In the
presence or absence of injury, LTF is induced through a mechanism of increased 5-HT
signaling, which strengthens synaptic connections on PMNs by stimulating BDNF
synthesis to activate downstream phosphorylation and trafficking of glutamate
receptors.224,268,288 Presence of 5-HT around putative PMN and synthesis of BDNF were
not dependent on APOE genotype. However, levels of synaptic NMDA receptors were
decreased in the presence of E4, suggesting a deficit in the signaling pathway
downstream of BDNF synthesis that prevents NMDA receptor trafficking. This
deficiency perhaps lies in BDNF activation of the TrkB receptor or in TrkB’s kinase
activity, although more in-depth mechanistic studies are needed to determine how the
human isoforms of apoE interact with this signaling cascade. Primarily, our data
emphasizes the importance of understanding how factors that contribute to diversity in
the human population, but are often incompletely represented by preclinical animal
models, can modify the efficacy of therapeutic approaches in spinally injured individuals.
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This is especially crucial in the context of therapeutic IH, which has undergone clinical
trials to evaluate its efficacy in enhancing breathing recovery, as well as for a variety of
other functional outcomes after SCI.41,140,142,403,404 By recognizing how factors such as sex
and genetic background impact the response to therapeutics, we can begin to develop
personalized approaches to overcome innate barriers to plasticity, regeneration, and
neuroprotection, thereby facilitating translation of therapeutics and improving functional
outcomes for people living with an SCI.
5.2 Methodological Considerations and Limitations
To accurately interpret our results, we must consider the limitations and potential
pitfalls of our experimental approaches. Fortunately, a vast body of literature describing
protocols of IH and other approaches to induce LTF, as well as the signaling required for
its manifestation in spinally intact or injured rats, is available to provide context for our
data. However, the same is not true regarding respiratory plasticity in mice. While this
presented challenges for both experimental design and data analysis, it also enhances the
value of the current studies for the field of SCI and neural plasticity. Examining the
respiratory response to IH in both sexes of a humanized mouse model will pave the way
for the use of more translationally relevant preclinical models. Due to the availability of
transgenic mice that express a variety of human genes, they are powerful tools for
exemplifying the diversity found in the human SCI population.

5.2.1

Induction of LTF in Rats Treated with Human ApoE Protein

Although LTF has been well-characterized as an augmentation of breathing
activity in response to IH or episodic 5-HT dosing, rats in the current study did not
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exhibit the expected increases in ventilation.139,224,268,382 In the absence of injury,
diaphragmatic activity remained constant in response to episodic 5-HT. Following C2
hemisection, E3-treated animals did exhibit a slight increase in diaphragmatic activity,
but this change did not reach significance. Although we followed the 5-HT dosing
protocol that MacFarlane and Mitchell (2009) showed to be effective in rats, some
aspects of our experimental preparation differed from those previously described.
Notably, many studies record phrenic neurograms instead of diaphragmatic
EMGs.247,268,382 This technique requires a phrenicotomy at least unilaterally, which
removes phrenic afferent feedback and alters PMN excitability.514,515 Indeed, rats that
undergo phrenicotomy prior to IH display enhanced LTF compared to those with intact
phrenic nerves.514 Therefore the presence of intact phrenic nerves in our animals may
have prevented more dramatic alterations in activity.
Many LTF preparations also include bilateral vagotomy and artificial ventilation
of animals in order to gain control of blood gases without interference from lung stretch
receptor feedback.247,268,516 Because our apoE-treated rats were freely breathing, both
phrenic and vagal feedback could have masked IH-induced breathing changes. An
additional consequence of performing diaphragmatic EMG recordings in freely breathing
animals without pCO2 monitoring is that we could not control for changes in metabolic
rate. Small mammals such as rats and mice can respond to hypoxic exposures by
activating hypoxic hypometabolism, a decrease in metabolic rate which decreases O2
consumption to negate the need for increased ventilation when exposed to low
environmental O2.441 Due to confounding factors that may have decreased our sensitivity
for detecting LTF, it is even more remarkable that we observed a divergence in the
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breathing response to IH in injured E3 and E4 rats. Although the observed trend did not
reach statistical significance, we did observe significant E4-dependent changes in
synaptic NMDA receptor levels, indicating that human apoE4 may prevent neural
plasticity and synaptic strengthening in the injured spinal cord.384,385
Inherent in our dosing protocol is some uncertainty regarding the diffusion pattern
of intrathecal 5-HT and apoE, as well as what cell types these molecules interacted with.
This 5-HT dosing protocol has been shown to induce LTF of phrenic nerve activity
without altering activity of the hypoglossal nerve, suggesting that 5-HT reaches PMN in
the cervical ventral horn but does not communicate with brainstem respiratory nuclei.382
Therefore, human apoE proteins, which were applied to the spinal cord in the same
manner presumably followed a similar diffusion pattern. However, we did not assess the
distribution of apoE in the spinal cord or brainstem. ApoE, especially in its lipidated form
binds receptors in the LDLR family, which are expressed by a variety of cell types
(neurons, microglia, astrocytes, and oligodendrocytes), to activate an assortment of
downstream signaling pathways.517–520 Intrathecal administration of apoE could have led
to inconsistent distribution of the protein between cell types, as well as differences
between animals, increasing variability in our data. To address this uncertainty and to
ensure that human apoE isoforms were present at physiologically relevant levels in the
spinal cord throughout developmental stages and recovery after SCI, subsequent studies
in APOE targeted replacement mice were crucial.
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5.2.2

Insights into a Novel Approach for Studying Respiratory Motor Plasticity in Mice
The literature describing the respiratory response to IH in mice is sparse.

Consequently, there is a lack of knowledge regarding best practices for induction and
measurement of LTF on this model. Although a few studies have shown that mice do
express LTF, the methods of induction, as well as the type of LTF evaluated (e.g.
hypoglossal, ventilatory, etc.) are inconsistent. None of them utilized spinally injured
animals.231–233 Therefore, the optimal IH protocol for injured animals was determined
based on previous studies in rats and mice, as well as our own observations in mice.
Previous studies have shown that spontaneous recovery of diaphragmatic activity occurs
by 2 weeks after lateral C2 hemisection in 40% of mice.287 All but two animals in this
study recovered EMG activity by three weeks post injury (94% had spontaneous
recovery), indicating that the mice had viable synaptic inputs on phrenic motor neurons
that could undergo synaptic strengthening in response to IH. In rats, which recover
diaphragmatic activity much more slowly after hemisection when compared to mice
(Warren et al. 2018, personal observation), the crossed phrenic pathway (CPP) is not
capable of mediating IH-induced LTF for over 2 weeks post injury due to lack of 5-HT in
the phrenic motor nucleus. However, Michel-Flutot et al. (2021) recently shown that the
mouse CPP is effective in response to respiratory challenge such as mild transient
asphyxia as early as seven days post injury521. Based on data from previous studies, three
weeks post injury was determined to be the time point when mice would be capable of
inducing LTF through synaptic strengthening of CPP inputs on phrenic motor neurons,
although further studies are needed to determine how expression of mouse LTF may be
enhanced or depressed at more chronic timepoints after injury.
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In addition to the timing of therapeutic IH after injury, we also needed to
determine the optimal IH protocol for inducing LTF. While much is known about impact
of hypoxia severity and length on spinal plasticity in rats, this has not been welldescribed in mice.230 Considering previous IH protocols that have been effective in mice,
we chose a protocol similar to that used in freely breathing mice by Terada et al. (2008).
The protocol in the current study applied three 5-minute hypoxic (11% O2) bouts
separated by normoxic periods of 5-minute duration. This was sufficient to induce
increases in breathing when preliminarily tested in wild type mice (data not shown). This
protocol also replicates the “modest” IH exposures commonly applied to rats in order to
activate the Q pathway to LTF without increasing blood pressure, systemic inflammation,
and oxidative stress, which can result from more “severe” IH.224,268,522,523 The Q pathway
is initiated through IH-induced release of 5-HT from spinal projections of the raphe.465
This stimulates 5-HT2 receptor signaling on PMNs and results in synthesis of new BDNF
that signals through the TrkB receptor.226,268,288,524 In contrast, more severe or sustained
exposure to IH induces LTF through a 5-HT7 or adenosine 2a receptor-dependent
signaling cascade that activates PKA to stimulate synthesis and transactivation of
TrkB.477,525,526
Both the Q and S pathway are thought to activate phosphorylation and trafficking
of glutamate receptors downstream of TrkB activation, thereby strengthening synaptic
connections on PMN.226 However, simultaneous activation of Q and S cascades leads to
crosstalk inhibition, preventing augmentation of breathing activity.229,479,480 Because LTF
signaling mechanisms have not been so thoroughly scrutinized in mice, it is unknown
whether signaling pathways and crosstalk events are comparable across species.
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Therefore, we are uncertain whether the IH protocol utilized in our study activated the Q
pathway, S pathway, or both. Further studies examining how different IH strategies alter
signaling in mouse PMNs will allow for optimization of IH protocols in mice, thereby
ensuring that results are not confounded by crosstalk inhibition.
Another factor to be considered in the interpretation of our data and in future
studies is the influence of circadian rhythms on breathing control and plasticity. Humans
and rodents exhibit oscillations in body temperature, metabolism, and ventilation
throughout a 24-hour period.527 Diaphragmatic EMG recordings in our rats and mice
were performed at varying times throughout the day and therefore animals were not
consistently in the same part of the circadian cycle. In addition to potential impacts on
baseline respiratory activity in these animals, the circadian clock also regulates various
types of neuroplasticity, including respiratory motor plasticity in the form of LTF.528–530
Activity of the serotonergic raphe exhibits rhythmicity with the sleep/wake cycle and
PMNs themselves express circadian clock genes.530,531 Expression of 5-HT2 receptors,
BDNF, and TrkB also changes throughout the day, suggesting that animals exposed to IH
or episodic 5-HT at different times may have varied in their propensity for plasticity.530
Although disregarding time of day as a biological variable may have dampened the
treatment effect in our animals, it simultaneously increases clinical relevance because
studies investigating the neuroplastic response to IH in spinally injured individuals have
also not performed IH at the same time of day in every subject.41,142,381,403,404
Similar to influences of circadian rhythms, hormone cycles could also impact the
propensity for plasticity in our animals. The estrous cycles of the female rats and mice in
the current studies were not tracked to determine levels of progesterone or estrogen at the
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time of treatment or diaphragmatic EMG recording. Progesterone and estrogen receptors
are present in the CNS, including in the region of raphe serotonergic neurons. Here,
signaling of these hormones increases expression of tryptophan hydroxylase, the ratelimiting enzyme of 5-HT synthesis.532 Estrogen has also been shown to enhance levels of
5-HT2 receptors and progesterone functions as a breathing stimulant that has been used to
treat respiratory disorders.374,533,534 Interestingly, LTF in males requires conversion of
testosterone to estradiol and female LTF is more pronounced during stages of the estrus
cycle when 5-HT levels are high, emphasizing the importance of sex steroid hormones in
5-HT-depended spinal plasticity.372,373,535 Indeed, Dougherty et al. (2017) found that
induction of LTF is enhanced when circulating estradiol levels are highest. After
ovariectomy-induced abolishment of LTF, administration of exogenous estradiol is
sufficient to restore respiratory motor plasticity.536 Because we did not control for estrous
cycle phase in our female animals, differences in hormone and 5-HT levels may have
increases inter-animal variability and limited our ability to detect apoE isoformdependent effects.
Measuring the respiratory response to episodic 5-HT dosing and IH without
controlling for time of day and levels of sex hormones may contribute to variability in
our data and limit the interpretation thereof. However, this paradigm more accurately
reflects the condition of human subjects receiving therapeutic IH in clinical investigations
where conditions cannot be so tightly controlled. A limitation for the translational
applicability of the current studies is that homogenous animal populations and preclinical
injury models are not representative of human SCI. While the lateral C2 hemisection is a
reproducible injury that ensures the sparing of crossed phrenic fibers, it does not
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accurately model the diversity of SCIs seen in people. Human injuries are more closely
replicated by contusive injury models. While less reproducible, contusion injuries
realistically injure a variety of spinal fibers, including those of the CPP, which are likely
to be damaged in individuals who have experienced a cervical SCI. Unfortunately, this
means that C2 contusive injury models, unlike C2 hemisections, can lead to complete
loss of breathing function in animals, presenting ethical and logistical concerns. To most
accurately examine the potential for plasticity and recovery of function after cervical SCI,
previous work has shown the viability of contusing the cord caudal to our hemisection
injury at the C3/C4 level to preserve independent ventilation.210,537,538 Performing a
similar contusive injury in APOE mice would strengthen the clinical relevance of our
studies, an effort that is crucial to improving translation of therapeutic approaches for
SCI. Indeed, a recent review by Fouad et al. (2020) emphasizes the importance of
incorporating factors which cannot be controlled in the human population (sex, age,
genetics, injury pathology, etc,) into preclinical studies to increase the validity of animal
models, despite the risk of contributing to data variability.377
5.3 Future Directions
While the above data provides evidence that both APOE genotype and sex
influence spinally mediated plasticity in rodent models of LTF, our results have also
generated many more questions regarding the mechanisms behind these changes. Of
particular interest is our description of how humanized mice respond to IH, which differs
from the ventilatory response in rats. Future studies will contribute to our understanding
of the role of apoE isoforms in modulating the function and plasticity of neural circuitry,
including its interactions with various cell types in the spinal cord. Crucially, based on
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our findings, future investigations will examine ways to address apoE isoform-dependent
deficiencies in recovery of function and the response to SCI therapeutics. This will
enhance the potential for translation of therapeutic approaches that will better serve the
spinal cord injured population.

5.3.1

ApoE-astrocyte interactions in spinal and respiratory plasticity.

Astrocytes are the primary producers of apoE in the central nervous system.303
ApoE that is synthesized and lipidated by astrocytes is internalized by neurons upon
receptor binding, thereby providing cholesterol for growth and synaptogenesis.308 While
this uptake of apoE is crucial for the modulation of neuronal activity, apoE also impacts
the functioning of astrocytes themselves. During development, these cells play an
important role in synapse remodeling. Each astrocyte can ensheath thousands of synapses
and is sensitive to synaptic activity. In response to prolonged inactivity of excitatory or
inhibitory synapses, astrocytes can phagocytose and degrade synaptic material to refine
developing neural circuitry.323,539 Interestingly, during the first step of this process, the
function of phagocytic receptors are modulated by ABCA1, the transporter responsible
for astrocytic lipidation of apoE.540 The three isoforms of apoE uniquely interact with
ABCA1, leading to different lipidation profiles of brain apoE.395,397 In addition to
transporting lipids extracellularly, ABCA1 also translocates lipids within the membrane,
suggesting that the apoE isoforms may alter how ABCA1 controls local membrane
phospholipid composition and phagocytic receptor localization.540 During development,
this could lead to APOE allele-dependent differences in synaptic connectivity in the
breathing circuitry. Specifically, apoE4 impairs phagocytosis, which could explain the
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increased 5-HT+ fiber staining in the phrenic motor nucleus of 4 mice in the current
study (Chapter 3&4).324 Future studies investigating synaptic pruning mediated by in
spinal cord astrocytes from APOE targeted replacement mice would provide further
insights into the development of breathing circuitry and PMN synaptic connectivity in
intact, genetically distinct spinal cords.
Following SCI, phagocytosis is crucial to remove debris created by injuryinduced Wallerian degeneration, apoptosis, and demyelination. In the presence of apoE4,
reduced phagocytosis could allow lingering breakdown products to activate persistent
immune responses, aggravating secondary injury cascades and potentially leading to
auto-immunity in the CNS.541,542 Investigating phagocytic processes in spinal astrocytes
could reveal whether the APOE alleles alter the ability to remove inflammatory mediators
from the injury milieu in order to prevent tissue damage. Genotype-dependent differences
in this process could perhaps contribute to the neuroanatomical-functional paradox of
SCI described by Fouad et al. (2020).
In addition to phagocytic processes, the apoE isoforms also modulate astrocytic
metabolism. Astrocytes are not only important for exporting lipids for apoE-mediated
transport, they are also the primary CNS cell type performing -oxidation of fatty
acids.543 Indeed, cortical astrocytes contain higher levels of tricarboxylic acid (TCA)
cycle enzymes than neurons, contributing significantly to the 20% of energy produced in
the brain that is produced by fatty acid oxidation.501,544,545 The fatty acid octanoate easily
crosses the blood brain barrier and is responsible for much of the brain’s anaplerotic flux,
contributes to gluconeogenesis for glucose oxidation, and itself undergoes fatty acid
oxidation to provide energy.544 Due to the importance of metabolism of lipids such as
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octanoate as precursors to ATP synthesis in the CNS, APOE genotype-dependent effects
on lipid homeostasis have been of interest in the Alzheimer’s Disease literature. Human
subjects expressing the 4 allele perform -oxidation at a higher rate than those who lack
4.546,547 This hyperactivity and increased ATP synthesis is associated with cognitive
impairment, an effect aggravated by age.548,549 However, some studies also indicate that
the apoE4 protein leads to mitochondrial dysfunction and reduced ATP synthesis.506,550 In
addition to its influence on lipid metabolism, apoE4 has also been associated with
impaired glucose uptake and hypometabolism.502,551 Despite contradictory conclusions
about the impact of apoE isoforms on ATP production, these studies demonstrate that
apoE modulates flux through metabolic pathways in neurons and astrocytes.
Measuring bioenergetics of astrocytes found in the phrenic motor nucleus or
brainstem respiratory nuclei before and after SCI could reveal how apoE isoforms
influence metabolism to change breathing function. SCI induces to a significant loss of
mitochondrial function, leading to free radical production and exacerbating secondary
damage, which may be further intensified depending upon apoE isoform-dependent
impacts on mitochondria in the cervical spinal cord.11 Mitochondria could therefore be a
powerful therapeutic target for alleviating isoform-dependent deficits in metabolism to
enhance respiratory plasticity and the recovery of motor function after SCI.552,553
Astrocytes contribute to the neural control of breathing in both the intact and
injured state. In the rhythmic pre-Bötzinger complex (preBötC), astrocytes contribute to
central chemosensation. Ablation of brainstem astrocytes attenuates the HVR, similar to
the effect of inhibiting peripheral chemosensation of the carotid body, emphasizing the
importance of this central CO2 sensitivity. Detection of elevated pCO2 and low pH
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stimulates the release of vesicular ATP.554–556 Rhythmogenic preBötC neurons are
excited by ATP and respond to purinergic signaling by increasing inspiratory frequency,
thereby augmenting breathing activity upon astrocytic detection of low pH.557,558
At the level of the phrenic motor nucleus in the cervical spinal cord, astroglial
cells interdigitate with PMN, preventing direct communication between the motor neuron
dendrites.559 Within hours after a C2 hemisection, these astrocytic processes actively
retract, allowing the number of dendrodendritic appositions to increase, which is
accompanied by the formation of additional excitatory bulbospinal synaptic connections
on PMNs.560,561 This is thought to be a mechanism of plasticity contributing to activation
of the latent crossed phrenic pathway after cervical SCI. APOE genotype-dependent
influences on astrocytic metabolism or Ca2+ homeostasis may impact their ability to
undergo structural reorganization that prompts strengthening of PMN connectivity. ApoE
isoforms could also alter their capacity for sensing and transmitting information about
brainstem CO2 levels through ATP release, potentially attenuating the respiratory
response to hypoxia. Future studies investigating the impacts of apoE on astrocytes’
chemosensation function and capacity for remodeling in the breathing circuitry would
contribute to our understanding of how genetic diversity in the human population may
influence individuals’ capacity for respiratory plasticity in response to injury and
ventilatory challenge.

5.3.2

The inflammatory milieu after SCI: impact of APOE genotype

As discussed in Chapter 1.1.1, the inflammatory response to SCI is a dynamic
process that can paradoxically contribute to secondary injury, as well as neuroprotection
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and neural plasticity. Interestingly, compared to apoE3 animals, humanized E4 mice
express higher levels of pro-inflammatory cytokines after CNS insult, which is associated
with a decline in synaptic markers.562–565 Clinically, the importance of understanding how
apoE isoforms modulate CNS inflammatory responses is underscored by data showing
that anti-inflammatory drugs can reduce risk of Alzheimer’s, but only in individuals
expressing apoE4. This suggests that some detrimental effects of the E4 isoform may be
alleviated by targeting neuroinflammation.566
In addition to APOE genotype-dependent influences, inflammatory profiles after
neurotrauma are also modulated by factors such as age and sex. Genotype-dependent
effects in our data diverged according to sex, indicating that it will be important to
investigate the mechanism behind the observed sex differences. As previously discussed,
LTF itself is modulated by levels of sex hormones, especially estrogens, which are
required for LTF even in males.371–373,434 Following neurotrauma, the acute inflammatory
response to CNS injury also differs between males and females, with males exhibiting
greater microglial activation and peripheral myeloid cell infiltration.567,568 The divergent
response of immune cells is attributed to the immunosuppressive properties of estrogens.
These female sex hormones attenuate the release of pro-inflammatory cytokines,
upregulate anti-inflammatory cytokines, and enhance the T-cell response to clear myelin
debris and improve functional outcomes in females.569,570 In contrast to estrogens,
testosterone is associated with excitotoxicity and oxidative stress after SCI.571,572 Sex
hormones also impact mitochondrial function, as demonstrated by the role of estrogens in
maintaining metabolic homeostasis.573 Breakdown of metabolic processes after SCI
further exacerbates secondary injury cascades, suggesting an additional neuroprotective
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advantage provided by female sex hormones.11,574 Conclusions from these previous
studies indicate that APOE genotype and sex may interact to modulate the inflammatory
response to SCI, leading to differences in respiratory plasticity and functional recovery.
To determine how sex and APOE alters respiratory and spinal plasticity through
modulating inflammation, future studies will utilize a more recently characterized model
of plasticity that relies on the presence of inflammatory mediators. This form of
respiratory motor plasticity is known as inactivity-induced motor facilitation (iPMF) and
leads to augmentation of breathing activity similar to that observed during LTF.238
However, it differs from LTF in both its means of induction and the signaling pathways
that lead to its manifestation. While LTF develops in response to heightened inspiratory
drive elicited by exposure to hypoxia, iPMF results from a lack of respiratory drive. High
levels of mechanical ventilation removes the drive to breath, leading to a neural apnea.
When inspiratory drive is restored and phrenic nerve activity returns, compensatory
plasticity becomes evident in the form of enhanced phrenic activity.238 This facilitation is
dependent upon signaling of the TNF- cytokine, implicating the involvement of
inflammatory responses to apnea.237 Therefore, evaluating lesion characteristics and
iPMF in male and female mice expressing human APOE alleles will provide insight into
how sex and APOE genotype impact both immune activation and plasticity after SCI.
Astrocytes may also be key mediators in the induction of iPMF. Astrocytes are
known to respond to synaptic inactivity by releasing TNF-. This signaling stimulates
synaptic localization of glutamate receptors in neurons, thereby strengthening synaptic
connections.241 Although this mechanism is typically associated with gradual changes in
synaptic scaling, it could also contribute to more acute synaptic enhancements that lead to
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the development of iPMF34. Utilizing iPMF as a model of plasticity in intact and spinally
injured animals will allow for the investigation of how astrocytic activation and
signaling, glutamate receptor trafficking, and respiratory plasticity are impacted by APOE
genotype.

5.3.3

Considering age as a biological variable in studies of the apoE isoforms.

APOE rose to notoriety in the Alzheimer’s Disease field as the most significant
genetic risk factor for developing this disease. However, Alzheimer’s is a disease of
aging, and accordingly, age is the primary determinant of Alzheimer’s risk. Aging further
exacerbates apoE4- and sex-dependent effects on brain pathology and cognitive decline.
Indeed, previous data indicates that apoE4 may enhance synaptic plasticity in some brain
regions in young humanized APOE mice, but this effect disappears with age.447,448
Females are at greater risk of developing Alzheimer’s, as well as more pronounced E4dependent tau pathology and deficits in neural circuitry connectivity even before disease
onset.575,576 In aged mice expressing 4, estradiol replacement therapy enhances LTP,
improves memory, and reduces Alzheimer’s risk, indicating that female sex hormones are
neuroprotective against detrimental effects of apoE4 in the CNS.577,578
Together, evidence from the Alzheimer’s Disease literature underlines the
importance of considering both age and sex as biological variables when investigating the
influence of apoE isoforms on neural plasticity and CNS disease outcomes. This is
especially relevant for the current work because spinal cord injuries are becoming
increasingly common in older individuals. SCIs used to be a young person’s injury, with
an average age of 29 at the time of injury in the 1970’s. As people live longer and the
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population ages, the average age has increased, with falls emerging as a more prevalent
cause of injury in the older population. Although the average age of injury is currently
43, SCIs have a bimodal distribution, proving to be most common in young adults and
elderly individuals.2,579 In our study, APOE humanized mice were 3 months old
(representative of young adults) when they received an SCI. Future experiments using
aged animals would be valuable in determining whether age exaggerates genotype and
sex effects on spinal and respiratory plasticity in a manner agreeing with trends described
in the neurodegeneration literature.
SCI in older individuals elicits pathological responses that are distinct from those
found in young adults, activating secondary injury cascades that could determine the
extent of tissue damage, injury severity, and the response to therapeutic interventions.580–
583

Clinically, it is difficult to isolate age-dependent influences on outcomes after SCI due

to a variety of covariates including age-related comorbidities, lack of precise outcome
measures, and variability in injury characteristics.584 For example, lengths of stay in
rehabilitation facilities are reduced in the older SCI population because older individuals
are more likely to sustain incomplete lesions. Despite the higher prevalence of complete
injuries, younger people still recover independent walking after SCI more frequently than
elderly individuals.585 Due to the challenging nature of clinical SCI aging studies, it is
important to develop preclinical models that will accurately reflect the human condition,
including representation of genetic diversity, sex, and age. By utilizing humanized mouse
models, future studies will provide a means of studying how APOE genotype-dependent
injury pathology evolves with age.
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Previous studies have shown that mitochondrial function declines with age,
leading to increased production of reactive oxygen species.586 Some types of agedependent mitochondrial dysfunction are more pronounced in the spinal cord than in the
brain, suggesting that if apoE isoforms inhibit spinal plasticity through altering
mitochondrial bioenergetics, these detrimental effects will be exacerbated by aging.587
Accordingly, the E4 isoform is associated with heightened oxidative damage in the
Alzheimer’s brain, although E4’s impact on spinal cord ROS production remains
unexplored.588 However, in wild type animals, increased mitochondrial ROS production
after SCI activates spinal cord macrophages, which more commonly develop a proinflammatory phenotype in aged animals.580,581 Strikingly, even M2 macrophages, which
are typically considered protective in young animals, produce more ROS while
concurrently releasing fewer anti-inflammatory cytokines after SCI in older
animals.580,582 Reducing macrophage activation and ROS production enhances
neuroprotection and improves functional recovery after SCI in aged mice, presenting a
promising therapeutic target if apoE isoform-dependent effects on oxidative stress and
immune activation are discovered.583

5.3.4

Therapeutic interventions for overcoming apoE-induced constraints on breathing
plasticity
The emergence of APOE genotype-dependent impacts on respiratory and spinal

plasticity in our data raises a critical question: how do we ameliorate functional deficits
that result from an individual’s genetic make-up? While sex differences also contributed
to genotype effects in humanized mice, it is possible that sex effects could be ameliorated
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through hormone replacement. In the brain, estradiol replacement has shown efficacy in
enhancing plasticity to improve learning and memory in women who express the 4
allele.577,578 Estradiol may similarly restore spinal plasticity in 4 females, while also
acting as a neuroprotective antioxidant after SCI.589 Because previous data has also
indicated that excess hormone replacement can exacerbate brain aging in females who
lack the 4 allele, the effects of estradiol on CNS function and plasticity in the presence
of human APOE alleles must be further investigated to assess its potential risks and
benefits.590 Estrogen signaling is also important for plasticity in the male CNS, which is
emphasized by data showing that estradiol is required for LTF in male rats.372 Indeed,
estradiol treatment can improve functional outcomes in male rats that sustain a traumatic
brain or spinal cord injury, emphasizing the importance of testing its therapeutic potential
in both sexes of humanized APOE mice.370,591,592
Although modulating the levels of sex hormones may alleviate some of the
observed impacts of APOE genotype on the propensity for plasticity in our animals, a
more effective approach may be to directly target apoE proteins. To overcome barriers to
plasticity that arise from the unique structures and molecular interactions of each apoE
isoform in the brain, apoE mimetic peptides and structure correctors have been
developed. The amino acid substitutions at positions 112 and 158 lead to different
intramolecular interactions in apoE isoforms, altering their ability to interact with other
molecules.593 Protein levels of apoE in the CNS are also APOE allele-dependent, with
lower levels observed in individuals expressing 4.594 This suggests that interactions
between apoE and its receptors are altered in E4 animals due to both its structure and
decreased availability in the CNS.396 Mimetic peptides are derived from the receptor
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binding domain of apoE, which is common between the E2, E3, and E4 proteins. This
allows the peptides to interact with apoE receptors and mediate the neuroprotective and
anti-inflammatory actions of apoE3.595–597 Indeed, mimetic peptides have shown
preclinical efficacy in reducing CNS inflammation and improving functional outcomes
after SCI and TBI, in addition to protecting against Alzheimer’s pathology.598,599
Mimetic peptides increase apoE receptor activation by increasing levels of the
receptor binding domain that can effectively bind apoE receptors. In contrast, small
molecule structure correctors interact with the apoE4 protein itself in order to interrupt
intramolecular domain interactions that result from the Cys112Arg substitution. This
causes E4 to acquire a more open tertiary structure that resembles E2 or E3.600–602
Structure correctors prevent apoE4-induced impairment of neurite outgrowth and
mitochondrial dysfunction.601,603 Although this therapeutic strategy has not been tested in
the context of SCI, future exploration of the possibility of converting apoE4 into the
functional equivalent of apoE3 could reveal enhanced respiratory plasticity in spinally
injured E4 females.
While directly targeting the structure or molecular interactions of apoE isoforms
may alleviate their detrimental impacts on CNS function and plasticity, they could also
have unintended side effects in the periphery, where apoE is also highly expressed.317
Therefore, it may be more translationally relevant to target signaling pathways that are
altered by apoE isoforms in the brainstem and spinal cord where the neural circuitry that
mediates breathing is housed. One crucial signaling molecule that is modulated
differentially by the apoE isoforms in the CNS is calcium.604 Specifically, apoE4 disrupts
Ca2+ homeostasis by increasing influx of extracellular Ca2+. The resulting increase in
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intracellular calcium levels is associated with increased neuronal cell death.328 SCI also
stimulates Ca2+ influx, further exacerbating the disruption of Ca2+ homeostasis caused by
apoE4, which could explain why detrimental effects of E4 were only observed after
injury in our rat model.605
Mitochondria function as cellular Ca2+ regulators. Excessive Ca2+ can interrupt
mitochondrial bioenergetics and lead to opening of the mitochondrial permeability
transition pore, allowing for the release of reactive oxygen species and apoptotic
proteins.553,606 As previously discussed, oxidative damage stimulates inflammatory
processes and vice versa, demonstrating that loss of Ca2+ homeostasis has significant
implications for metabolism and secondary injury after SCI.
High calcium levels could also inhibit synaptic plasticity through activation of
calcineurin, a Ca2+-dependent phosphatase607. While some entry of Ca2+ through calciumpermeable AMPA receptors can be lead to beneficial enhancement of synaptic
transmission, excessive Ca2+ signaling can have the opposite effect.608 Increased Ca2+
influx in mice expressing 4 is associated with heightened activity of calcineurin, which
reduces the density of dendritic spines and inhibits synaptic plasticity, possibly through
dephosphorylation of glutamate receptors.329,609 Together, previous studies describing the
interactions of apoE isoforms, Ca2+ signaling, cytotoxity, and synaptic plasticity suggest
that restoring calcium homeostasis may alleviate E4-associated deficits in respiratory
plasticity before or after SCI. The therapeutic efficacy of approaches that prevent
mitochondrial permeability transition or which reduce calcineurin activity, such as
cyclosporine A or FK-506, respectively, should also be investigated for their ability to
promote neuroprotection and spinal plasticity in humanized APOE mice.610–613
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5.4 Conclusion
Together, our data shows that both sex and human APOE genotype determine the
propensity for spinal and respiratory plasticity. When considered in the context of the
neurotrauma and Alzheimer’s Disease literature, this general conclusion is not surprising,
although the specific genotype-dependent responses did not follow the patterns that have
previously been described in the brain. The 4 allele has previously been associated with
attenuated synaptic plasticity and worse functional outcomes in traumatic brain injury
and Alzheimer’s, effects which are more pronounced in females. However, the current
study demonstrated that both the 3 and 4 alleles can inhibit spinal and respiratory
plasticity, depending on sex and the injury status of the spinal cord. This is the first
investigation of how genetic diversity in the human population may alter the propensity
for spinal and respiratory plasticity, as well as the ability to respond to SCI therapeutics.
Our novel findings underscore the importance of considering biological variables in the
human SCI population when developing therapeutic approaches. While preclinical animal
models can never comprehensively represent the extent of diversity found in people,
utilizing multiple species, transgenic animals, both sexes, and clinically relevant injury
models can provide better predictors of the efficacy of treatment strategies in diverse
patient populations. Understanding how factors such as APOE genotype impact the
response to therapeutics that are entering clinical trials, including IH, will aid in the
development of personalized strategies to overcome barriers to functional recovery.
Fundamentally, our data will pave the way for improving translation of SCI therapeutics
in order to improve functional outcomes and quality of life for individuals living with
SCI.
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Figure 5.1 Graphic summarizing sex- and genotype-dependent differences in
the respiratory response to IH
Injured (left) and C2 hemisected (right) APOE targeted replacement mice displayed
unique responses to IH, which were dependent upon sex and APOE genotype. (Created
with BioRender.com)
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Figure 5.2 Graphic illustrating the signaling pathway that leads to
manifestation of LTF.
Numbers indicate the molecules that were quantified in APOE targeted replacement mice
or apoE-treated rats. The panel on the bottom right summarizes whether there were apoE
isoform-dependent differences in the levels of these molecules: 1-2) Injured APOE mice
displayed genotype-dependent differences in the amount of 5-HT density of the PNN
around phrenic motor neurons. 3) ApoE isoforms did not influence the levels of BDNF in
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apoE-treated rats or APOE mice. 4) ApoE4 was associated with a decline in synaptic
NMDA receptors in C2 hemisected rats. (Created with BioRender.com)
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APPENDICES
Appendix 1. List of Abbreviations:
ABCA1 = ATP binding cassette A1
AD = Autonomic dysreflexia
AIS = American Spinal Injury Association Impairment Scale
AMPA = -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ANOVA = Analysis of variance
ApoE = Apolipoprotein E
ATP = Adenosine triphosphate
BDNF = Brain derived neurotrophic factor
CNS = Central nervous system
CPP = Crossed phrenic pathway
CSPG = Chondroitin sulfate proteoglycan
DP = Diaphragm pacing
ELISA = Enzyme-linked immunosorbent assay
GDNF = Glial cell-derived neurotrophic factor
HIV = Human immunodeficiency virus
HVR = Hypoxic ventilatory response
LDLR = Low density lipoprotein receptor
LTF = Long term facilitation
LTP = Long term potentiation
MP = Methylprednisolone
MRI = Magnetic resonance imaging
NADPH = Nicotinamide adenine dinucleotide phosphate
NIH = National Institutes of Health
NLI = Neurological level of injury
NMDA = N-methyl-D-aspartic acid
NMDA = NMDA receptor
NSAID = Nonsteroidal anti-inflammatory drug
NTS = Nucleus tractus solitarius
OCT = Optimal cutting temperature
PBS = Phosphate buffered saline
PFA = Paraformaldehyde
PMN = Phrenic motor neuron
PNN = Perineuronal net
RMANOVA = Repeated measures ANOVA
ROI = Region of interest
SCI = Spinal cord injury
TBI = Traumatic brain injury
TMS = Transcranial magnetic stimulation
VLDL = Very low density lipoprotein
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Appendix 2. Copyright for published data

Data from Chapter 3 has been published in eNeuro. The following is their statement
regarding use and reproduction of published material:
“This is an open-access article distributed under the terms of the Creative Commons
Attribution 4.0 International license, which permits unrestricted use, distribution and
reproduction in any medium provided that the original work is properly attributed.”
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